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Figure 1: Scheme of blood cell production and the action of hematopoietic 
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1984) 
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el-usive 
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1.1. Hematopoiesis 
The peripheral blood contains a number of cell types with highly 
specialized functions, i.e., red blood cells, platelets, lymphocytes, 
monocytes and granulocytes. Blood cells have a limited life span and need 
to be produced continuously. Hematopoietic stem cells, localized in the 
bone marrow, guarantee the permanent supply of functional blood cells. 
Hematopoiesis is regulated by a number of polypeptide hormones which act at 
various stages of differentiation. The hematopoietic compartment can be 
subdivided in a) pluripotent stem cells with self-renewal capacity, b) 
progenitor cells committed to differentiation and c) functional end cells. 
In mice, pluripotent stem cells can be assayed by injecting lethally ir-
radiated animals with bane marrow cells and counting of spleen nodules that 
develop 8-12 days later (Till and McCulloch, 1961). Human as well as murine 
progenitor cells (except those of the lymphoid lineages) can be studied 
conveniently in vitro using semi-solid colony culture systems. A simplified 
scheme of hematopoietic cell differentiation is shown in fig. 1. The stimu-
latory hormone like factors involved in this process are indicated as well. 
1.2. Leukemia 
Leukemias are neoplastic diseases which are characterized by the 
accumulation of hematopoietic cells. In several types of leukemia (with the 
notable exception of chronic myeloid leukemia) there is an excess of a 
homogeneous morphological cell type that closely resembles that of a normal 
cell at a given stage of differentiation. Thus, far example, leukemias may 
either present as well differentiated lymphocytic or monocytic cells, as 
half-way differentiated cells (e.g., lymphoblastic, promyelocytic, mega-
karyoblastic, erythroblastic), or, instead, as undifferentiated cells that 
share properties with the hematopoietic stem and progenitor cells. In 
contrast, in chronic myeloid leukemia (CML), the neoplastic cells cover a 
broad range of differentiation stages of myelomonacytic, erythroid, mega-
karyocytic and B lymphocytic (fialkow et al., 1977; 1978), and rarely also 
ofT lymphocytic lineages (Griffin et al., 1983). Evidence is multifold to 
indicate that leukemic cell proliferation is a clonal event, i.e., orig-
inating from one transformed cell. It is not certain whether the differen-
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tiation stage of the leukemia in general reflects that of the originally 
transformed cell, or rather represents an accumulation of more 
differentiated cells descending from precursors (fig. 2). Clearly, in CML, 
the latter situation exists. 
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1.3. Growth factors in neoplasia 
Figur>e 2: Two modeLs of Leukemic ceZL 
diffe~entiation. P~ogeny of 
the leukemic: stem cells 
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that of the Leukemic stem 
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An important objective of cancer research is to understand how neo-
plastic cells escape the normal regulatory mechanisms of growth. One hy-
pothesis is that abnormalities in response to stimulatory (hormone-like) 
factors result in the unbalanced production of neoplastic cells. Three 
abnormal patterns of growth stimulation of neoplastic cells have been 
postulated. Firstly, as a result of neoplastic transformation,tumour cells 
may have acquired the ability of autostimulation by producing growth fac-
tors themselves (i.e., autocrine stimulation) (Sporn and Todaro, 1980). 
Evidence in favour of an autocrine mechanism of tumour growth was obtained 
from studying the expression of a viral oncogene (transforming gene of a 
tumour-inducing virus) derived from simian sarcoma virus (SSV), a virus 
causing sarcomas and gliomas in experimental animals. The putative trans-
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forming protein (p28v-sis) of SSV structurally resembles platelet derived 
growth factor (PDGF) (Waterfield et al., 1983), a polypeptide hormone that 
stimulates the growth of fibroblasts. Moreover, antibodies against PDGF 
inhibit the growth of SSV-transformed human fibroblasts in culture. These 
findings support the notion that autocrine stimulation, mediated by a 
PDGF -like factor, contributes to the growth of the SSV-transformed cells 
(Johnsson et al., 1985). 
Secondly, oncogenic tranformation may result in the aberrant ex-
pression of membrane receptors for growth factors. This possibility is 
illustrated by the finding that the oncogene V-erb B is homologous to the 
gene encoding for epidermal growth factor receptor (Downward et al., 1984). 
Finally, it is possible that following oncogenic transformation the 
cells become completely independent on external growth regulation. This may 
result from the autonomous activation of intracellular events leading to 
proliferation. for example, the product of the src oncogene, a protein 
tyrosine kinase, may directly trigger the intracellular effects of epider-
mal growth factor (Collett et al., 1978); Levinson et al., 1978; Ushiro et 
al., 1980). Growth factor independent cellular proliferation occurs also in 
human tumour cells that contain products of the res oncogenes (i.e., guano-
sine diphosphate and guanosine triphosphate binding proteins) (Weinberg, 
1984, 1985). 
Similar mechanisms may be operational in the neoplastic transform-
ation of hematopoietic cells. In mice, leukemic cell growth has been as-
sociated with alterations in the normal response mechanism to external 
growth stimuli, i.e.: 
l) Infection of murine myeloid cells with Abelson - Mu LV renders the cells 
growth factor (IL3) independent (Pierce et al., 1985; Cook et al., 
1985). 
2) Recombinant murine retroviruses expressing v-myc oncogenes abrogate 
factor requirements of IL2 and IL3 dependent cell lines (Rapp et al., 
1985); 
3) The constitutive synthesis of IL3 by the murine leukemia cell line 
WEHI-38 is due to the presence of a retroviral insertion close to the 
promotor region of the IL3 gene (Ymer et al., 1985); 
4) The product of the oncogene fms is closely related (perhaps identical) 
to the cell surface receptor of the murine monocyte/macrophage colony 
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stimulating factor CSF-1 (Sherr et al., 1965; Sariban et al., 1985). 
In man, the HTLV induced T -cell neoplasms provide as yet the only 
example of altered growth factor response in leukemia. HTLV-1 induces the 
constitutive expression of membrane receptors and renders the cells inde-
pendent on activation by antigen for proliferation. Eventually, the HTLV-1 
transformed cells may also lose dependence on IL2 ( Wong-Staal and Gallo, 
1965). 
The examples mentioned above all deal with transformation by viruses. 
It is not clear how these findings relate to the growth characteristics of 
leukemias with a non-viral etiology. 
!.4. In vitro models for neoplastic cell growth 
To assess the in vitro response of malignant cells to growth and 
differentiation stimuli most investigators have utilized continuous cul-
tures of immortalized tumour cells (cell lines). Rarely, these approaches 
have dealt with primary tumour material of individual patients. The advan-
tages of cell lines are their relatively easy handling in culture and their 
supply of cells in unlimited numbers. However, the growth characteristics 
of a cell line are far from representative of the original neoplasm from 
which it was derived, as fresh tumours only rarely develop immortalized 
cells in culture. Moreover, as a result of prolonged in vitro maintenance, 
initial requirements for external stimuli may have altered in cell lines. 
Because of the highly 11 artificial" growth features of cell lines their 
contribution to our understanding of tumour growth is restricted. 
Fresh tumour specimens are often difficult to obtain and provide 
limited cell numbers. Nonetheless, there is a great interest in the devel-
opment of convenient culture assays for primary tumour specimens as these 
directly reflect growth factor responses of cells following their malignant 
transformation in the host. 
1.5. Classification and phenotyping of lymphoid malignancies 
Different pathological subtypes of lymphoid malignancy are associated 
with certain stages of lymphoid maturation. Utilizing immunologic markers 
(in combination with morphological analysis) a precise definition of human 
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leukocyte differentiation stages and their neoplastic counterparts is 
possible. This approach has benefited immensely from the development of 
monoclonal antibody (MCA) technology (Kohler and Milstein, 1975). 
A scheme of lymphoid differentiation proposed on the basis of immunologic 
marker analysis is depicted in Figure 3. In figures 4, 5 and 6 the relati-
onship between immunophenotypes and the lymphoid malignancies relevant to 
the experimental work described in this thesis is shown in detail. 
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1.6.1. In vitro culture of T lymphocytes 
The existence of a soluble factor involved in the proliferation of T 
cells emerged from the work of Morgan and colleagues. They noted that T 
lymphocytes can be cultured in vitro for months under the stimulatory 
influence of supernatants conditioned by lectin-activated leukocytes 
(Morgan, Ruscetti and Gallo, 1976). This factor, according to its function, 
was originally designated as T cell growth factor but later it was named, 
more neutrally, interleukin 2 (IL2). IL2 is released by activated normal T 
lymphocytes, in particular by those belonging to the T helper subset (Robb, 
1984). In addition, several T lymphocytic leukemia cell lines were found to 
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synthesize IL2, sometimes in excessive amounts (Gillis and Watson, 1980). 
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1.6.2. Biochemistry of interleukin 2 
Purification of IL2 from crude culture supernatants revealed some of 
its biochemical characteristics. Human IL2 has been identified as a glyco-
protein with a variable molecular weight (ranging from 17,000 to 22,000 D) 
(Robb, 1984). This variability can be ascribed to differences in glyco-
sylation of the ll2 molecule. Following treatment with neuraminidase and 
glycosidase to remove carbohydrate components, IL2 has a mere molecular 
weight of about 15,000 D and an isoelectric point of 8.2 (Robb and Smith, 
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1981). Removal of the carbohyd~ates exe~ts no effect on the in vitro bio-
logical activity of IL2 (Robb, 1982). 
The gene for IL2 is located on human chromosome 4 q (Seigel et al., 
1983). Molecular cloning of human IL2 eDNA revealed that this DNA encodes 
for a polypeptide of 153 amino acids of which the first 20 starting from 
the N-terminal region of the polypeptide presumably function as a signal 
peptide, to be cut off when "mature" secretable IL2 is produced (Taniguchi 
et al., 1983; Clark et al., 1984). Expression of IL2 eDNA in monkey COS 
cells or in E. coli bacteria has led to the availability of large amounts 
of highly purified (recombinant) IL2 (Taniguchi et al., 1983; Devos eta!., 
1983; Rosenberg et al., 1984). 
1.6.3. Characterization of membrane receptors for interleukin 2 
At an early stage, it was already recognised that IL2 exerts its 
effect on T cells by interaction with receptor molecules present on the 
cell membranes (Bannard et al., 1979; Ruscetti and Gallo, 1981). Studies by 
Robb et a!. with radiolabeled material then disclosed that IL2 acts as a 
hormone as regards affinity, specificity and saturability of its binding to 
T cells (Robb et al., 1981). Robb et a!. estimated the number of receptor 
sites per normal activated T cell at 5,000 - 15,000. 
Uchiyama et a!. prepared the monoclonal antibody anti-Tee directed 
against the human IL2 membrane receptor. The antibody blocks the interac-
tion between growth factor and its receptor (Uchiyama et al., 1981; Leonard 
et a!., 1982). Using this monoclonal antibody, the human IL2 receptor was 
further characterized and identified as a glycoprotein with a molecular 
weight of 47,000- 53,000 (Leonard et al., 1982). Later, cloning of an IL2 
receptor eDNA and its expression in monkey - COS cells led to the biochemi-
cal definition of the receptor structure (Cosman et al., 1984). The human 
IL2 receptor gene is located on chromosome 10 (Leonard et al., 1985). 
Studies with the anti-Tee monoclonal antibody in combination with radio-
labeled IL2 affinity experiments revealed the existence of two distinct 
receptor classes, one with high and one with low affinity for IL2, similar 
to what has been found for the receptors of epidermal growth factor and 
nerve growth factor (Robb and Greene, 1983; Kawamoto et al., 1983; Buxser 
et al., 1983). Normal T blasts stimulated with PHA for 72 hrs were found to 
-19-
express approximately 3,500 high affinity (Kd 3.6 x lo-12M) and 25,000 low 
affinity (Kd 28,300 x l0-12M) receptors per cell (Robb et al., 1984). 
Molecular heterogeneity of IL2 receptors is probably caused at the post-
translational level, as examination of several T cell types with the eDNA 
clone does not provide indications for the existence of more than one 
structural IL2 receptor gene (Leonard et al., 1984). 
It is at present unknown whether or how law-affinity IL2 receptors 
are involved in the physiological response to the growth factor. IL2 con-
centrations, assumed to be physiological in vivo, would occupy less than 1% 
of the low-affinity sites, whereas the high-affinity sites would be satu-
rated (Robb et a!., 1984). This argues against a direct participation of 
the low affinity sites in the IL2 response. On the other hand, it cannot be 
excluded that in close cellular interaction with IL2-producing cells, the 
local IL2 concentrations would be excessively high, leading to an increased 
occupation of the low affinity receptors (Robb et a!., 1984). It is also 
possible that the low affinity sites reflect a pool of non-functional 
11 precursor11 components awaiting their biochemical modification to become 
highly affinitive (Robb et al., 1984). 
1.6.4. Physiological roles of interleukin 2 in the immune response 
Over the years, it has become clear that IL2 is not only a simple 
proliferation factor for T cells, but that the factor has a central role in 
the immune response (Fig. 7). IL2 induces the secretion by T cells of other 
lymphokines, thereby indirectly influencing a variety of immune functions. 
One of these is gamma interferon (IFN)'), a multi functional factor that, 
e.g., induces macrophage activation and antibody secretion by 8 cells (Pace 
et el., 1983; Sidman et a!., 1984; Leibson et el., 1984). 
Other lymphokines produced by T cells under the direct regulatory influence 
of IL2 include so called 8 cell growth- end differentiation factors 
(Leanderson et al., 1982; Howard et al., 1983; Inaba eta!., 1983). 
A number of authors have recently published data indicating that IL2 
directly regulates the proliferation of B cells. Functional IL2 membrane 
receptors were detected on human 8 lymphocytes activated with Staphylo-
coccus aureus strain Cowan I (SAC) and SAC activated B cells proliferated 
in response to pure IL2 (Tsuda et al., 1984; Mingari et al., 1984; Prakash 
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et al., 1985; Nakagawa et al., 1985; Zubler et al., 1984; Muraguchi et al., 
1965). ILZ receptors on the activated B lymphocytes (B blasts) are struc-
turally identical to those present on activated T cells (Mingari et a!.·, 
1965; Lowenthal et al., 1965; Boyd et al., 1985). The total amount of ILZ 
receptors on B blast cells, including high- and low-affinity types, is 
approximately half of that on activated T cells (Lowenthal et a!., 1985). 
IL2 receptors an B and T blasts have identical binding-characteristics and 
show the same, i.e., 1 : 10, ratio of high- versus low-affinity receptor 
numbers (Lowenthal et al., 1965). 
Differentiation of B cells (i.e., stimulation of immunoglobulin 
secretion) occurs at very high concentrations of IL2, i.e., above 100 units 
.ml-1, with an optimal response at 104 units .ml-l (Ralph et al, 1984). 
This could suggest that a low-affinity interaction between receptor and 
growth factor is involved in the induction of the differentiation of l:i 
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cells by IL2. Blacking of the IL2 receptors on SAC activated human B cells 
by the monoclonal antibody anti-Tee resulted in a 90 per cent inhibition of 
Ig secretion by these cells (Mittler et al., 1985). 
How the effect of IL2 on B cell proliferation and maturation relates 
to the activities of other materials such as B cell growth factors (BCGF's) 
and 8 cell differentiation factors (BCDF), still awaits clarification. 
Studies in this direction will greatly benefit from the availability of 
cytokine preparations obtained by recombinant techniques and of antibodies 
reactive with the receptors for these cytokines. 
1.6.5. Regulation of interleukin 2 production and interleukin 2 response 
from limiting dilution culture experiments in which large numbers of 
T lymphocytes are expanded from a single clonogenic cell, it has been 
estimated that approximately 60 per cent of all T lymphocytes can produce 
IL2 and do not require exogenous IL2 for proliferation (Wee and Bach, 19~4; 
Gullberg and Smith, 1986). This has led to the notion that the majority of 
T lymphocytes are self-perpetuating in their IL2 driven proliferative 
response (Meuer et al., 1984). 
The physiological signal far IL2 production by T lymphocytes is 
activation through the simultaneous recognition of foreign antigen and 
major histocompatibility (MHC) antigens an the surface of macrophages which 
present the foreign antigen (figure 8). In this interaction, the T-cell 
receptor complex is directly involved (review; Acuto and Reinherz, 1985). 
Subsequently, the T lymphocytes release factors (/ IfN; MAf) that activate 
macrophages. The activated macrophages enhance IL2 production by the T 
cells via elaboration of the lymphokine interleukin 1 (ILl). Activated 
macrophages also produce prostaglandins, which can, dependent on concen-
tration, eventually down-regulate IL2 production by the activated T cells. 
Efrat and colleagues have obtained evidence for another regulation 
mechanism for IL2 production. They assume the existence of labi~e as yet 
unidentified protein(s) with an inhibitory effect on the formation of 
biologically active IL2 mRNA. Accordingly, inhibition of synthesis of these 
putative repressor proteins by blocking of translation (with the drug 
cycloheximide) leads to superinduction of IL2 mRNA (Efrat et al., 1984; 
Efrat and Kaempfer, 1984). 
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The capacity of T and B cells to respond to IL2 is strictly dependent 
on the expression of membrane receptors with high affinity for the growth 
factor (1.7.2. and 1.7.3.). Normally, expression of IL2 membrane receptors 
occurs after activation of the cells. In addition to the mechanism de-
scribed above for antigen activation, T lymphocytes can be directly acti-
vated in vitro by lectins, e.g., PHA or Concanavalin A (Con A), the phorbol 
ester !2-0-tetra decanoyl phorbol-13-acetate (TPA) or monoclonal antibodies 
(anti-T3) reactive with the T-cell receptor complex. Likewise, B lympho-
cytes express IL2 receptor antigens following activation by lectins (e.g., 
pokeweed mitogen), TPA or anti-lg antibodies (Fig. 7). 
Little is known about the regulation of IL2 receptor expression and 
function after activation. It has been suggested that IL2 itself is in-
volved in this process and that IL2 augments transcription of the IL2 
receptor gene (Wakasugi et al., 1985; Welte et al., 1984, Smith and 
Cantrell, 1985; Depper et al., 1985). Experiments designed to investigate 
the intracellular mechanisms by which IL2/IL2 receptor interaction promotes 
the proliferation of T cells have indicated that protein kinase C is in-
volved in intracellular signal transduction (Farrar and Anderson, 1985). 
IL 1 
T IL2 .. _ 
~ macrophage 
PGEt 
PGE2 
........ '.'f..' ..... ~ IL2 
T-lymphocyte 
Figu~e 8: PhysioZogioa.Z ~eguZation of IL2 p~oduction I adapted f~om 
Sch~eie~, 1984) 
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1.7. Introduction to the experimental work 
The experimental work presented in this thesis deals with the analy-
sis of the in vitro growth and differentiation characteristics of acute 
lymphoblastic leukemia ( T end non-T), T cell non Hodgkin's lymphoma and B 
cell chronic lymphocytic leukemia in primary cell culture. For these 
studies, reproducible cell culture assays for the growth of these lymphoid 
tumours first needed to be developed. Considerable attention has been paid 
to the response of these neoplasms to the polypeptide hormone inter-
leukin 2. The experiments described in chapters 2 and 3 deal with the in 
vitro colony growth of non-T acute lymphoblastic leukemia (ALL) and with 
the effect of interleukin 2 on these cells in combination with a factor 
elaborated by feeder leukocytes. The requirements of the ALL cells for 
activation with a lectin (PHA) or a phorbol ester (TPA) for colony growth 
have also been investigated. To assess whether non-T ALL cells differen-
tiate toward more mature cell types during in vitro growth, the morphologi-
cal and immunological phenotypes of colony cells were determined. To com-
pare the differentiation capacities of ALL with those of acute leukemia of 
the myeloid differentiation lineage (AML) the abilities of AML to produce 
more mature progeny under comparable in vitro conditions were studied 
(chapter 4). Chapter 5 deals with an analysis of growth requirements of 
8 cell type chronic lymphocytic leukemia (CLL) in colony culture and 
specifically with the role of IL2 in the proliferation of B CLL cells. This 
analysis is extended in chapter 6, in which the results of binding exper-
iments with radiolabeled IL2 are presented. These experiments were carried 
out to determine numbers and affinity of IL2 receptors expressed by B CLL 
cells- In addition, the hypothesis that certain CLL cells might be capable 
of self-stimulation via the autocrine production of IL2 is approached in 
this chapter. In chapter 7, culture characteristics of acute lymphoblastic 
leukemia and non Hodgkin's lymphoma (NHL) of the T cell differentiation 
lineage are presented. The studies described in chapter 8 are our first 
attempts toward the characterization of membrane phenotypes and growth 
requirements of normal T -lymphocytic precursor cells in the human bone 
marrow. For this purpose, we applied the human long-term bone marrow cul-
ture system. Knowledge of the growth end differentiation features of normal 
lymphoid progenitors is essential for our understanding of whether or how 
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the leukemic counter parts of these cells reflect a modified response to 
growth and differentiation stimuli. In chapter 9 a brief overview of our 
current understanding of the role of IL2 in the proliferation of neoplastic 
T and B cells is presented. Moreover, the results of this thesis are dis-
cussed in this chapter with reference to their implications for our insight 
into the control of proliferation and differentiation of the different 
types of lymphoid leukemia/lymphoma. 
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Common and Pre-8 Acute Lymphoblastic Leukemia Cells Express Interleukin 2 
Receptors, and Interleukin 2 Stimulates In Vitro Colony Formation 
By lvo Touw, Ruud Delwel, Reinder Bolhuis, George van Zanen, and Bob LOwenberg 
The role of interleukin 2 !IL 2) as a possible regulator of in 
vitro proliferation end differentiation of non-T acute lym-
phoblastic leukemia (ALL) cells was investigated. For this 
purpose. leukemic cells from the blood or bone marrow of 
eight untreated patients with common or pre-8 ALL were 
analyzed using the anti-Tac monoclonal antibody (reactive 
with the IL 2 receptor) in indirect immunofluorescence. 
The receptors for IL 2, which were initially absent from tt\e 
cell surface. were induced on high percentages of the ALL 
cells after the in vitro exposure to the lectin phytohemag-
glutinin or the phorbol ester 12-0-tetradecanoylphorbol-
1 3-acetate in six patients, suggesting that the cells had 
become sensitive toIL 2. In colony cultures to which feeder 
leukocytes and IL 2 had been added. colony growth was 
obtained in five of eight cases. Whereas the cells from one 
patient formed colonies in the absence of exogenous 
stimuli, the cells from others were dependent on the 
addition of feeder leukocytes plus IL 2. In the letter cases, 
I NTERLEUKIN 2 (IL 2) is the soluble factor responsible for the in vitro proliferation of antigen or lectin-activated 
T lymphocytes.' Prior activation is required to induce recep-
tors for IL 2 on the cell surface membrane. The monoclonal 
antibody anti-Tac specifically binds to these receptors (also 
called Tac antigens).2·l 
Recently. activated human B cells have also been demon-
strated to express IL 2 receptors. and results from lH-
thymidine incorporation assays indicate that a subpopulation 
of these cells proliferates in the presence of immunopurified 
IL 2 without the addition of other factors.4 In addition. it has 
been shown that m vitro colony formation by B chronic 
lymphocytic leukemia cells is induced by IL 2.~ 
Here we present our first attempts directed toward the 
characterization of factors required for the in vitro colony 
formation by neoplastic 8 cell progenitors, ie, common and 
pre-8 acute lymphoblastic leukemia (ALL) cells. The find-
ings suggest that, in certain cases, IL 2 may be involved in 
the proliferation of these leukemias. ALL cells initially lack 
but express IL 2 receptors following exposure to I2-0-
tetradecanoylphorbol-l3-acetate (TPA) or to phytohemag-
glutinin (PHA). The addition of IL 2 to colony cultures can 
stimulate ALL colony formation. 
From the Dr Daniel den Hoed Cancer Center and Rorterdam 
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feeder leukocytes alone. releasing some IL 2. stimulated 
growth suboptimally et different cell concentrations. Their 
stimulative effect was significantly enhanced when leuko-
cyte-derived IL 2 or pure recombinant IL 2 was supple-
mented. Alone. IL 2 (up to 500 U/mL) did not support 
colony formation. Apparently. IL 2 and feeder leukocytes 
ere both required for the induction of colonies in these 
cases of Al.L. From cell sorting of fluorescent anti-common 
ALL antigen (CALLA) stained cells it appeared that colonies 
descended from cells with high as well es low or negative 
CALLA expression. lmmunophenotyping demonstrated the 
presence of the original leukemia markers on colony cells. 
but was not indicative of maturation of ALL toward more 
differentiated 8 cells. We suggest that 11. 2 can stimulate 
the in vitro proliferation of certain neoplastic 8 lymphocyte 
progenitors. 
o 1985 by Grunt~ & Srrsrton. Inc. 
MATERIALS AND METHODS 
Patients ami separation of leukemia cells. E1ght untreated 
patientS with ALL were studied. The \c'ukemic cells were ci::J.ssified 
as common or pre·B ALL cells on the basis of immunologic 
phenotyping6 (Table 1). Lcuke'TliC cells were isolated from periph-
eral blood or bone m;;~rrow following Ficoll-lsopaquc (Nygaard. 
Oslo) separation.' 
Contaminating E rosette-positive lymphocytes were then removed 
from the leukem1c cell fractions by roscmng with 2-aminoethyhso-
thiouronium bromide (AET)-treated sheep erythrocytes and Ficoll· 
lsopaque sedimentation accordmg to Madsen et al.3 
Immunofluorescence studies Surface antigens on fresh and 
cultured cells were ass;:ayed by means of indirect immunofluores· 
cence using murine monoclon::~l antibodies (MoAb) and goat anti· 
mouse immunoglobulin (Ig) coupled with fluorescein isothiocyanate 
(GAM/FITC, Nordic. Tilburg. The Netherlands). Details on the 
labeling procedures have been g1ven clsewhere.9 Cells were evalu· 
ated for specific fluorescence With either a Zeiss fluorescence 
microscope {200 cells per slide were scored) or a fluorescence-
activated cell sorter (FACS 440, Becton Dickinson, Sunnyvale. 
Ca!il). Control incubauons with GAM/FITC alone. included in 
each test to check for nonspecific binding of the conjugate, were 
neg<~tive in all experiment5. Cell surface membrane-associated 
immunoglobulins (slg) were ass<:~ycd as described.1° Cytoplasmic 
immunoglobulin M heavy chains (Cy ~)were stained in cytoccntri-
fuged cells (Shandon, Chesh1re. England) with 1:25 diluted goat 
anti-hum::~n lg M/FlTC (GAHulgM/FITC, NordicV 1 Two 
hundred cells per slide were examined with a fluorescence micro· 
scope. Control stainings with goat anti-human lgG/FITC and goat 
anti-human 11: or A light cham/FITC were neg<~tivc. 
Dual stainings: after the first MoAb (nnti-Tac; IgG2a) treatment 
and labeling with 1:40 diluted goat anti-mouse lgG2a coupled to 
tetramethylrhodaminc isothiocyanate (GAM/IgG2a/TRITC; Nor-
dic), the cells were spun on a microscope slide and fixed for ten 
minutes at -20 °C in 5% volfvol acetic acid in methanol. After three 
washings with phosphate-bufl'ered saline (PBS), they were further 
treated with either 1:10 diluted MoAb VIL AI (lgM) and 1:40 
diluted goat o.nti·mouse lgM FITC conjugate (GAM/lgM/FITC) 
Table 1. IL 2 Recaptor Expreuion in Eight Case• of ALL 
L..,kemlt Phenotype IL 2 A9CII?tor E~pressJon 
?alieni (P..,.Cflnl8ge ol Pot1illve Celle)t (Parc:enuge ol PosJd~~tt Celle)t 
Aoo Belo;ooe 18 h PHA 1BhTPA 
"· '"' 
Source• 
""-"' '" 
BA, intube~lon ~~~don-;- lncuba!.lon:t 
1 61 P6 60 50 62 0 53 43 
2 2 PB B3 B6 67 0 57 62 
3 17 BM 76 45 70 0 3B 51 
4 7 6M 75 75 76 0 24 26 
3 PB 60 0 95 0 63 64 
6 16 6M 60 0 27 0 0 0 
7 43 PB 53 0 74 0 62 65 
6 36 BM 91 0 99 0 0 0 
Blast cell phenotyping also included the T ~II mar~&rs T3, T1 1, and WT1. Thes.a were rtegative in all cases. Patients No. 1 through 4, pre-B ALL; 
patlants No. 5 through 6. eommon ALL. 
"Leukemic calls wee Isolated from peripheral blood (PB) or bona marrow (BM). 
t0atermin&d by fluOI'aSCenoe microscopy. 
=Details ars given in Materials and Methods. 
or GAHulgM/FITC for the simultanc:<~us vLsualimtion of JL 
receptors and common ALL antigens or IL 2 receptors and cytoplas-
miC IgM heavy chains, respecuvcly. 
Control stainings (VIL AI [IgM] + GAMJigG2ajTRITC, anti-
T::~c [IgG2a] + GAMjlgM/FITC, GAM conjugates without 
MoAb pretreatment) were all negative. 
Monoclonal antibodies. The follow1ng MoAb were used in this 
study (in parentheses arc the diluuons used in indirect immunofluo-
rescence); {I) anti-Tac {1:1.000), anti-IL 2 surface membrane 
recepto~ {Or T. Uchiyama, Kyoto, Japan); {2) VTL AI {1:100), 
antl·common ALL antigen (CALLA) 1l (Dr W. Knapp. Vtenna); (3) 
BA2 (1:250), anti-pre-B cell differentiation antigen13 (Hybritech, 
San 01ego); (4) wn (1:100). anti-pan-T cell antigen14 (Dr W.J.M. 
Tall.. NiJmegen. The Netherlands); (5) OKT!l (1:40). ant1-sheep 
erythrocyte rosette receptor (Ortho Pho.rmaceutical Corp. Ran tan. 
NJ): (6) OKT3 (1:40), anti-mature thymocyte and T lymphocyte 
antigen (Onho Pharmaceutical Corp); and (7) S4-7 (1:500). ::~nu­
myeloblnst- granulocyte and monocyte antigen" (Dr G. Rovera, 
Philadelphia). 
Colony culture. Colony culture experiments were performed 
according to a previously described culture system with PHA and 
1rradiated (2.500 rad) human peripheral blood leukocytes a~ stimu-
lators.1' This system supJXlrts the formation of normal T lymphocyte 
as well as myeloid leukemia colonies16·17: 2 x 10' cells were plated in 
each culture dish. On certatn occasions, modifications were made to 
the system: (I) replacement of PHA (reagent grade; Wellcome, 
Dartford. England) by 100 ng of the phorbol ester TPA (Sigma 
Chemical Corp. St Uluis): (2) add1tion of IL 2; and (3) omission of 
feeder leukocytes. Two sources of IL 2 were used: 15.000 mol wt 
fractions of gel-filtered (Ultrogcl AcA 54: LKB, Bromma, Sweden) 
culture medta from lectin-stimulated human leukocyte cultures and 
pure IL 2 obtained by recomb1nant DNA techniques (riL 2: Biogen 
SA. Geneva) 
Suspension culture. Suspension cultures were performed in 
6-mL tubes; 2 x I 06 cells were cultured 1n I mL of alpha medium 
(with 10% voljvo] fetal calf serum) with elther 100 ng/mL TPA or 
I%voljvol PHA for 18 hours in a fully humidlll.ed atmosphere of 5% 
CO: at 37 °C, They were washed three times with PBS and prepared 
for indirect immunofluorescence. 
Cell sorting. In one series of experiments, cells were inoculated 
into culture following MoAb VIL Al (anti-CALLA) and GAM/ 
FITC incubat1ons and fluorescence-activated cell sorting (by FACS 
440). 
RESULTS 
Induction of /L 2 membrane receptors on pre-B ALL 
cells. Fresh ALL cells did not eltpress IL 2 receptors on 
their membranes as assessed with the MoAb anti-Tac. On 
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Fig 1. Flow cytofluorometrlc anal~ls of membrane antigen• 
expre:Liaed by !'re-B ALL cett:LI·ot patient No.1 following lncubstion 
with TPA. In each panel. the hiatograma of the log fluor88eence 
lnten:LIIty (hori:rontalaxi•l v relative cell numbe!"11 (vertical exi11) ore 
11hown. The UJ:Iper grspha repreeent ltalnlng• with MoAb snd goat 
anti-mouae IQ coupled to fluoreecein ieothioeyanate !GAM/FITCJ: 
the lower grsph• rapreeant control 1tainlng1 with GAM/FITC 
alone. {A) anti· Tac. (B) VIL AI. (C) BA2. (D) WT1. (E) OKT1 1. and 
(F) OKT3. 
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the other hand. IL 2 receptors were found in high percent· 
ages of cells following incubation in suspension with TPA or 
PHA in each of four cases ofpre-B ALL and in two of three 
cases of common ALL (Table 1). Less than l% of the 
incubaled cells formed E rosettes, indicating that the anti-
Tac binding was not due to contaminating E-positive T 
lymphocytes. Evidence for the presence of IL 2 receptors on 
pre-B cells following TPA exposure was obtained when the 
cells from patient No. 1 were phenotyped in more detail. 
Cytofluorometric analysis (Fig 1) demonstrated the binding 
ofanti-Tac (57% positive). anti-CALLA (54% positive). and 
anti-pre-8 cell antigen (BA2) (66% positive) antibodies on 
the incubated cells, whereas the T cell markers T3. Ttl, and 
WTI all remained negative. A similar binding pattern (not 
shown here) was found after incubation with PHA. In 
addition, two-color fluorescence labeling methods revealed 
the simultaneous expression of the IL 2 receptors with 
CALLA and with Cy JJ, on individual cells; SO% of the 
CALLA-positive cells expressed the IL 2 receptoi"'S (200 
CALLA-positive cells counted) (Fig 2Al and A2). and such 
receptors were found on 47% of the Cy ,LL·positive cells (Fig 
281 and 82). As expected. IL 2 receptor.> could be induced 
on normal peripheral blood T lymphocytes using these 
methods (24% to 55% anli-Tac-positive cells after PHA and 
TPA incubation, respectively). 
ALL colony formation. Colony data from PHA-supple-
mented cultures are summarized in Table 2. In four cases 
(patients No. l, 4. 7, and 8) colony formation was obtained 
(in a range of 47 to 63 colonies per IO' plated cells) -in the 
presence of irradiated feeder leukocytes (in the culture 
underlayer) and IL 2. 
The stimulative effect of IL 2 is evidem from the compari-
son with cultures with leukocytes but without the addition of 
IL 2. Colony formation by cells from patients No. 1, 4, and 7 
was enhanced by the extra IL 2. We hypothesized that 
suboptimal concentrations of IL 2 had been produced by the 
feeder leukocytes. 
In these cases. PHA and IL 2 alone, ie. without leukocytes. 
were not active (Table 2) even when IL 2 was present in 
concentrations up to 100 U/mL (not shown). Apparently 
feeder leukocyte-derived factor(s) other than IL 2 were also 
essential for these ALL cells to form colonies. 
The additional role of leukocyte stimulation is illustrated 
in cultures reconstituted with increasing numbers of feeder 
cells in the presence of 25 units of IL 2 (Fig 3). Colony 
numbers increased progressively when titrated numbers of 
feeder leukocytes were added to the cultures. In addition. the 
stimulative effect of IL 2 is evident from these experiments: 
colony numbers were signifiCantly higher in the cultures 
supplied with exogenous IL 2 than in those without e"tra IL 
2. These results suggest that IL 2. in combination with 
leukocyte-derived factoi"S. was required for in vitro colony 
formation by the pre-BALL cells. 
To exclude the possibility that contaminating molecules in 
the IL 2 preparation had been responsible for the stimulation 
of colony growth, the cells of patient No. I were cultured 
with increasing concentrations (25 to 500 U/mL) of pure riL 
2 in the presence ofPHA and 2 x 106 feeder leukocytes. The 
addition of riL 2 enhanced colony growth in a dose-
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Fig 2. Two-c:olor lmmunofluorase~•nce microscopy of pr8-B 
ALL c111111 of patllln"t No.1 aftllr incubation with TPA for 18 hour"ll. 
The arrow• indicate double fluore11c11nt cells. {A) aMi· Tee {A 1) 
end VIL AJ {enti·CALLA) IA2); (B) anti-Tee {B1) and enti·CY 1J.(B2). 
dependent fashion. Colony numbers in cultures with 500 riL 
2 were about three times higher than those in cultures 
without riL 2. Similarly toIL 2. riL 2 (500 U/mL) could not 
induce colony formation in the absence of additional feeder 
leukocyte stimulation. 
Cultures from the cells of patients No. 2. 3, and 5 did not 
give rise lO colonies under any of the conditions tested. On 
the other hand. cells from patient No.6 produced colonies in 
PHA containing culture medium without further additives. 
Table 2. ALL Colony Formation in PHA-Supplemented Culture• 
Colon~a per 1 O' f'lated Callt 
2. x !O'Irredlated 
lmmunologl~ Mark.,.. on 
Colony Call•• (Pereantage Poaltlva) 
f'atlent ,_ Leukocyt&ll + 2 x tO' Irradiated "u 
"· 
Stlmul~r~~ 16 U IL.l LeukOt;yte& 
"' 
<oM CALLA BA2 c,. ,,, WT1 
1 49 31 0 0 53 69 29 0 0 0 
' 
0 0 0 0 
3 0 0 0 0 
4 63 0 0 0 10 58 NO 0 12 a 
5 0 0 0 0 
' 
25 22 eo 80 49 76 0 0 22 NO 
47 36 5 0 57 77 0 0 0 10 
a 54 49 2 0 22 67 0 0 0 11 
All eKperimenta included control cultures without the addition of PHA; no colonies were formed in these cultures. NO, not determined. 
•Pooled colonies were harvested from the plates w1th ll Pasteur pipette, suspended to a singl&-eellsuspenaion. and prepared for Immunofluorescence 
microscopy as described in Materials and Methods. 
indicating that proliferation occurred independem of exoge-
nous growth stimulators. 
Phenotyping of ALL colony cells. Colony cells were 
examined morphologically and immunologically. Their 
microscopic appearance was consistent with that of lympho-
blasts. Immunologic phenotyping (Table 2) of the colony 
cells confirmed the presence of the preculture ALL markers 
(CALLA, BA2, Cy ~). although the percent expressions 
before and after culture differed in some instances. Indica-
tions for the in vitro maturation of ALL cells were not 
obtained. A loss of CALLA expression was noted following 
culture in two of eight cases, but this was not accompanied by 
the acquisition or cytoplasmic IgM heavy chains or the 
appearance of slg (Table 2). 
The cultured cells were checked for the presence of T 
lymphocytes with markers E and WTI inasmuch as the 
applied culture conditions are known to be highly permissive 
forT cell colony formation (Table 2). Significant contami-
nating proliferation of T lymphocyte colony-forming cells 
did not occur in each of these patients. The presence of 
myelomonocytic cells was excluded using marker MoAb 
$4-7. 
Expression of CALLA on ALL colony-forming 
cells, Using a FACS 440 cell sorter, VIL AI- and GAM/ 
FITC- stained cells from patients No. 1 and 8 were sorted in 
two fractions: (1) cells with a high CALLA density and (2) 
cells without CALLA or with a low CALLA density. The 
.:!:. 80 
' 
i. 
'" 
., 
' 
I h 
results listed in Table 3 show that colony-forming cells were 
recovered from both fractions. 
DISCUSSION 
IL 2, previously referred to as T cell growth factor ,1 has 
been identified as the essential stimulatory component for in 
vitro T lymphocyte proliferation. However. recent studies 
have suggested that IL 2 can also stimulate the proliferation 
of human B lymphocytes.~ Very little is known about factors 
involved in the growth of precursor cells of the human B 
lymphocyte lineage. The present experiments provide indica· 
tions that IL 2 can act on leukemic B cell progenitors, ie, 
common and pre-BALL colony-forming cells. Cells obtained 
from eight patients at diagnosis were studied. In six cases. 
the ALL cells could be induced to express membrane recep-
tors for IL 2 (which they initially lacked) by the in vitro 
exposure to a lectin (PHA) or a phorbol ester (TPA), similar 
to normal peripheral blood T lymphocytes. These findings 
raised the question of whether ALL cells may respond toIL 2 
and proliferate in culture. To investigate this possibility, we 
plated the cells in a colony culture system containing PHA or 
TPA and leukocyte feeder cells either with or without the 
addition of human IL 2. Colony growth was obtained with 
the cells of five patients. 
The addition of leukocyte-derived IL 2 to the culture 
medium significantly enhanced colony formation by the 
leukemic cells of patient No. 1, whereas those from patient 
A 
1 l 
~ 80~---------------------, 
' 
i. 
.~ 40 
.§ 
' ~2.0 
Fi1i1 3. Pre-B ALL colony forma-
tion in petient No. 1 with (r::ll or 
wi1hOU'! (0125 unitl of IL 2 added to 
the upper leye,.. of the culturee. 
Colonlaa (ISO calli or mora) were 
counted on day 7 of the cuhure. The 
effect of IL 2 on colony growth wee 
aaselled In relstlon•hip with varying 
numbers of irradietad peripheral 
blood leukocyte• in the underleyer. 
Sectiona A and B indica1e the ell pari-
manta in which cultures were sup-
plemented wlth TPA (100 ng per 
di•hl and PHA (0.01 mL per dish}. 
respectively. 
0 0.5 1.0 1.5 2.0 -6 
irrodior-<1 r .. d., l•ukocylel (~ 10 ) 
0 0.5 1.0 1,5 2.0 -6 
irrodior•d feO<I•r leulcocy~e• (x 10 ) 
-39-
Table 3. CALLA on ALL Colony-Forming Cella 
Ceil R..:owry Colony-Forming 
Soned Frac:tjons• 1%1 Cells per 10' 
Patient No. 1 
Unfrectionated 100 47 
CALLA-negative or weakly 35.4 40t 
positive+ 
CALLA-positive 64.6 46 
Patient No. 8 
Unfract"IOnated 100 24 
CALLA-negative or weakly 25.4 6 
positive+ 
CALLA-1)03itive 74.6 27 
Colonies were grown in the PHA leukoc:yre feeder system supple-
mented w"•th 25 units o1 IL 2. It was not possible in these coses to 
~~&perete the CALLA-nagotive cells from the cells weakly expressing tl'le 
antigen smce histogram analysis o1 the CALLA fluorescence distribution 
did not reveal distinct CALLA-positive and CALLA-negative populet!ons. 
•Cella were stained with MoAb VIL A1 and GAM/FITC and sorted on 
the bas"lll o1 fluorescence Intens-ity. 
tColony cells. were harvested end analyzed tor CALLA expression. 
Forty-three percent of the cells showed bright fluorescence after VIL A 1 
end GAM/FITC mining. 
+Fluorescence intensity did not eKCeed the maxJmol fluorescence of 
eells steil'led with GAM/FITC alone. 
No.4 were absolutely dependent on the supply of IL 2. Pure 
(recombinant) IL 2 ex.erted a similar effect. These results 
support the idea that the in vitro proliferation of ALL cci!s 
can be stimulated by IL 2. The findings also suggest that IL 2 
was not the only growth factor involved in these cases: 
omission of feeder leukocytes from IL 2-containing cultures 
abrogated colony growth. and a positive relationship between 
feeder cell numbers and ALL colony response was estab-
lished (Fig 3). In this respect, the stimulation of the ALL 
colony-forming cells clearly differs from that of clonogenic T 
lymphocytes. Normal E rosette-positive peripheral blood T 
cells produce colonies in PHA and IL 2-containing cultures 
and do not need additional feeder cell stimulation (data not 
shown). 
A second difference r:elates to the optimal IL 2 concentra-
tion needed for colony growth: T colony-forming cells are 
stimulated mallimally by 10 to 2.5 UjmL of IL 2. whereas 
ALL colony numbers (patient No. I) do not reach plateau 
values in the presence of .SOO UfmL of IL 2 (data not 
shown). 
In view of the IL 2 receptor expression on high numbers of 
the cells following stimulation with PHA or TPA. a role for 
IL 2 in ALL colony formation through o. direct interaction 
between IL 2 and IL 2 receptors on the clonogenic ALL cells 
is strongly suggested. Nevertheless, the alternative ell.plana-
tion for these findings. ie. that the effect of IL 2 had been 
indirect (on the feeder cells). has to be considered. Unfortu-
nately, we have not yet been able to produce a cell-free source 
of stimulation that can efficiently replace the leukocytes. 
which is a prerequisite to address this problem. 
Although we have, so far, only studied a small group of 
patients. a marked diversity in growth requirements was 
noted. In discrepancy with the essential culture conditions 
described above for patients No. 1 and 4, the cells from 
patient No. 6 produced colonies independently of exogenous 
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growth factors. In addition. the leukemic cells of patients No. 
2, 3. and 5 did not give rise to colonies. although they were 
capable of IL 2 reoceptor expression. This inability to prolifer-
ate may reflect different requirements for growth factors 
other than IL 2. For example. this could indicate that in 
certain cases the applied leukocyte feeder does not provide 
sufficient concentrations of these factors for proliferation. 
Recently, the murine growth factor. IL 3, has been shown 
to support the growth and maturation of mouse pre·B cell 
clones. 17 It is possible that an analogous regulator produced 
by the feeder leukocytes is involved in pre-B ALL cell 
proliferation in humans. 
ALL colony-forming cells were analyzed for CALLA 
expression by fluorescence-activated cell sorting (Table 3). 
In the two cases investigated, colony-forming cells were 
recovered from cell fractions with bright as well as dull or 
negative CALLA fluorescence. These findmgs are consistent 
with the CALLA positivity of ALL colony-forming cells. but 
they do not exclude the possibility of a coexistent CALLA-
negative precursor subset. Further investigations along this 
line appear to be of extreme importance in view of the 
immunotherapeutic use of anti-CALLA monoclonal anti-
bodies. 
We have not obtained indications for the in vitro differen-
tiation of ALL cells to a more mature cell type. neither in 
PHA- nor in TPA-supplementcd colony cultures. The very 
limited capacity of ALL to differentiate in vitro has been 
noted byothers.19•20 and so far, only one case of ALL has been 
reported in which the leukemic cells matured to slg-bearing 
B cells. 21 Recently. Ralph and co-workers demonstrated that 
high concentrations (ie, lOl to 104 UfmL) of IL 2 can induce 
the maturation of normal human B lymphocytes.22 The 
question of whether high IL 2 concentrations arc also effec--
tive in inducing differentiation of ALL cells cannot yet be 
answered. 
We conclude that the induction of IL 2 receptors and the 
subsequent proliferative response in the presence of IL 2 in 
vitro found in ALL cells raises the possibility of a direct 
regulatory role of IL 2 in early stages of human B cell 
difl'eren.tiation. 
ACKNOVJLEDGMENT 
The expert technical assist01nce of C.C.A.M. Brooders, M. Wit-
tcvcen, 0. Pclgrim. I. Dulfcr,and L.I. van Eyk is acknowledged. We 
thank Dr T. Uchiyama (Kyoto University Hospital, Japan) for the 
donation of the anti-Tac monoclonal antibody. Dr L.A. Aardcn 
(Central Labomtory of the Netherlands Red Cross Blood Transfu-
sion Service, Amsterdam) for his gift of human IL2, W. de Vries for 
help in preparing the photomicrogr:J.phs, and I. DiJkstra and 
S. Overdulvc for typing the manuscript. Recombinant IL 2 of high 
purity and specific scuvity of 1.9 x 10• units per mg protein was a 
gift from Biogen SA, Geneva. 
REFERENCES 
I. Morgan DA. Ruscctti FW, Gallo RC: Selective in vitro growth 
of T lymphocytes from normal human bone marrows. Science 
193:1007.1976 
2. Uchiyama T. Broder S, WaidllUinn TA: A monoclonal anti-
body (anti-Tac) reactive with activated and functionally mature 
human T cells. J Immunoll26:1 393, !981 
3. Leonard WJ, Depper JM. Uchiyama T, Smith KA, Wald-
mann TA. Greene WC: A monoclonal antibody that appears to 
recogn1ze the receptor for human T cell growth fnctor: Partial 
characterizatiOn of the receptor. Nature 300:267, 1982 
4. Tsudo M, Uchiyama T, Uchino H: Expression ofTAC antigen 
on activated normal human B cells. J Exp Med 160:612, 1984 
S. Touw l. Ulwenberg B: Interleukin 2 stimulates chrome lym-
phocytic leukemia colony formation in vitro. Blood (in press) 
6. Foon KA, Schroff" RW, Gale RP: Surface markers on !eukem1a 
and lymphoma cells: Recent advances. Blood 60·1, 1982 
7. Btlyum A: Separation of leukocytes from blood and bone 
marrow. Scand J C!in Lab Invest 21:77. 1968 (suppl 97) 
8. Madsen M, Johnsen HE, Wende!boe Hansen P. Christiansen 
SE: Isolation of human T and B lymphocytes by E-rosette gradient 
centrifugation. Characterization of the isolated subpopu!:ltions. J 
Immunol Methods 33:323. 1980 
9. Touw I, Ulwenberg B: Variable ditferentJauon of human acute 
myeloid leukem1a during colony formation in vitro: A membrane 
marker ana!ys1S with monoclonal antibodies. Br J Haematol 59:37. 
1985 
10. Schuit HRE. Hijmans W, Asma GEM: Identification of 
mononuc!e.;1r cells in human blood. I. Qualitative and quantitative 
dnta on surface markers after formaldehyde fixation of the cells. 
Clin Exp Immunol41:5S9, 1980 
11. Greaves M, Verbi W, Vogler L. Cooper M, Ellis R, Ganesha-
guru K, Hoffb1.1nd V, Janossy G, Bollum FJ: Antigenic and 
enzymatic phenotypes of the pre-B subclass of acute lymphoblastic 
leukeml:l. Leuk Res 3:353, 1979 
12. Knapp W. Majdic 0, Bettelhe1m P, Liszka K: VIL-A!. a 
monoclonal antibody reactive with common acute lymphatic leuke-
mia cells Leuk Res 6:137. 1982 
13. Kersey JH, LeBien TW, Abramson CS, Newman R. Suther-
land R. Greaves M: A human hemopoietic progenitor and acute 
lymphoblastic leukemia-associated cell surface structure identified 
with monoclonal anubody J Exp Med 153:726,1981 
14. Tax WJM, Tidman N, Janossy G, Trejdosiewiez L, Willems 
R, Leeuwenberg J. de Witte TJM, Capel PJA. Koene RAP: 
Monoclonal ant1body (WT1) directed against a T cell surface 
glycoprotein: Charactenstics and immunosuppressive activity. Clin 
Exp Immunol55:427,1984 
IS. Ferrero D. Paghard1 GL, Broxmeyer HE. Venuta S, Lange B, 
Pessano S, Rovera G: Two antigenically distinct subpopulations of 
myeloid progenitor cells (CFU-GM) nrc present in human periph· 
era! blood and marrow. Proc Nat! Acad Sci USA 80:4114, 1983 
!6. U~wenbcrg B, Swart K. Hagemeyer A: PHA-induced colony 
formation in acute nonlymphocytic and chronic myeloid leukemia. 
LeukRes4:143, 1980 
17. Ulwenberg B. de Zeeuw MC: A method for cloning T 
lymphocytic precursors in agar. Am J Hematol6:35, 1979 
18. Palacios R. Henson G. Steinmetz M, McKearn JP: Interleu-
kln 3 supporu growth of mouse pre-B-ee!! clones in vitro. Nature 
309:126, 1984 
19. Nadler LM, Ritz J, Bates MP, Park EK. Anderson KC, 
Sal!an SE, Schlossman SF: Induction of human B cell antigens in 
non-T cell acute !ymphob!nstic !eukem1a. J Ciin Invest 70:433, 
1982 
20. Sacchi N, LeBien TW, Trost S, Breviario D. Bol!um FJ. 
Phorbol ester-mduced changes in human leukemic pre-B lines. Cell 
lmmunol84:65, 1984 
21. Cossman J, Neekers LM,Arnold A, KorsmeyerSJ: Induction 
of differentiation ln a t;~Se of common acute lymphoblnstic leukemia. 
N Eng! J Med 307:1251, 1982 
22. Ralph P, Jeong G, Welte K, Mcrtelsmann R, Rabin H, 
Henderson LE, Souz.a LM, Boone TC, Robb RJ: Stimul;1tion of 
immunoglobulin secretion in human B lymphocytes as a direct effect 
of high concentrations of IL 2. J Immuno! 133:2442, 1984 
-41-

13 In Vitro Colony Forming Cells of Acute Lymphoblastic Leukemia: Analysis of 24 Cases with Recombinant lnterleukin 2 as Growth Stimulus 
In: "Minimal, Residua.Z Disease 
in Aaute Leukemia: 1986" (Ed.s. 
A. Hagenbeek a:nd B. LOZJenberog), 
Marlinus Nijhoff PubZ.isheros, 
Do~~eoht/Bo•ton, pp 141-148 
IN VITRO COLONY FORMING CELLS OF ACUTE LYMPHOBLASTIC LEUKEMIA: ANALYSIS OF 
24 CASES WITH RECOMBINANT INTERLEUKIN 2 AS GROWTH STIMULUS 
Iva Touw, Willem Hofhuis, George van Zanen, Ruud Oelwel and Bob LOwenberg 
1. Introduction 
In vitro colony assays are considered prom1s1ng techniques for the 
detection of clonogenic leukemia cells. It is thought that leukemia cells, 
giving rise to colony growth in vitro (L-CFU), contribute to the perpetual 
growth of the tumor in vivo. Therefore, L-CFU are regarded as relevant in 
vitro end points for evaluating the remission status of leukemias, and for 
assessing the efficacy of purging procedures applied to autologous marrow 
transplants. 
Efficient colony systems for acute myeloid leukemia (AML) exist since the 
mid-seventies {1-3). On the other hand, attempts at developing colony 
assays for acute lymphoblastic leukemia (ALL) have met less success. 
Positive results on the growth of ALL colonies were initially reported by 
Izaguirre and colleagues, who used a colony system with both irradiated T 
cells and culture media conditioned by activated T cells added as growth 
stimuli (4). Although this system was later applied with good results to 
the colony growth of B cell chronic lymphocytic leukemia (5), its repro-
ducibility for ALL appeared unsatisfactory (6). Using a modification of the 
colony system developed for AML in our laboratory (3), we have recently 
reported on the successful culturing of ALL colonies in 5 patients (7). 
We established that both the lymphokine interleukin 2 (IL2) and an ad-
ditional factor produced by peripheral blood leukocytes are essential 
stimuli for colony formation. Activation of the ALL cells with the lectin 
phytohaemagglutinin (PHA) or a phorbol ester is also required for colony 
growth. From suspension culture experiments, it became evident that in 
vitro activation induces membrane receptors for IL2, which had been lacking 
from the fresh ALL cells (7). 
Here, we present the data of studies on IL2 receptor expression and 
in vitro colony formation in 24 cases of non-T ALL, including the immu-
nological subtypes pre-S ALL, commOn ALL, and unclassified ALL. 
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2. Materials and Methods 
2.1. Leukemia cells 
ALL cells were isolated from the peripheral blood or bone marrow of newly 
diagnosed patients not receiving cytoreductive therapy. They were collected 
from light density fractions after Ficoll lsopaque centrifugation and 
sedimentation of E rosette forming lymphocytes (7). On the basis of immu-
nologic phenotyping three subtypes of ALL were distinguished, i.e., pre-B 
ALL, common ALL and unclassified ALL (for definition see under 
table 2). 
2.2. Immunofluorescence 
Surface antigens on fresh and cultured cells were detected in indirect 
immunofluorescence. Cells were first treated with monoclonal antibody (30 
min. at o· C, followed by washing with phosphate buffered saline to remove 
excess antibody), and then with goat anti mouse immunoglobulin conjugated 
with fluorescein isothiocyanate (GAM/FITC) (30 min. at o• C, followed by 
washing to remove excess GAM/FITC conjugate). Subsequently, the cells were 
prepared for fluorescence microscopy (Zeiss microscope with epilumi-
nescence) or flow cytometry (FACS 440, Becton-Oickinson). 
Surface and cytoplasmic immunoglobulins were essayed using goat anti human 
immunoglobulins coupled to FITC as described (7). The presence of terminal 
deoxynucleotidyl transferase (TdT) in the nuclei of cytocentrifuged cells 
was assessed using an indirect immunofluorescence kit (Gibco). 
2.3. Monoclonal antibodies (MCA) 
MCA used in this study with their specifications are listed in 
Table 1. 
-45-
TABLE 1. Monoclonal antibodies 
Antibody Specificity .:.:..:..:.___:__ __ _ 
VIL A1 common ALL ant1gen 
VIM 2 myelo monocytic antigen 
BA 1 B cell associated antigen 
BA 2 B cell assoc1ated antigen (p 24) 
B 1 B cell specific antigen (p 30) 
B 2 B cell specific antigen (p 140} 
anti-IL2 receptor membrane receptor tor iL2 
WT1 T cell specific ant1gen 
2.4. Colony culture 
Source 
Dr. w. Knapp, V1enna Austria 
Dr. w. Knapp, V1enna, Austria 
Hybrl tech, San D1ego, USA 
Hybn tech, San Diego, USA 
Coulter Corp., Hialeah, USA 
Coulter Corp., Hialeah, USA 
Becton • Dickinson, Mountam View, USA 
Dr. w. Ta:w;, NiJmegen, The Netherlands 
ALL colonies were grown in a double layer culture system in 35 millimeter 
diameter culture dishes (1-4 
recombinant 
milliliter culture volume) supplemented with 
IL2 (riL2) (25 units per culture dish), and 2 1% vol./vol. PHA, 
x 106 irradiated (2500 red) feeder leukocytes. Colonies containing 50 or 
more cells were scored on day 7 of culture. The colony system has been 
described in more detail elsewhere (7). After counting, colony cells were 
mass harvested end their phenotypes were assessed in indirect immunofluor-
escence. 
2.5. Suspension culture 
To evaluate ALL cells for their capacity to express membrane receptors for 
IL2 after in vitro activation, 2 x 106 cells were incubated for 18 hrs at 
37" C/5~ C02 in culture medium supplemented with 1~ vol./vol. PHA (7). The 
cells were then prepared for indirect immunofluorescence with the MCA all2r 
(anti-IL2 receptor). 
). Results 
3.1. Induction of membrane receptors for IL2 on ALL cells 
Data on the presence of receptors for IL2 on the surface membran-e of 
ALL cells are summarized in Table 2. In all cases, non-activated cells were 
IL2 receptor negative. On the other hand, significant proportions of the 
ALL cells of most patients expressed the IL2 membrane receptors, following 
incubation in vitro in the presence of PHA. 
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Table 2. Expression of IL2 membrane receptors in cases of non-T ALL 
ALL 1mmunol0<;11c 
SUbtype• 
pre-B ALL. 
(n : 8) 
Common AL.L. 
(n • 12) 
UnclaSSified ALL 
(n ~ 4) 
non stimulated 
cells expressing 
IL2 receptors 
1ncodence ol 
cases 
0/8 
0/12 
Of• 
In VItro activated (PHA) cells 
e11.presslng 1L2 receptors 
1ncodence of 00 of IL2 receptor e)(pressmg cells 
cases 
mean range 
7/8 
" 
5-57 
9/12 41 3-78 
4/• 
" 
6-30 
pre-B AL.L: TdT. CylgM, CALLA pos1t1ve 
Common AL.L: TdT, CAL. LA posltove: CylgM negat1ve 
UnclaSSified ALL: TdT POSitive; CALL.A, CylgM negative: no T cell or myeloid markers 
3.2. Induction of ALL colony formation 
Under optimal culture conditions, a linear colony response with 
titrated cell numbers plated in culture was apparent (fig. 1). 
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FIGURE 1. ALL co~ony fo~tion with 
tit~ted ce~Z numbe~s inoculated in 
euZ tu~e u:n.d.ero varoious stimulator-y 
conditions. Optimal stimu~ation was 
obtained with PHA, 1'IL2 p~us i7'-
7'adiated feede?' ~eukocytes (I-I), 
and roesulted in a ~inearo eoZony 
~esponse (7'==0.968). 0-0: stimu-
~ation with PHA p~us feede?' ~euko­
cytes but no IL2; 'V - 'V: stimu-
~ation with PHA pZus 1'IL2 but no 
feede1' ~eukocytes. 
Omission of IL2 from the cultures generally reduced colony formation, 
whereas the absence of feeder leukocytes resulted in a complete lack of 
colony growth in most cases (fig. 1). Plating efficiencies among the dif-
ferent immunological categories of ALL are shown in fig. 2. from the series 
of 24 cases, the cells of 18 patients gave rise to ALL colonies, thus 
indicating a positive colony response in 75% of non-selected cases. Plating 
efficiencies ranged from 15 to 127 per 105 plated cells (mean: 44 colony 
forming cells per 105). No significant differences were evident between the 
pre-B ALL, common ALL and unclassified ALL with respect to colony forming 
abilities. 
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FIGURE 2. PZatirl(! efficiencies in diffepent irnmu:n.o~O[Jica~ subtypes of ALL 
c~osed symbo~s: ALL ceHs e:rpPessed membmne PeceptoPs foP IL2 afte.,. 18 hT's 
suspension cut tur>e (Table 2). Open symbols: ALL cells wer>e IL2 roeceptoro 
negative aftero suspension culturoe (Tab!E(2) 1 but in the colony fo~ng cases 
moroe than 15$ of the colony ce'LZs expr>essed IL2 roeceptoros. 
A comparison between childhood All (age younger than _12 yrs) and adult ALL 
(age 12 yrs and older) revealed that the culture system is equally permiss-
ive for colony growth of childhood and adult ALL (Fig. 3). 
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TABLE 3. Immunological markers expressed on fresh cells and on colony 
cells: Three examples of different immunological subtype. 
Marker CASE A (uncla:SIIIfleO ALL) CASE B (commor~ AI.L) CASE C (pre B-ALL) 
'!!. positive % positive % POSitive % poslt1ve % positive % positive 
fresh cells colony cells tresn cells colony cells fresh cells COIOI'Iy cellS 
VII.. AT 0 
" 
22 60 53 
6A 1 2 0 .. 
" 
n.d. n.d. 
6A 2 0 0 67 
" " " 
61 0 0 0 
" 
0 
62 0 0 0 0 0 
Cy, 0 0 0 so 29 
"' 
0 0 0 0 
E 0 0 0 0 0 0 
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3.3. Phenotyping of ALL colony cells 
Morphological analysis of colony cells revealed that these had a 
lymphoblastic appearance. Immunofluorescence studies indicated that the 
immunophenotype of the colony cells closely resembled that of the fresh 
cells- Convincing indications for in vitro differentiation of ALL cells, as 
evidenced by the acquisition of new maturation antigens were not obtained. 
Representative colony phenotypes as compared with the preculture blasts of 
each immunological subtype of ALL are given in Table 3. In these analyses, 
colony cells always contained less than 10 per cent contaminant normal 
cells as assessed by E resetting (T cells), immunofluorescence analysis 
with MCA WT l (T cells), VIM 2 (myelomonocytic cells) and staining of 
surface Ig (8 cells). 
4. Conclusion 
The data presented in this paper confirm and extend our ini tiel 
experiences on the in vitro growth of ALL colonies (7). The culture system, 
with IL2 and feeder leukocytes as growth stimuli, and PHA for the acti-
vation of the ALL cells, permits colony formation in 18/24, i.e., 75% of 
the cases. The system is efficient for the different immunological subtypes 
(i.e., pre-8, common, unclassified) of ALL and can be applied to childhood 
as well as adult leukemia. The linearity observed between colony response 
and cell numbers plated allows quantitative analysis. These features open 
perspectives for the general applicability of this colony assay in monitor-
ing residual clonogenic ALL cells in bone marrow aspirates during the 
remission phase of the disease. For this purpose, it will be first necess-
ary to investigate the behaviour of normal marrow progenitors in the colony 
system. It can be anticipated that the feeder leukocytes added to the 
culture will not only elaborate the factors into the medium required for 
ALL colony formation but also factors that stimulate the outgrowth of 
normal hematopoietic colony forming cells (e.g., CFU-GM). To avoid contami-
nant growth of non-leukemic cells it may be necessary to remove the normal 
progenitors by monoclonal antibody labeling followed by cell sorting or 
complement lysis procedures before plating the remission bone marrow sample 
in culture. 
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A second matter of importance, which deserves extensive investigation, is 
the question whether the cells forming colonies in the culture system 
represent the total ALL clonogenic cell population or only a subset of 
proliferative ALL cells. Testing the stimulating capacities of purified 
lymphokines, separately or in combination with other stimuli, will be 
necessary to address this problem. 
Colony cultures are of great value for studying the cell biology of 
leukemia. For example, comparisons of the colony forming responses of 
leukemic cells and their normal counterparts to proliferation and differen-
tiation stimuli will add to our understanding how growth and differen-
tiation is altered in leukemia. At the same time, the analysis of factors 
required for leukemic cell growth may provide insights into the regulation 
of normal cell proliferation and differentiation. Recent studies have shown 
that IL2 stimulates the growth of normal as well as leukemic B lymphocytes, 
thus establishing that the activity of IL2 (previously termed T cell growth 
factor) is not limited to T cells (8-10). Very little is known about fac-
tors involved in early stages of B cell development. Our data on the induc-
tion of IL2 receptors on ALL blasts, and the stimulative effect of IL2 on 
ALL colony forming cells raise the possibility that IL2 acts on cells of 
the B cell lineage from the earliest recognisable differentiation stage, 
i.e., that of unclassified (non-T) ALL. 
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SuMMARY. The capacities of human acute myeloid leukaemia (AML) cells for 
differentiation were evaluated by the degree of maturation of the cells following in 
vitro colony formation. For this purpose highly purified blast cells were seeded into 
culture. Exogenous differentiation inducers, other than the colony stimulating 
materials. were not added to the cultures. Phenotypes of the colony cells were 
determined by use of monoclonal antibodies directed against a number of 
maturation antigens. In all 10 cases marked changes in the surface phenotypes of 
the cells post culture were seen. Differentiation was incomplete and quite variable as 
compared with normal myeloid colonies. Following colony formation myeloid 
maturation antigens became apparent on the cells of the one patient with 
morphologically undifferentiated leukaemia. The residual differentiation capacities 
among individual cases of human AML. as revealed in vitro. are diverse and do not 
parallel the morphological maturation features of the blasts prior to culture 
according to the FAB nomenclature. This approach may be utilized to improve the 
classification of human AML and to disclose the lineage relationship of certain 
cytologically unclassifiable leukaemias. 
The induction of maturation in human myeloid leukaemias m culture has been studied with 
a number of differentiation inducing agents (i.e. phorbolesters. retinoic acid. dimethylsulfox-
ide). Thus. human leukaemic cell lines can be stimulated to mature (Koeffler. 1983). 
Although these Al\1L-derived cell lines serve as useful model systems. they do not reflect the 
variability of the disease in individual patients. Attempts at differentiation induction of AML 
cells from individual patients have been carried out in suspension cultures. These studies 
Correspondence: Dr B. LOwenberg. Rotterdamsch Radio-Therapeutisch Instituut. Groene HillediJk 301. 
30i5 EA Rotterdam, The Netherlands. 
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demonstrated that AML cells. following exposure to phorbolesters or retinoic acid. did develop 
to macrophage-like cells in a variable proportion of cases (Breitman et al, 1981; Fibach & 
Rachmilewitz. 1981). Pure AML blasts were not used in the experiments, so that one cannot 
quantify the contribution of normal cell admixture to the different degrees of maturation. 
In this repon we describe the differentiation capacities of AML during proliferation in 
vitro. These studies were carried out using a colony culture technique to which leucocyte 
feeder cells and phytohaemagglutinin (PHA). but no specific differentiation inductive agents. 
were added. This system has been demonstrated specifically to grow acute myeloid leukaemia 
colonies as evidenced by cytogenetic analysis (Swart et al. 1982). 
Purified blast cells from 10 patients with untreated AML were cultured. Murine 
monoclonal antibody (McAbs), directed against granulocyte and monocyte differentiation 
antigens as well as those specific for lymphocytic. erythroid and megakaryocyte lineages. 
were employed for the detection of surface antigens present on rhe blasts before and after 
culture. 
MATERIALS AND METHODS 
Human subjecrs. Ten patients with AML were studied at the time of diagnosis before 
chemotherapy was started. Either bone marrow aspirates (patients 1. 2. 4. 6 and 10). 
peripheral blood cells (patients 3. 5. 7 and 9) or a mixture of marrow and blood cells (patient 
8) were used. Leukaemia subtypes were classified according to the FAB nomenclature 
(French-American-British Cooperative Group, 1976). The marrow cells of three normal 
donors were used to obtain reference data. 
Cell separation. 97-100% pure leukaemic blasts were prepared from bone marrow 
aspirates and blood by means of discontinuous albumin gradient centrifugation and E rosette 
sedimentation as described previously (Swart et al. 1982). Normal marrow mononuclear 
cells were collected after Ficoll-Isopaque separation (BOyum. 1968). 
Colony assays. Leukaemic colonies were grown in the PHA leucocyte feeder system as 
reported in detail (Swart et al. 1982). On day 7 of culture, colonies of 50 cells or more were 
harvested with a Pasteur pipette and a monocellular suspension was established by vigorous 
pipetting. Cells were washed twice with Hanks Balanced Salt Solution (HBSS) and prepared 
for immunofluorescence studies. It has previously been reported that contamination of the 
purified blast suspensions with T lymphocyte colony forming cells (TL-CFC) which interfere 
with leukaemic growth in these cultures does not occur under these conditions (Swart et al. 
1982). Nevertheless, by means of E rosette tests. we always excluded that T cell colony 
growth was involved. Normal myeloid colonies were grown from bone marrow mononuclear 
cells in the Pike & Robinson double agar layer system. with minor modifications (Swart & 
LOwenberg. 1980), and in a colony method containing human placenta conditioned medium 
(HPCM). according to Burgess er al (1977). On day 12 of culture. dishes were flushed with 
HBSS. as a result of which the upper layer containing the colony cells is detached from the 
underlayer. The collected colony cells were washed twice with HBSS to remove residues of 
agar prior to immunofluorescence staining procedures. 
Indirect" immunofluorescence studies. The presence of surface antigens on uncultured and 
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cultured cells was assessed by indirect immunofluorescence. Following fixation with 
paraformaldehyde (Schuit et al. 1980). cells were incubated with murine monoclonal 
antibody and afterwards with goat anti~mouse Ig immunoglobulin coupled to fluorescein 
isothiocyanate (GAM;FITC) at 4°C according to standard procedures. Incubations were 
carried out in duplicate at two plateau concentrations of McAb to verify maximal labelling. 
GAM/FITC (Nordic Immunological Reagents. The Netherlands) was used in a 1 :40 dilution. 
providing optimal brightness of the fluorescence. Two hundred cells per slide were scored for 
specific membrane fluorescence with a Zeiss fluorescence microscope using Plan-neofluar 
25 x and 63 x lenses. Control incubations with GAM/FITC only. included in each test to 
check for nonspecific binding of the reagent to the cell surface. were negative in all 
experiments. 
Monoclonal antibodies. The binding patterns of the monoclonal antibodies used in this 
study are summarized in Table I. 
Table I. Specifications of monoclonal antibodies (McAb) 
Titres used in 
mdirect immuno-
McAb fluorescence assays Reactivity Reference or source 
B2.12 1:500-1:1000 Granulocyte and Vander Reijden eta/, 
monocytes 1983 
B4.3 1:500-1:1000 Granulocytes Van dcr Reijden eta/, 
1983 
Bl3.9 1:500-1:1000 Granulocytes Vander Reijdcn eta/, 
1983 
S4-i 1:500 MyeloblastS-granu- Ferrero eta/, 1983 
locytes, monocytes 
IV BS 1:500-1:1000 Erythrocytes Dr P. M. Lansdorp,. 
(glycophorin A) 
C2 1:500-1: 1000 Platelets Dr P. M. Lansdorp 
(glycoprotein ITa) 
CIS 1:500-1:1000 Platelets Dr P. M. Lans.dorp 
(glycoprotein Ilia) 
WTI 1:100 All thymocytes and Taxetal. 1981 
T lymphocytes 
OKia 1:40 lll.A-Dr bearing cells Ortho Pharmaceutical 
Corporation 
OKT3 1:40 Mature thymocytes Ortho Pharmaceutical 
and T lymphocytes Corporation 
OKT6 1:40 Common thymocytes Ortho Pharmaceutical 
and epidermal Corporation 
Langerhans cells 
• Cencral Laboratory of The Netherlands Red Cross Blood Transfusion 
ServJce, Amsterdam. 
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RESULTS 
The results from immunofluorescence studies on AML blasts before and after colony culture 
in the PHA-leucocyte feeder assay are summarized in Table II. 
Myeloid and monocytic differentiation ant1gens 
The colonies contained higher percentages of cells react1ve with the marker 84.3 
(granulocyte) and S4-i (myelo-monocytic) as compared with the pre-culture cells in all 
instances tested. In five out of 10 cases a higher expression of granulocytic antigens reactive 
with the McAb Bl3.9 was evident after colony culture. 
On the other hand. no significant shifts in reactivity with the myelomonocytic marker 
McAb 82.12 were apparent. 
HLA-Dr ('!a-like') antigens 
Reactivity with the anti Ia McAb was not significantly altered after colony formation with the 
exception of patient 1. In this case. initially 5% of the leukaemic blasts were Ia positive. which 
increased to i2% in the colonies. 
Erythroid and platelet associated ant1gens 
In none of the cases the expression of the erythroid specific marker glycophorin A (reactive 
with McAb IVBS) or the platelet associated glycoproteins Ila and lila (reactive with McAb C2 
and CIS respectively) was seen on the A1vlL blasts prior to or after colony growth. 
Induction of the T6 antigen during colony formation 
In one patient (no. 4) 48%ofthe colony cells expressed the T6 antigen. normally present on a 
subpopulation of thymocytes. This antigen was not found on the cells before culture. 
On the other hand. 39% of the pre-culture cells expressed anotherT cell marker. i.e. WTl. 
which could not be detected after culture. The cells did not react with ann-T3 McAb or with 
sheep red blood cells (E rosette formation) before or after colony formation. 
Normal granulocyte-macrophage colonies 
Reference immunofluorescence data from normal granulocyte-macrophage colonies were 
collected (Table III). Colonies were grown from three different bone marrow samples. in Pike 
& Robinson and HPCM assays. All three samples showed high reactivities with B2.12 
(52-i9%). B4.3 (44-iS%) and withS4-7 (40-89%) after culture in both sysrems; the colony 
cells showed variable staining vvith Bl3.9 (18-65%). whUe reactivity with OKT6 was 
negative (less than 1 %). 
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Table II. Membrane immunonuorescence with monoclonal antibodies of purified AML blasts before and after colony culture 
Percentage of cells reactive with monoclonal antibody' 
84.3 813.9 82.12 S4-7 !a T6 
Cytologic 
subtype Before Before Bdorc Before Ref ore !Jefore 
Patient (PAD)! culture Colonies culture Colonies culture Colonies culture Colonies culture Colonies cullure Colonies 
1 M1 0 64 0 6 0 1 24 93 5 72 0 2 
2 M1 3 49 <l 16 28 30 0 47 83 so 1 4 
3 M1 1 59 0 ll lO 6 ll 68 66 63 u 0 
•t M2 lO 31 <1 2 23 20 23 86 64 72 0 48 
5 M2 3 45 0 40 ll 19 n.ll. n.d. 62 59 0 2 
6 M2 0 8 () 0 l 1 43 48 41 42 0 2 
7 M4 <l 18 <1 0 7 1 17 79 64 58 0 0 
8 M4 4 72 <l <l 3 1 3 87 54 58 0 0 
9 M4 2l 46 8 8 17 8 53 68 58 68 6 5 
lO U§ 3 71 <1 64 42 56 2 2l 26 l2 0 0 
Monoclonal antibodies are described In Table l. Purified A~IL blasts were plated in the PHA-lcucocyte feeder assay for colon}' 
formation. The numbers of colonies per 105 plated blasts from these patients ranged from 127 to 1075 (mean 334/105). 
• Reactivity with McAb C2. ClS (antiplatelet) and lVBS (antiglycophorin) was ncgali\'C (less than 2% staining) in all patients before 
and af'ter c:ulture. Data from pallcnts 3, 7 and lO represent means of two separate experiments. Positive :staining in indi\•idual 
experiments differed less than 6% from these mean values. 
t Morphologic subtypes based on the classification of the French-American-British Cooperali\'e Group. 
:f: Blast cells oft his patient were tested forT lymphoid markers, i.e. E roscUing and McAb OKTJ anll WTL Prior to cullure 39% oflhc 
blasts stained with \VTl, whereas E and T) nuorescence were negative. ll%ofthe blast cells v.•ere positi\·e in Sudan black Rstaining: 
non specific-esterase, acid phosphatase and Periodic acid Schiffstalnings were all negative. Colony cells had lost WTI reactivity (0% 
staining) while E and Tl fluorescence remained ncgath•c. 
§Undifferentiated leukaemia, negati\•e for Sudan black B. non spec-Ific-esterase, acid-phosphatase and Periodic acid SchilT stainings. 
Table m. Membrane immunofluorescence of normal GM-colony 
cells with a series of monoclonal antibodies (McAb) 
Percentage positive colony cells 
A B c 
Leucocyte Leucocyte Leucocyte 
McAb feeder HPCM feeder HPCM feeder HPCM 
82.12 73 53 70 52 
-· 
79 
B4.3 56 44 65 75 74 
813.9 19 18 52 40 65 
S4-i 46 46 40 72 89 
T6 <1 <1 <1 <1 
Bone marrow samples from three different donors designated A. B 
and C. Two colony methods were applied: one with a leucocyte 
feeder according to Pike & Robinson (1970) and one with human 
placenta conditioned medium as stimulator. 
~ Not determined. 
DISCUSSION 
Acute myeloid leukaemias display a morphological and functional block in differentiation. 
The above-described experiments were designed to determine the capacities of AML cells from 
individual patients to differentiate during proliferation in culture. Maturation stages of AML 
colonies were compared with those of the noncultured blast cells. After colony growth, the 
progeny of AML cells exhibited a more mature myeloid phenotype than did the preculture 
blast population (Table II). This was evident in all cases and thus appears to be a common 
feature in human AML. Recently, it has been shown in our laboratory that the B4.3 antigen 
was not expressed on the leukaemic colony forming cells from patients 1 and 3. which 
supports the suggestion that this marker was acquired during proliferation and differentia-
tion in culture (Wouters & Wwenberg, 1984). 
Marie et a1 (1981) have previously demonstrated that the number of cells carrying a 
granulocyte maturation antigen (My-1) was higher following AMI. colony formation as 
compared with preculture values. These authors did not use purified blast suspensions in 
their studies to avoid interference of normal cells with A.M:L phenotyping and therefore the 
question as to whether AML cell differentiation occurred during in vitro colony growth was 
not answered conclusively. In another series of experiments (Ozawa et al. 1983) differentia-
tion in colony culture of progenitor cells of individual AML patients was suggested on the 
basis of cytochemical staining of the colonies. Limited data of the preculture blast phenotypes 
were given. so that a strict comparison between pre and post culture data cannot be derived 
from their studies. The experiments reported herein with pure blast cells and an extended 
number of monoclonal antibodies add evidence that human AML cells undergo further 
differentiation into granulocytic-monocytic directions upon proliferation in vitro. 
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We used mass harvested cells for the analysis after culture. One could raise the question as 
to whether the non-colonycells on the plates contributed to the results. We estimated that the 
numbers of single cells in the culture dishes represented less than 1% of the cells present in 
colonies. This makes it unhkely that individual cells persisting in culture are a s1gnificant 
factor in the observed phenomena of differentiation. 
As compared with the progeny of normal granulocyte-macrophage colony formers (Table 
II), the expression of myeloid surface markers on the AML colony cells was incomplete. 
Morphologically, the AML cells found in the PHA-leucocyte feeder colony cultures did not 
mature to granulocytes or monocytes but remained of blast appearance (Swart et al. 1982). 
Apparently. AML cell differentiation during colony formation was partial. also from a 
morphological point of view. It appears unlikely that differences between normal and 
leukaemic colonies were due to the variations in the culture techmques. In patients from 
which we were able to grow colonies in the Pike & Robinson assay (patients 3. 4. 8 and 10) 
the colony cells showed phenotypes comparable to those obtained from the PHA-leucocyte 
feeder system (data not shown). 
The finding that colony cells of patient 4 expressed the common thymocyte related 
antigen T6 was unexpected. Earher. the expression of myeloid markers on acute lymphoblas-
tic leukaemia cells has been reported (Bettelheim et al, 1982). It was suggested that this 
phenomenon may reflect derepression of gene activity. Our observation that the T6 marker 
was acquired in culture while it had been completely absent from the preculture AML blasts 
(also confirmed by Fluorescence Activated Cell Sorter analysis; data not shown) raises the 
possibility that leukaemic cells showed aberrant gene expression as a result of proliferation in 
culture. Alternatively. a certain relationship between the AML cells of this case and the T6 
positive epidermal Langerhans cells. which belong to the haematopoietic system (Volc-
Plat:zer et al, 1984), may be suggested by this observation. 
Although we investigated only a limited number of patients. it appears that the capacity 
of the AML blasts to acquire myeloid differentiation antigens during in vitro colony formation 
is not related to the morphological maturation stage of the preculture cells. Analysis of the 
maturation of AML blasts cells m colony culture provided information on the differentiation 
capacities ofthe leukaemic cells that was at variance with the differentiation stages as defined 
by means of FAB criteria. We suggest that the application of colony culture systems in 
combination with cell surface marker analysis for determining the differentiation capacities 
of proliferating leukaemic blasts in individual patients. may eventually be of use for refining 
the current classification of leukaemias based on morphological and cytochemical para-
meters. 
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lnterleukin 2 Stimulates Chronic Lymphocytic 
Leukemia Colony Formation In Vitro 
BZood 66:237-240, 1985 
CONCISE REPORT 
Interleukin 2 Stimulates Chronic Lymphocytic Leukemia 
Colony Formation In Vitro 
By rvo Touw and Bob LOwenberg 
The requirements of clonogenic cells of B cell-type chronic 
lymphocytic leukemia (B CLL) for interleukin 2 (IL 2) were 
analyz.ed. Using the cells of five patients, we measured IL 2 
receptor &ltpression on the cell surlace and the colony-
forming abilities of the cells in response to IL 2. In four of 
the cases, significant percentages of the CLL cells 
expressed IL 2 membrane receptors (as ass..,.sed with the 
monoclonal antibody anti-Tee), indicative of their potential 
sensitivity to IL 2. Pure recombinant interleukin 2 (r-IL 2) 
was added to colony cultures that also contained the lectin 
phytohemagglutinin (PHA) or the phorbol ester 12-0-
tetradecenoylphorbol-1 3-acetate (TPA) to activate the CLL 
I NTERLEUKIN 2 (IL 2) is the soluble factor required for the in vitro proliferation of activated T lymphocytes. 1 
With the availability of pure IL 2 preparations (obtained by 
recombinant techniques? and the development of mono-
clonal antibodies reacting with IL 2 receptor molecules on 
the cell surface membraneY it now becomes clear that IL 2 
can also directly act on normal human B lymphocytes as well 
as on neoplastic B cell progenitors, and induce a proliferative 
response of those cells.~ 
Earlier, we reponed that the proliferation of common and 
pre-B acute lymphoblastic leukemia (ALL) cells depends on 
IL 2 plus additional leukocyte factor(s). On this basis, a 
colony culture technique for ALL has been deve!oped.a.9 
Using a modificatton of this culture assay. it is shown here 
that B cell-type chronic lymphocytic leukemia (B CLL) 
cells. when activated by the lectin phytohemagglutinin 
(PHA) or the phorbol ester 12-0-tetradecanoylphorbol-13-
acetate (TPA). form colonies in response to recombinant IL 
2 (r·IL 2). In contrast to clonogcnic ALL cells, CLL colony 
formers do not require extra leukocyte stimulation for prolif-
eration. 
MATERIALS AND METHODS 
Patients arul separatfon of leukemia Cl'lls. Nucleoted cells of 
five patients with CLL were ISOlated from the peripheral blood by 
Ficoll-Isopaque separation. None of the patientS had received cyto-
rcductJve therapy for at lea.st 12 weeks prior to examination. 
Residual T lymphocytes were removed from the Ficoll interface cells 
by rosctting with 2-aminocthylthiouronium bromide (AET)·treated 
sheep erythrocytes and sedimentation of the rosetted cells through 
Ficoli-Isopaque.9 In the non-resetting (less than 0.5% positive) 
leukemic cell fractions, 97% to 100% of the cells were characterized 
morphologically as small lymphocytes. 
Colony culture. Colony cultures were performed in 35-mm 
diameter culture dishes (1.4 mL culture volume). essentially as 
described for non·T ALL.1 However, one maJOr modification was 
introduced, ic, that feeder leukocytes were not included in the 
culture system. Instead. pure r-IL 2 (81ogen SA. Geneva) added to 
the culture upper layer served as stimulator in combination with 
either 0.75% voljvol PHA (reagent grade, Wellcome, Dartford, 
England) or 70 ng/mL TPA (Sigma Chem1cals, StLouis). Colonies 
(SO cells or more) were counted on day 7 of culture. Colony cells 
were then mass-harvested with a Pasteur pipette. washed three times 
with phosphate-buffered saline, and prepared for immunofluores-
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cells. Colony formation completely depended on the pres-
ence of r-ll 2 and PHA or TPA in culture, with the 
exception of one case, in which the addition of ll 2 was not 
required for colony growth in TPA-supplemented cultures. 
Twenty-five to fifty units of r-ll 2 per milliliter of culture 
medium provided optimal stimulation. Under these condi-
tions, a linear r•lationship was obsef'Ved between plated 
eel! numbers and colony numbars formed. Morphologic•! 
and immunologic analysis of colony calls indicated that 
these were monoclonal CLL cells that had matured toward 
plasmacellular lymphoeytes and plasma cells. 
o 1985 by Grurre & Stratton, Inc. 
cence. morphological and cytochemical anolysis (M:ay-GrUnwald· 
Giemsa, nonspecific esterase and Sudan black 8 staining of cytocen· 
trifuged cells). and E rosette formation. 
lmmunofiuoresct"nce studies. The presence of Immunoglobulin 
(lg) chJ.ins on the cell surface :and in the cytoplasm was assessed by 
immunofluorescence microscopy as described.' using goat anti· 
human (GaHu) immunoglobulin antisera coupled with fluorescem 
isothiocyanate (FITC) or tetramethylrhodamine isothiocy3nate 
(TRITC). G;~Hu IgG/TRITC. GaHu K/FlTC. GaHu X/TRITC 
(Kailestad, Austin, Tex.). GaHu lgDJFITC, GaHu IgM/TRITC. 
and GaHu IgA/FITC (Nordic. Tilburg. The Netherlands) were all 
used in titers of 1:40. 
In dual staining procedures. incubations with TRITC-coupled 
antisera always preceded those with the FITC-couplcd antibodies. 
Cell surface membrane receptors for IL 2 were assayed in indirect 
immunofluorescence using the monoclonal antibody anti· Tacl and a 
goat anti-mouse lg FITC conJugate (GAMJFITC; Nordic). 
RESULTS 
Colony scimulation. In four of the five cases. a signifi-
cant proportion of the fresh CLL cells was found to express 
IL 2 receptors on the cell surface (Table l). Culture experi· 
mellts then disclosed that B CLL colony formation was 
induced by IL 2 when PHA or TPA was added as well. No 
colonies were formed in cultures containing IL 2 alone. PHA 
or TPA alone. or without any of these substances (Table 1). 
As an e'xception, TP A alone induced colony growth from the 
cells of patient No. 4. In all instances, colonies consisted of 
monoclonal B cells (see below): E rosette tests, and Sudan 
black B and nonspecific esterase stainings of cells harvested 
from the cultures were negative, indicating that contaminat-
ing T lymphocyte and myelomonocytic growth did not occur. 
To assess the optimal dose of IL 2 required for colony 
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Tabla 1. IL 2-Da.,.ndont Colony Formal ion in Five Ca~ of B CLL 
Peripheral Blood Pov~entaga ol Colony No. per Culture Dllh" 
LeL>k.ocyte Count Tec-poejtl"" 
Pet~nt No. lx 10-"/Ll CU. Cello PHA+IL2 TPA+IL2. PHA TPA IL 2 Nonet 
1 
"' " 
38 ,. 0 0 0 0 
2 244 61 26 8 0 0 0 0 
3 44 80 16 
" 
0 0 0 0 
4 ,, as 44 70 0 66 0 0 
5 15 0 19 31 3 0 0 0 
•eLL eelle (2 x 10•1 were cultured per dieh; values are mean& of triplicate cultures. 
tColooy stimulation: PHA. 0. 7% vol/vol; TPA, 100 ng per culture dish; IL 2, 2.5 units par culture d.lsh (culture volume. 1.4 ml). 
formation, IL 2 was added in increasing amounts (0.05 to 
1,000 units) to the culture dishes. In PHA-supplemented 
cultures, colony numbers (patient No. 1) already reached 
plateau values at 10 units of IL 2 per dish (Fig lA). In 
contrast, a maximal size of colonies was obtained at a higher 
dose, ie, SO units per dish. Funher increases of IL 2 concen-
trations in culture (100 to 1.000 units per dish) reduced the 
colony size (Fig IA). Similar resultS were obtained with the 
cells of patients No.3 and S in TPA plus IL 2-supplemented 
cultures. A cell titration experiment performed in the pres-
ence of 50 units of IL 2 (optimal growth) revealed a linear 
relationship between cell numbers plated and colony nwn-
bers formed (Fig I 8). This feature makes the colony system 
suitable for quantitative SlUdies. 
The polyc\onal B cell mitogen Staphylococcus aureus 
strain Cowan I was ineffective in the induction of IL 
2-stimulated B CLL colony growth either alone or in combi-
nation with PHA orTPA. 
Immunologic and morphological analysis. Immuno-
fluorescence analysis was performed on the cells after colony 
formation and the immunophenotypes of the colony ceUs 
were compared with those of the preculture cells. These 
studies revealed that high percentages of colony cells 
expressed the same immunoglobulins with single light chains 
in the cytoplasm or on the cell surface as the CLL cells prior 
to culture (Table 2). Bright cytoplasmic immunofluorescent 
staining suggested plasmacellular maturation within the 
Fig 1. B CLL colony formation (patiant No. 1 J lnducad by r·IL 2 
and PHA. Colony numbara ar• axprauad as maan values of 
triplicate c:ullur•• :!: SD. (AI Colony num~~ and aJza following 
l"tlmulation with tttratad coneantratlona of r·IL 2 (eulture volume, 
1.4 ml). Eatim81ad eall numbara pra1ent in tha pradominant "ty.,. 
eoloniH serva aa a maall.lra of eolony 1iza. +.50 to 100 cell• par 
eolony: + +.100 to 200 cell• per eolony; + + +. 200 to 500 ealla 
par eolony: + + + +. 500 to 1.000 calli par eolony. (B) Linear 
da.a-ra1ponae relationship (r - .99351 batw9on eall numbare 
plat•d and th• numbar• of coloni" formed in tha praaance of 50 
unJta of r-IL 2 par eultur• dish. 
CLL colonies. Substantial morphological changes were 
noted during colony growth in the TPA- and IL 2-stimulated 
cultures. indicative of the differentiation ofCLL colony cells 
into plasma cells (Fig 2, a2 and b2). In the PHA- and IL 
2-supplemented cultures, the majority of colony cells resem-
bled plasmacellular lymphocytes (Fig 2, al and bl). In all 
cases, I 5% to 20% of the colony cells expressed IL 2 receptors 
on their cell surface. 
DISCUSSION 
It has been shown previously that B CLL cells produce 
colonies in vitro following activation by the plant lectin 
PHA. 11 •12 Successful culturing of the CLL colonies was 
dependent on the presence of (irradiated) T lymphocytes. 
The nature of the stimulatory components produced by the T 
lymphocytes has remained unknown. Moreover. the question 
of whether the lectins exerted a direct effect on the clono-
genic CLL cells or an indirect influence through the T cells 
(or lxlth) has not been answered. The data presented in this 
report show that lectin (PHA)- or phorlxll ester (TPA)· 
activated B CLL colony formation occurs in the absence ofT 
lymphocytes (or other stimulator cells) when pure IL 2 is 
added to the cultures as the single source of stimulation 
(Table I). Membrane receptors for IL 2 were found on high 
percentages of the fresh CLL cells, with the exception of 
patient No. S (Table 1). In addition. such receptors were also 
detectable on the colony cells. including those of patient No. 
S. These results provide evidence that IL 2 in the presence of 
PHA or TPA directly stimulates CLL proliferation. 
In common and pre-BALL. PHA and TPA were found to 
induce IL 2 receptors on the cell membrane initially not 
expressed on the untreated cells.8.9The role of these factors in 
CLL proliferation is not immediately clear, as high percent~ 
ages of untreated CLL cells may already express IL 2 
receptors (Table I). Recent results from )H·thymidine incor-
Table 2. Immunoglobulin Chain a in CLL Colony Calle 
Patlan! 
Cytop!a.mlc lg Cell Slrloce !g 
"· 
PoeJd"" Negative Positive Neoat.lvo 
,. M (95)),. (95) A. D. G.K MA(14) A.D. G.K 
,. M (28) K (89) A. D. G. A M + DK (95) A.D. G. A 
3j M (45) K (64) A. O.G.A M + 0K(84) A.D. G. A 
4• M (87)K (84) A, D,G,A MK(50) A, D,G,A 
Sj M (64)K (65) A. D.G,A M + D~t(84) A. D,G.A 
Numbere in perenthesee ere the percentages ot poait!vo colony cells 
(200 cells counted). 
•Aasessed In PHA + IL 2-lnduc:ed colonies. 
tAssnsed i!"l TPA + IL 2-induced colo.,in. 
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a1 
• 
• 
Fig 2. May-Griinwald-Giamu morphological [a) and anti-~ IQ IIQht chain/FITC •mmunologlc 8talning of cytocantrifuged ~lony calla. a1 
and b1. PHA plull IL 2-lnducad colonlaa (patlan' No.2); a2 and b2. TPA ptua IL 2-inducad colonie:~~ (patlant No. 5). Original magnification 
x 830; currant magnification x41 0. 
poration experiments suggest that PHA (or TPA) activation 
of the CLL cells is required for the continuous expression of 
IL 2 receptors on the proliferating cells in culture from day 3 
on (lvo Touw and Bob LOwenberg. unpublished data). 
Morphological analysis revealed maturation of the CLL 
colony cells. In the TPA-supplemented cultures, colony cells 
expressed the morphology of plasma cells (30% to 75%) or 
intermediate plasmacellular differentiation stages (Fig 2a2 
and b2). In vitro differentiation of CLL cells induced by 
TP A has been noted by others. ll,l 4 In the colonies formed in 
the cultures stimulated with PHA, plasma cell development 
was less prominent (2% to 5%). Nevertheless, the abundant 
presence of M and K or A immunoglobulin chains in the 
cytoplasm (Table 2) and the plasmacytoid appearance of the 
colony cells (Fig 2al and bl) indicated that maturation 
occurred to some extent. High concentrations of IL 2 have 
recently been reported to induce plasmacellular maturations 
of normal B lymphocytes. 1' We wondered whether higher IL 
2 concentrations in PHA cultures would drive CLL colony 
cells toward further differentiation stages, but morphological 
analysis of the colony cells grown in the presence of 500 to 
1,000 units of IL 2 did not provide evidence for this. 
The cells of patient No.4 were exceptional in that they did 
not require addition of IL 2 to culture for TPA-activatcd 
colony formation (Table 1). This raised the question of 
whether minimal numbers of residual (E-positive) T lympho-
cytes had been responsible for the effect through the elabora-
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tion of IL 2 into the culture medium. This possibility appears 
unlikely, since a second E rosette depletion of the CLL cells 
did not eliminate colony growth in cultures with TPA alone 
(data not shown). More plausible explanations are that the 
CLL cells of this patient produced stimulatory components 
themselves or that their colony-forming abilities do not 
depend on growth factors. These alternatives arc presently 
under investigation. 
To this end, it appears that IL 2 has become established as 
a growth and differentiation inducer of normal and neoplas-
tic B cells,,_w including CLL colony-forming cells. Notably, 
CLL cells prohferate in vitro without the need of other 
growth factors, similar to normal B lymphocytes. The exis-
tence of other lymphokines with the capacity to stimulate B 
ceil proliferation, referred to as B cell growth factors 
(BCGFs), has been postulated in a large series of publica-
tions, as recently reviewcd. 16 In order to understand the 
putative role of BCGFs in normal and neoplastic B cell 
regulation additional toIL 2. purification to homogeneity of 
these activities is now of crucial importance. 
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THE PROLIFERATIVE RESPONSE OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA TO 
INTERLEUKIN 2: FUNCTIONAL CHARACTERIZATION OF THE INTERLEUKIN 2 MEMBRANE 
RECEPTORS 
Iva Touw, Lambert Dorssers* and Bob LOwenberg 
The Dr Daniel den Hoed Cancer Center/Rotterdam Radio-Therapeutic Institute, 
Rotterdam and *Radiobiological Institute T.N.O., Rijswijk, The Netherlands 
In order to determine the growth properties of 8 cell chronic lymphocytic 
leukemia (8 CLL) and to identify possible abnormalities thereof, we exam-
ined the in vitro action of interleukin 2 (ll2) in 4 patients. Using radio-
labeled IL2 and monoclonal antibodies reactive with ll2 membrane receptors 
we show that CLL cells, following their activation in vitro, express IL2 
receptors of high as well as low affinity type, exactly as has been re-
ported for normal T and B blasts. In three of the four reported cases, CLL 
proliferation (measured with 3H-thymidine incorporation) depended on the 
addition of phytohaemagglutinin (PHA) to activate the cells and IL2 (opti-
mal concentration 10-100 units of IL2 per ml). In contrast, the cells of 
the fourth case of CLL (CLL-4) proliferated in an autonomous fashion, i.e., 
without a need for PHA and IL2 in culture. Specific blocking of the IL2 
binding sites with anti IL2 receptor monoclonal antibodies almost com-
pletely inhibited the proliferation of these cells, indicating that func-
tional ll2 receptors were required for the autonomous proliferation. The 
demonstration of low concentrations of IL2 activity in the culture medium 
conditioned by the cells suggests that endogenous Il2 had been responsible 
for the spontaneous 3H-thymidine uptake by the Cll cells of patient 4. 
However, we were unable to extract Il2 mRNA from the cells (neither fresh 
nor after various in vitro incubations) in quantities detectable by 
Northern blot analysis which would prove that the CLL cells of patient 4 
were actively synthesizing ll2 during culture. Thus, individual cases of B 
CLL are subject to variable growth regulation involving functional ll2 
receptors on the cell surface: a) following activation with PHA the cells 
respond to exogenous IL2 in a fashion similar to normal 8 lymphocytes, or 
b) the cells are stimulated by endogenous IL2 (or an IL2-like activity) and 
do not require activation with PHA. 
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INTRODUCTION 
Interleukin 2 (IL2) is one of the polypeptide hormones controlling 
the proliferation and differentiation of B cells via surface membrane 
receptors (1-lO). Studies in our laboratory have focused on the role of ll2 
in the proliferation of leukemic B cells, one of the purposes being to 
analyze whether the leukemic cells express abnormal responsiveness to the 
hormone (11). Using a colony culture technique, we have shown that in acute 
lymphoblastic leukemia (ALL) of B cell origin, i.e., common ALL and pre-S 
ALL, ll2 stimulates proliferation, although only when additional factors 
derived from leukocyte feeder cells are present in culture as well (12,13). 
The nature of the latter factors has not been established yet. 
In B cell chronic lymphocytic leukemia (B CLL), IL2 as a single sti-
mulus induces in vitro colony formation, provided that the CLL colony 
forming cells are activated with the phorbol ester 12-0-tetradecanoyl 
phorbol l3 acetate (TPA) or the lectin phytohaemagglutinin (PHA) (14). 
Proliferation of CLL cells stimulated by IL2 and TPA has also been reported 
in 3H Thymidine incorporation assays (15). 
In the present study we characterize the function of the ll2 membrane 
receptors of B CLL cells by using a radiolabeled IL2 preparation and fur-
ther analyze IL2 responsiveness in micro culture. We demonstrate that in 
vitro activated CLL cells express twa classes of ll2 receptors, one with a 
high affinity and one with a low affinity for IL2, a property which these 
cells share with normal activated T and B blasts (5). Results from the 
micro culture experiments show that CLL cells or three patients require ll2 
and activation by PHA for proliferation. On the ather hand in a fourth 
case, CLL cells proliferate without supplementation of IL2 and PHA to the 
cultures. The results of additional experiments suggest that the "sponta-
neous" proliferation of these CLL cells is in fact not IL2 independent, but 
controlled by endogenous IL2. 
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MATERIALS AND METHODS 
Leukemic cells 
CLL cells were isolated by Ficoll-lsopaque separation from the peripheral 
blood of patients which had not received cytoreductive therapy for at least 
12 weeks (16). T lymphocytes were removed by resetting with 2-aminoethyl-
thiouronium bromide (AET) - treated sheep erythrocytes followed by a second 
Ficoll-Isopaque separation (17). The T cell depleted leukemic cell frac-
tions contained 97-100% small lymphocytes and always less than 0.5% 
E-rosette forming cells. Peripheral blood leukocyte counts and immunotypes 
are listed in Table 1. 
TABLE 1. 
Patient 
CLL ,! 1 
CLL f. 2 
CLL f. 3 
CLL f. 4 
HEMATOLOGICAL DATA OF CLL PATIENTS 
Peripheral blood 
leukocyte count 
(x 10-9/1) 
379 
161 
268 
152 
lmmunotype 
lg heavy chain 
M 
M+D,A,G 
M+D 
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Ig light chain 
K 
Cell cultures 
Proliferation of CLL cells was measured by 3H thymidine eH TdR) uptake. 
Cells (1 x 105) were cultured in triplicate in round bottom microtiter 
wells (Greiner, Alphen a/d Rijn, The Netherlands) in 100~1 culture medium. 
This culture medium consisted of Dulbecco's modified Eagle's minimal essen-
tial medium, heat inactivated fetal calf serum (6.7% v/v), heat inactivated 
horse serum (6.7% v/v), trypticase soy broth (6.7% v/v) supplemented with 
dialysed bovine serum albumin (0.75% w/v), egg lecithin (3 x 10-5 M), Na2 
Se 03 (10-7 M), iron saturated human transferrin (7. 7 X w-6 M)), and 
beta-mercaptoethano1 (10-4 M) as modified from Guilbert and Iscove (18). 
Additions to the cultures included 0.1% v/v phytohaemagglutinin (PHA, 
reagent grade, Wellcome, Dart ford, England), pure recombinant IL2 with a 
specific activity of 1.9 x 106 units per milligram protein or approximately 
3 x 1013 units per Mol (Biogen SA, Geneva, Switzerland), and monoclonal 
antibodies reactive with IL2 membrane receptors (see below). Cultures were 
performed in triplicate. Sixteen hours before harvesting of the cells 
(Titertek cell harvester 550), 0-1JUCi of 3H-TdR (Amersham, U.K.) specific 
activity 2 Ci/mmol) was added to each microwell. Radioactivity was measured 
by liquid scintillation counting (Beckmann LS 3800). 
Suspension cultures of CLL cells and normal peripheral blood mononuclear 
cells were performed in test tubes a) to assess IL2 activities elaborated 
into the culture medium, b) to extract RNA from the in vitro stimulated 
cells, and c) to determine binding of radiolabeled IL2 to in vitro stimu-
6 lated cells. Cells (2 x 10 per ml culture medium) were incubated either 
with PHA (0.1% v/v) plus TPA (10 ng/ml), PHA alone, or without additions. 
After various incubation periods (ranging from 4 hrs to 7 days) followed by 
centrifugation, the culture supernatants were collected, filter sterilized 
(0.22 urn filter, Millipore, Bedford, Mass.) and stored at -20• c. for the 
purpose of RNA extraction, the cells were washed twice with Hanks Balanced 
Salt solution (HBSS), collected in Eppendorf micro centrifugation tubes, 
quickly frozen (30 sec.) in liquid nitrogen and stored at -eo•c. for radio-
labeled IL2 binding experiments, the cells were incubated for one hour in 
fresh culture medium and washed five times with ice cold alpha-medium sup-
plemented with 1% w/v BSA. 
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ILZ producing Jurkat cells (a gift from Dr. L.A. Aarden, Central Laboratory 
of the Red Cross Blood Transfusion Service, Amsterdam, The Netherlands) 
were cultured in RPM! medium supplemented with 10% heat inactivated FCS in 
T75 culture flasks (Greiner). For induction of ILZ mRNA the cells were 
cultured in the presence of PHA (1% v/v) and TPA (10 ng/ml) for 6 hrs. 
After two washings with HBSS, the cells were collected for RNA extraction, 
frozen in liquid nitrogen and stored at -ao•c as described above. 
Murine ILZ dependent CTLL cells (a gift from Mrs. S. Knaan-Shanzer, Radio-
biological Institute TNO, Rijswijk, The Netherlands) were cultured as 
described (19). To estimate ILZ concentrations in CLL culture supernatants, 
10, 20 and 40% v/v of these supernatants were tested for their stimulatory 
effects on the proliferation of the CTLL cells. These estimations were 
compared with the proliferative response of the CTLL cells to titrated riL2 
concentrations. 
Cytogenetic analysis 
Spread metaphases of cultured CLL cells were checked for cytogenetic abnor-
malities using Q-, R-, and G Banding Techniques (20). These analyses were 
performed by Dr. A. Hagemeijer and Mrs. E.M.E. Smit (Department of Cell 
Biology and Genetics, Erasmus University, Rotterdam, The Netherlands). 
Monoclonal antibodies reactive with IL2 receptors 
four MoAbs reactive with membrane receptors for ILZ were used: three of 
these, i.e., mouse MoAbs anti-IL2 receptor (Becton Dickinson, Mountain 
View, California), anti-TAC (21) and rat MoAb 18 E 64 (22) compete with IL2 
for binding to the receptor. 
The fourth, rat MoAb 36 A 1.2., has been shown not to interfere with IL2 
binding (22). 
Indirect immunofluorescence 
For immunologic detection of IL2 membrane receptors, cells were treated 
with anti IL2 receptor MoAb and with goat anti mouse immunoglobulin coupled 
with fluorescein isothiocyanate (GAM/FITC, Nordic, Tilburg, The Nether-
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lands) and analyzed on a fluorescence activated cell sorter (FACS 440, 
Becton-Dickinson, Sunnyvale, CA) as described (12). 
RNA extractions, Northern blotting and hybridization with IL2 eDNA probe 
RNA was extracted by two different methods yielding comparable amounts and 
quality of total RNA, i.e., hot phenol extraction (in the presence of 
Vanadyl-ribonucleoside complexes to inhibit RNase activity), and the 
Guanidinium/Cesium chloride method (23). Poly (A)+ RNA was isolated by 
paper affinity chromatography using poly (U) coated paper (Medac, Hamburg, 
Germany) (24). RNA was electrophoresed on formaldehyde-agarose gels (21) 
and blotted onto nylon hybridization membrane (Gene Screen Plus, New Eng-
lend Nuclear, Boston, Massachusetts). The human IL2 eDNA used for hybridiz-
ation was obtained from TPA stimulated Jurkat cells and cloned in a 
G-tailed pBR322 vector (prepared and kindly supplied by Dr. H. Pannekoek, 
Central Laboratory of the Red Cross Blood Transfusion Service, Amsterdam, 
The Netherlands) before use in_ hybridization. The gel purified IL2 eDNA 
fragment containing nucleotides 377-837 (24) was isolated from the vector 
by digestion with Pst I (Boehringer, Mannheim, FRG) followed by polyacryl-
amide gel electrophoresis of the digest. The ILZ eDNA fragment was radio-
actively (32P) labeled by random priming using oligodeoxynucleotides, 
essentially according to Feinberg and Vogelstein (26). Hybridizations were 
carried out as described (23). Autoradiography using Kodak Xomat AR X-ray 
film occurred at -7o•c in the presence of an intensifying screen. 
Binding of radiolabeled IL2 
Before treatment with radiolabeled IL2, the cells were incubated (1 h at 
37• C) in fresh culture medium and washings (5 times with alpha medium 
containing 1% w/v BSA) to remove endogeneous IL2 (24). Then, 106 cells in 
50 /"1 alpha-BSA medium were placed in wells of medium pre-wetted (alpha-
BSA) millititer 96 well 5.0 /"m filter bottom plates (Millipore). To deter-
mine the amount of specific binding, serial dilutions of pure, recombinant 
125r IL2 (Amersham, U.K.) ranging from 6.25 - 800 pM were added to the 
cells. The cells were incubated with the radiolabeled IL2 for one hour at 
37• C. These conditions allow for optimal saturation of high and low affin-
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ity binding sites (27). To correct for nonspecific binding of the 125r IL2, 
incubations were also performed in the presence of excess (i.e., thousand 
fold concentrations) of non-labeled recombinant IL2. All incubations were 
carried out in duplicate. At the end of the incubations, the medium con-
taining the unbound radiolabeled IL2 was sucked away by placing the fil-
tration plates on a vacuum filtration holder (Millipore Filter System). 
Duplicate samples from the incubation medium were taken to determine un-
bound radioactivity. The cells retained by the filter bottoms were then 
washed twice with lOOfl icecold alpha-BSA medium. After drying (30 min. at 
room temperature) the filter bottoms were punched out and collected in 
gamma counter vials. Radioactivity was counted in a 4/200 automatic gamma 
counter (Micromedic System, Horsham, Pa). The data were analyzed using the 
11 ligand" computer program of Munson and Rodbard (28). 
RESULTS 
Expression of ILZ receptors on the CLL cells and binding of radiolabeled 
ILZ 
ILZ receptors, as assessed in indirect fluorescence with MoAb all2r 
and flow cytometry, were absent or weakly expressed on the fresh CLL cells. 
In all cases IL2 receptors were maximally expressed on the cells after 18 
hrs of suspension culture in the presence of 0.1% PHA. Flow cytometric 
histogram analysis indicated that IL2 receptor densities on the in vitro 
activated CLL cells were lower than on PHA activated normal T lymphocytes 
(Fig. 1). 
A binding assay using 125r-IL2 was performed to determine affinity 
and numbers of IL2 receptors on the activated CLL cells. For comparison, 
IL2 receptors on activated T lymphocytes were also studied. Specific bind-
ing of the radiolabeled IL2 was measured at concentrations ranging from 
6.25 to 800 pM. Scatchard plot analysis (Fig.Z) indicated that CLL cells 
expressed two classes of receptors similar to the T cells, i.e., one with 
an affinity for IL2 in the picomolar range and one with an affinity in the 
nanomolar range. The data of these experiments are listed in Table 2. 
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TABLE 2. BINDING OF RADIOLABELED IL2 
Cell type$ High affinity binding If Low affinity binding11 
Kd(pM) Mean number of Kd(nM) Mean number of 
receptors per cell receptors per cell 
CLL f. 1 34 90 n.d. n.d. 
CLL f. 2 7.5 64 n.d. n.d. 
CLL f. 3 28 13 25 13-0 X 103 
CLL f. 4 1.2 11 62.5 20.5 X 103 
normal T 1ympho-
cytes+ 
donor f. 1 10.4 171 28.6 41-0 X 103 
donor f. 2 19 154 n.d. n.d. 
$ Cells had been cultured far 72 h in the presence of 0.1% v/v PHA 
# Estimated using the "ligand" computer program of Munson and Rodberd (27) 
n.d. Not determined 
+ Isolated from normal peripheral blood 
Proliferative response of CLL cells to Il2 
DNA synthesis by CLL cells in culture was estimated by 3H-TdR incor-
poration at various time points during 11 days. Cells were cultured under 
different stimulatory conditions, i.e., in the presence of PHA (0.1% v/v) 
and IL2 (50 units per ml), PHA alone, IL2 alone, and without these ad-
ditions (fig.3). In CLL cases ~ 1, 2 and 3, PHA and IL2 were required for 
induction of proliferation. Omission of one or both of these components 
resulted in significantly less or no incorporation of 3H-TdR. 3H-TdR uptake 
-78-
CLL·1 
' 
hs CLL-4 
0 ;~( 
5 
• 
tJ a i- £;,
0 
07~@?1 
10 
! 
5 !l-
/ /' 
-
0 
3 7 9 11 3 5 11 
DAYS I N CULTURE 
Figu1'e ;; 
3H-TdR incoPpo~tion by CLL ~ells unde1' diffePent stimulato1'y conditions in 
micY'o cultu7'e duM..ng 11 days of culturoe 
(A - A): P8A (0.1% v/V) + IL2 (50 u mC1 J; (. -. J P8A aLone; 
( f::,. - f::,. J: PIL2 aLone; and ! 0 - 0 J: no additions. Left paneL shorus the 
data of the expePiments ~th CLL I 1. CompapabLe PesuLts wePe obtaine~ with 
the oeLLs of CLL I 2 and CLL I 3. In the Pight paneL, the data of 8-TdR 
uptake of CLL I 4 aPe pLotted. 
ZO CLL·Z ZO CLL-4 
"' l ·:: m .. " m H l~ g m !l 1 0 " 
H: 
I!! 
ll! 
m 
if 0 
0 
,,, 
... 0 ::: 
1 10 Z5 50 1001000 0 50 1001000 
IL2 ADDED TO HICROCULTURES (UNITS.ML-1) 
Figuroe 4 
38-TdR incoPpomtion by CLL ceLLs in PeLation to the concentmtion of IL2 
added to the cultu1'es 
The ceLLs wePe incubated with OP ~thout IL2 fop 10 days. Left section: CLL 
I 2 ( oeLLs wePe cuLtuPed in the pPesence of 0.1% v/v P8AJ. Right section: 
CLL I 4 (ceLLs we~e ouZtuPed in the absence of P8A). 
-79-
was significantly reduced, i.e. by 45-77 per cent when anti IL2 receptor 
MoAb interfering with the IL2 binding had been added to the cultures (at 
their initiation). This confirmed that stimulation occurred through IL2 -
IL2 receptor interaction. 
In contrast, 3H-TdR incorporation by the cells of CLL '{. 4 was com-
pletely independent an the addition of PHA and IL2 to the micra cultures. 
To assure that the proliferating cells of the four patients were indeed the 
leukemic cells (and not, e.g., residual normal T lymphocytes) immunologic 
analysis was performed. From this it appeared that an day 7 of culture the 
cells expressed the clonal phenotypes characteristic of the neoplasm (Table 
1). The cultured cells contained less than 1% T cells, as assessed by E 
resetting and MoAb anti-T3 labeling in indirect immunofluorescence. Thus, T 
cells did not significantly contaminate the in vitro growth of the CLL 
cells. Leukemic cell growth was al~o confirmed by cytogenetic analysis. On 
day 7 of culture of the cells of CLL '{. 1, 13 of 15 of the spread metaphases 
expressed abnormal karyotypes, including inv. (X), 22P+ and +22. In CLL ~ 
4, 30 of 31 analyzed metaphases appeared abnormal (i.e., expressing 14 q+) 
after 7 days of culture. 
IL2 dependence was investigated by adding IL2 in increasing concen-
trations to the microcultures (Fig.4). In CLL ~ 1 through 3, optimal pro-
liferation occurred in the presence of 50-100 units of IL2 per ml. On the 
other hand, in CLL ~ 4, maximal incorporation of 3H- TdR was obtained in 
cultures without any addition of IL2. This could suggest that the cells of 
CLL ~ 4 lacked IL2 dependence, or that the cells produced IL2 and that 
proliferation was stimulated by endogenous IL2 (see below). 
Analysis of the 11Spontaneous11 proliferation of CLL cells (case # 4) 
In Cll i 1-3, proliferation depended on the presence of PHA and IL2. 
In contrast, in CLL i 4 the rate of proliferation reached a maximum 
although no IL2 (and PHA) had been supplemented to the cultures (Figs.} and 
4). Epstein Barr Virus nuclear antigen (EBNA) was absent in these cells, 
indicating that these cells had not been transformed by EBV. We addressed 
the question as to whether 11spontaneous 11 proliferation in CLL was truly IL2 
independent or possibly mediated through endogenous IL2. 
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first, we examined the effect of four different MoAbs, reactive with 
IL2 receptor determinants, on the proliferation of the cells of CLL #. 4 
(Table 3). The addition of MaAbs, aiL2r, anti-Tee and 18 £6.4, which com-
pete with ll2 for receptor binding, completely inhibited 3H-TdR incorpor-
ation. In addition, incubation of the cells with MoAb 36 Al.2, an anti IL2 
receptor antibody that does not block IL2 binding, did not exert inhibitory 
effect on proliferation. These results indicated that the IL2 receptors 
(and more specifically the IL2 binding sites of these receptors) had a role 
in the proliferation although the cells had not been exposed to exogenous 
IL2. We hypothesized that these receptors were activated by endogenously 
produced IL2. To test this possibility, IL2 activities elaborated by the 
CLL #. 4 cells into the culture medium, were estimated. Media conditioned by 
CLL cells in suspension cultures were collected at various times (1-7 days) 
and assayed on a murine IL2 dependent (CTLL) cell line. IL2 activities 
(i.e., at concentrations varying from 0.15 to 1.5 units per ml) were indeed 
detectable in these CLL cell conditioned media. Finally, we applied 
Northern analysis using an IL2 eDNA probe to test whether IL2 mRNA was 
present in the cells of CLL #. 4 (fresh and after various in vitro incu-
bations), which would indicate that the cells were capable of synthesizing 
IL2. We were repeatedly unable t~ detect ll2 mRNA in the cells of CLL # 4, 
even when relatively large quantities (i.e., estimated at 2 - 5 f9) of 
purified, poly(A)+, mRNA preparations had been loaded onto the gels 
(Fig.5). At the same time, IL2 mRNAs from control cells, i.e., PHA/TPA-
activated Jurkat cells, as well as from PHA/TPA-activated normal peripheral 
blood T cells were readily demonstrated (Fig.5). The inability to show IL2 
mRNA in cell samples of CLL # 4 could suggest that the endogenous IL2 in 
the culture media conditioned by these cells was nat due to active pro-
duction but represented an activity previously absorbed by the CLL cells 
from an exogenous source. On the .other hand it remains possible that the 
CLL cells did synthesize small quantities of IL2, but that the amount of 
IL2 mRNA remained below the detection level of the Northern Blot analysis. 
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TABLE 3. EFFECT OF FOUR DIFFERENT ANTI IL 2 RECEPTOR MoAbs ON THE "SPONTANEOUS" 
PROLIFERATION OF CLL CELLS (CLL ' 4)# 
Blocking of IL2 binding 3H-TdR incorporation (dpm x 10-3)* 
4.30 + 0.29 (100) 
all 2 r + 0.04!. 0.01 (0.8) 
anti-Tee + 0.02 !. 0.01 (0.4) 
18 E 6.4 + 0.12!. 0.02 (2.9) 
36 A 1.2 4.31 + 0.67 (100.3) 
# IL 2 (or PHA) were not added to the cultures. 
$ Each of the MoAbs was added at saturating concentrations (as assessed in 
indirect immunofluorescence) to microcultures at the initiation of the 
cultures. 
* Assessed on day 8 of culture. Data are expressed as mean ~ standard deviation 
of triplicate cultures. Figures in parentheses represent the percentages of 
control values. 
DISCUSSION 
Recently, it was shown that ILZ is a growth stimulator of B lympho-
cytes, and detailed information with respect to the responsiveness of 8 
cells to IL2, their requirements of activation for the expression of mem-
brane receptors for IL2, and the binding properties of the IL2 receptors 
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Figure 5 
Automdiog7'0.ph of a no1'the1'1Z bLot of poZy(A)+ RNA sampLes f1'om activated 
and nonactivated CLL ceZZs, Ju1'kat ceZZs and peY'ipheY'aZ bLood T Lymphocytes 
The bLot was hybY'idized with a mdioactive eDNA IL2 p1'obe. RibosomaL RNA 
1285 and 185) was Pun in a sepaY'ate Zane (stained with ethidium b1'omide) as 
a size marker'. 
Lane 1: CLL-4~ nonincubated cells; Lane 2: CLL-4~ aftero incubation (4 hros) 
~n the p1'esence of PHA and TPA; Lci.'iie3: CLL-4, 6 h1's PHA/TPA; Lane 4: 
CLL-4, 20 hros PHA/TPA; Lane 5: CLL-4, incubation (20 hr>s) UJithout adW 
ditions; Lane 6: CLL-1, 20 h.,.s PHA/TPA; Lane 7: pe1'iphe1'aZ bLood T Lympho-
cytes, 20 h1's PHA/TPA; Lane 8: Ju1'kat, 6 h1's PHA/TPA. 
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has become available (1-10). Similar studies carried out with leukemic 
cells should reveal whether the response of the cells to growth and differ-
entiation stimuli has been altered as a result of neoplastic transform-
ation. The present experiments were undertaken to determine the properties 
of IL2 receptors and the IL2 responsiveness of leukemic B lymphocytes, 
i.e., in four cases 6 CLL, and to establish whether these features were 
different from those reported for normal B lymphocytes. 
From radiolabeled IL2 binding assays it became apparent that acti-
vated CLL cells express two classes of IL2 receptors, i.e., with a high 
(picomolar range) affinity and with a low (nanomolar range) affinity (Table 
2). Similar data have been reported for murine B cell blasts (5). Mean 
densities of IL2 receptors per cell on the mouse blast cells appeared to be 
considerably (about 200 times) higher than those on human B CLL cells. On 
the other hand, Muraguchi et al., without discriminating between high and 
low affinity binding sites, estimated the mean numbers of IL2 receptors per 
normal activated human B cell at 320 (with a mean Kd of 457 pM) (4). The 
low mean numbers of high affinity IL2 binding sites per cell that we ob-
served in CLL (i.e., ranging from 11 to 90) could indicate that these 
functional receptors are not equally distributed over the total CLL cell 
population, but concentrated on the IL2 responsive clonogenic subfrection 
which comprises only a small minority (less than 0.1 per cent) of the total 
CLL cell population (14). It should be emphasized that the cell suspensions 
had not been enriched for blast cells as was described by Robb et al. (25). 
This may also explain why the mean numbers per cell of high affinity IL2 
receptors on normal activated T lymphocytes that we observed were 10-20 
times less than those reported by Robb et al. for density gradient purified 
T blasts (25). 
In three cases (CLL ~ 1, 2 and 3) proliferation as measured by 3H-TdR 
incorporation was stimulated by IL2. The optimal IL2 concentration in these 
cases was 50-100 units per ml, i.e., in the same order as reported for 
proliferation of normal B lymphocytes (fig.2) (4,10). For en optimal re-
sponse to IL2 the cells of CLL -1. 1, 2 end 3 also required activation by 
PHA. This lectin has been previously shown to activate CLL cells (14,29, 
30). In separate experiments not reported here, the phorbol ester TPA was 
used as the activation signal with comparable results. 
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In contrast to the above described resp~nse pattern of CLL i l, 2 and 
3, the cells of CLL ~ 4 proliferated independently on exogenous IL2 and did 
not require PHA as an activating factor (figs. 1 and 2). Nonetheless, after 
in vitro incubation the CLL -1. 4 cells expressed functional IL2 receptors 
with a high affinity for IL2 (Table 2). Upon further analysis it became 
evident that spontaneous proliferation of the CLL -1. 4 cells was most likely 
induced by endogenous IL2: Specific blocking of IL2 receptors with mono-
clonal antibodies almost completely abrogated cell proliferation (Table 3). 
Moreover, concentrations of IL2 activity within the picomolar range were 
detected in the growth medium in which the cells from CLL i 4 had been 
cultured. One could argue that this endogenous IL2 activity had been pro-
duced by activated contaminant T lymphocytes. for two reasons we consider 
this possibility unlikely: 
1) In the fresh (T cell depleted) material no T lymphocytes were detect-
able, and immunological and cytogenetic analysis indicated that T lym-
phocytic cells had not expanded during culture either. 
2) T lymphocytes require activation (e.g., by the lectin PHA) or a phorbol 
ester for IL2 production, whereas "spontaneous" proliferation of the CLL 
i 4 cells and elaboration of IL2 into the culture medium occurred in the 
absence of PHA. 
Therefore it is most plausible to assume that indeed the CLL cells (CLL ~ 
4) elaborated IL2 into the culture medium. The suggestion that normal and 
transformed 8 cells can produce cytokines, including ll2, was recently 
raised by several investigators (31-33). To investigate whether the cells 
of CLL i 4 were able to synthesize IL2 we attempted to detect IL2 mRNA in 
the cells, however, with negative results (fig.5). Thus, if the cells 
really produced IL2, they formed IL2 mRNA in a quantity below the detection 
level of the Northern analysis. Typically, this could be the case when only 
a small portion of the CLL cells, e.g., the proliferating subpopulation 
under the applied in vitro conditions, synthesized IL2. More sensitive 
detection methods, e.g., 51 nuclease mapping or in situ hybridization 
techniques, will be needed to clarify this issue. Other explanations for 
the failure to detect IL2 mRNA are that the cells of CLL 4 produced an 
IL2-like activity with a protein structure discrepant from T cell derived 
IL2, or that the CLL cells released IL2 that had previously been absorbed 
by the cells from external sources. 
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Taken together, the present experiments have established that the 
proliferation of Cll cells in vitro is regulated by IL2 through direct 
Il2-IL2 receptor interaction, similarly to that of normal B lymphoblasts. 
In addition, the experimental data could suggest that in some cases the CLL 
cells are capable of autocrine IL2 mediated stimulation. Autocrine growth 
may be the result of neoplastic transformation and it has been suggested as 
a mechanism of maintaining tumor cell proliferation (J4). On the other 
hand, it has become clear that normal cells may be controlled by autocrine 
mechanisms of growth as well. For example, T lymphocytes proliferate in 
response to autocrine IL2 (35). It is unknown whether (subpopulations of) 
normal B cells may also be capable of autostimulation. Therefore, at the 
present time, it remains uncertain as to whether the growth characteristics 
of the cells of Cll ~ 4 represent those of a normal B-lymphocytic subset, 
or whether they are typical of the transformed status of the neoplastic 
cells. Irrespective of this question, it is intriguing that primary tumor 
cells from individual patients, that apparently descended from the same 
type of cell (i.e., early B lymphocyte), may show markedly different in 
vitro growth characteristics. 
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!7 Acute Lymphoblastic Leukemia and non Hodgkin's Lymphoma ofT Lineage: Colony Forming Cells Retain Growth Factor (lnterleukin 2) Dependence 
BZood1 in pPess~ 1986 
ACUTE LYMPHOBLASTIC LEUKEMIA AND NON HODGKIN'S LYMPHOMA OF T LINEAGE: 
COLONY FORMING CELLS RETAIN GROWTH FACTOR (INTERLEUKIN 2) DEPENDENCE 
Iva Touw, Ruud Delwel, George van Zanen* and Bob LOwenberg 
The Or Daniel den Hoed Cancer Center/Rotterdam Radio-Therapeutic Institute 
and *Sophia Children's Hospital, Rotterdam, The Netherlands 
The regulatory role of interleukin 2 (IL2) in the proliferation of T 
acute lymphoblastic leukemia (T ALL) and T non Hodgkin's lymphoma (T NHL) 
cells from six individual patients was analyzed in a colony culture system 
to which pure recombinant IL2 (r-IL2), and the lectin phytohaemagglutinin 
(PHA) or the phorbolester 12-0-tetradecanoyl phorbol-13-acetate (TPA), had 
been added. The proliferative response was correlated with the inducibility 
of receptors for IL2 on the surface membrane of T ALL and T NHL cells by 
incubation with TPA or PHA for 18 hours. Leukemic T cell colonies, ident-
ified by immunophenotyping or cytogenetic analysis, appeared in vitro 
following TPA and IL2 stimulation in all six cases. Accordingly, receptors 
for IL2, initially absent from the cell surface, were found on high pro-
portions of the T ALL and T NHL cells after in vitro exposure to TPA. In 
contrast, colony formation stimulated by PHA, and the induction of 1L2 
receptors by PHA, were limited to the one case of T NHL with the mature 
thymocyte immunophenotype. The cells from the other patients, expressing 
common or prothymocyte phenotypes, did not respond to PHA. No colonies were 
formed in any of these cases when PHA or TPA were withheld from the IL2 
containing cultures. While colony growth depended absolutely on exogenous 
IL2 in three cases (ALL), in the three other cases (l ALL, 2 NHL) some 
colonies grew also when no IL2 had been added to the cultures. Upon further 
analysis of the cells of one of the latter patients, it was found that the 
cells produced IL2 and proliferated in response to this endogenous IL2. The 
results from this study indicate that the requirements of endogenous versus 
exogenous IL2 for cell proliferation in T ALL and T NHL, and IL2 receptor 
activation by PHA and TPA vary from patient to patient. In addition, they 
support the notion that T ALL and T NHL cells have not lost dependence on 
Il2 and IL2 receptor activation for in vitro growth. 
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INTRODUCTION 
Attempts at understanding the underlying mechanisms of tumor growth 
are concerned with the possibility that neoplasms are disturbed in their 
response to growth factors. Their uncontrolled outgrowth may be caused by 
an altered sensitivity to growth regulators (e.g., as a result of aberrant 
expression or function of membrane receptors) or to the acquired ability to 
self-produce factors (1). These phenomena have been described for a variety 
of tumors and in a number of cases they were found to correlate with the 
expression of oncogenes (2-4). Alternatively, proliferation of tumor cells 
may become completely independent on normal growth regulators (4). 
The availability of interleukin 2 (IL2) gene probes, pure recombinant 
IL2 preparations and monoclonal antibodies reactive with cell surface 
membrane receptors for ILZ (5,6) allow for the analysis of growth require-
ments of human T cell leukemias. These approaches have b_een pursued mainly 
in leukemias of mature T cell type, in particular those associated with the 
human T cell lymphotropic virus I {HTLV I) (7). Until now, however, scarce 
information is available on the control of proliferation by IL2 in immature 
type T cell neoplasms i.e., T acute lymphoblastic leukemia (T ALL) and 
certain T cell non Hodgkin's lymphomas (T NHL). 
In the present study, we have examined TALL and T NHL cells from six· 
individual patients for their proliferative response to ILZ. We applied a 
colony culture technique in which pure recombinant IL2 (r-ILZ) was added as 
the single growth factor. The lectin phytohemagglutinin (PHA) or the phor-
bol ester 12-0-tetradecanoylphorbol-13-acetate (TPA) was supplemented 
simultaneously for activation of the cells. Our findings indicate that 
distinct patterns of ILZ and activation requirements can be recognized in 
individual cases of T ALL and T NHL. However, like normal T cells, the 
leukemia cells remain dependent on TPA or PHA activation and ILZ for 
proliferation. The proliferating neoplastic cells do not acquire new 
surface antigens indicative of maturation to later cell stages, suggesting 
that their capacity to differentiate in vitro is very limited. We conclude 
that proliferation of T ALL and T NHL cells cannot be simply explained by 
the loss of control by ILZ or by the aberrant (i.e., independent on 
activation) expression of membrane receptors for IL2. 
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Table 1 SELECTED DATA OF PATIENTS WITH T ALL AND T NHL 
patient age sex diagnosis 
1 8 f T ALL 
2 4 f T ALL 
J 10 M T ALL 
4 JO M T All 
5 19 M T NHL 
6o 6J H T NHL 
blood leukocyte 
count (xlu-9/l) 
180 
lOO 
200 
5J 
40 
166 
leukemic immunophenotypex 
(~ positive cells) 
WTl n T4 T6 TH 
98 0 0 0 u 
45 0 0 u u 
lOU w 7 J lJ 
9H 0 J4 98 96 
n.d. 0 J4 J7 64 
96 98 94 0 0 
Patients no. 1-5 TdT positive; patient no. 6 TdT negative. In none of the cases the leukemic 
cells expressed Ia antigens. 
x : assessed by indirect immunofluorescence and E rosetting (200 cells counted) 
W : weak expression (see fig.!) 
• : 88~ of the cells expressed TlO antigens 
n.d. : not determined 
patient 5: diffuse, lymphoblastic lymphoma 
patient 6: diffuse, well differentiated lymphocytic lymphoma. 
E 
u 
75 
9J 
92 
HU 
95 
MATERIALS AND METHODS 
Patient data and immunologic phenotypes of leukemic T cells 
Selected clinical and immunological data of the patients entered into this 
study are summarized in Table 1. Patients with prothymocyte-like (stage I) 
leukemic cells (TdT+, WTl+, £+1-, T3-, 14-, T6-, T8-) had been diagnosed 
cyto-histopathologically as cases of T All (patients no 1 to 3), patients 
carrying thymocyte-like (stage II, stage Ill) malignant T cells (T3-, T6+, 
T4/T6+ or T3+, T4+, TlO+, T6-, TB-) as T ALL (patient 4) or leukemic T NHL 
(patients no 5 and 6) (6,9). 
Isolation of leukemic T cells 
Leukemic cells were isolated from peripheral blood or bone marrow using 
ficoll Isopaque separation (10). A further separation was applied to remove 
residual normal ([+, T3+) T lymphocytes as, in most cases, these could 
interfere with leukemic growth in the IL2 supple:nented cultures. In one 
case of E rosette negative TALL (i.e., patient no. 1) normal T cells were 
eliminated by E rosette depletion using 2-aminoethylthiouronium bromide 
(AET) treated sheep erythrocytes as described (1). In the other cases 
(i.e., patients no. 2, 3, 4 and 5) residual normal T lymphocytes were 
removed from the leukemic cell fractions on the basis of differential T3 
antigen expression on normal and neoplastic T cells by fluorescent staining 
of the T3 antigen (see below) followed by fluorescence activated cell 
sorting (FACS 440, Becton- Dickinson, Sunnyvale, Ca) (Figure 1). The cells 
of patient no. 6 were studied without further separation as both cytogen-
etic and immunologic analysis of fresh and cultured cells indicated that 
contaminating growth of normal T cells did not occur. 
Isolation of E rosette forming lymphocytes from normal peripheral blood 
samples 
E rosette forming lymphocytes were recovered from the sediment after cen-
trifugation of AET -E rosetted cells through ficoll-lsopaque as described 
( 1). Sheep erythrocytes were removed from these fractions by hypotonic 
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Figure 1 : Fluo~esaence activated cell so~e~ histogPams of Ficoll-
Isopaque isoZated ceZZs of patient no. 3 IT ALL) afte~ OKT3 + GAM/FITC 
I - ) and GAM/FITC contPoZ ( --- ) staining. 
The ALL cells of this patient sho~ed a weak T3-antigen ezpression~ whe~eas 
Pesidua.Z norrmaZ. T Zymphocytes (intePfe'Y'ing st.,.ongZy 7JJith leukemic coZ.ony 
gPowth) expPess the T3-antigens in a high density on their' cell suP[ace. To 
eZiminate the noPmaZ T ceZZs fpom the ALL ceZZ sampZe of this patient (and 
of patients no. 2~ 4 and 5) cell SOPting was pepforrmed on the basis of T3 
fluopescence intensity. The Ve1"tically d~ inte1"Pupted line indicates the 
level at which the cells wePe sepa~ted; ALL cells WB1"B recovePed left fPom 
the r~ction with low f!uopescence intensity. 
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lysis (incubation for 5 min at 37•c in 0.75% w/v NH4C1 in 3mM Tris-HCl pH= 
7.2) 0 
Immunofluorescence 
Surface membrane antigens on fresh and cultured cells were assayed by 
indirect immunofluorescence microscopy using murine monoclonal antibodies 
(MoAb) and goat anti-mouse Ig immunoglobulins coupled to fluorescein iso-
thiocyanate (GAM/FITC; Nordic, Tilburg, The Netherlands) (12). The presence 
of terminal deoxynucleotidyl transferase (TdT) in the cell nuclei was 
assessed on cytocentrifuged cells using an indirect immunofluorescence kit 
(Gibco, Ghent, Belgium). 
Monoclonal antibodies (MoAb) 
MoAb reactive with the T3, T4, T6, TS and T10 antigens and with the 
!a-antigen were obtained from Ortho Pharmaceutical Corp. (Heritan, N.J.) 
and all used in a 1:40 dilution. MoAb WT1, reactive with a pan-T cell 
antigen (3) was supplied by Dr. W.J.M. Tax (Nijmegen, The Netherlands) and 
used in a titer of 1:100. MoAb anti-IL2-receptor (all2r) obtained from 
Becton-Dickinson (Mountain View, CA) was used in a l:2U dilution. The 
anti-Tac (14). MoAb reactivity of this 
Hl3.9, detecting a 
antibody is identical to that of 
myelocytic antigen, was a gift from Or. P. Lansdorp 
(Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, 
Amsterdam) • 
Colony culture 
Colony cultures were performed basically as described for normal T cell 
colony formation (15) with the following modifications: 
1) Feeder leukocytes were not included in the system as a source of growth 
stimuli. Instead, pure recombinant ILZ (Biogen SA, Geneva, Switzerland) 
was added to the culture upper layer. 
2) Either PHA (reagent grade, Wellcome, Dartford, England) at a concen-
tration of 0. 7% v/v, or the phorbol ester TPA at a concentration of 7 
ng/ml (Sigma Chemicals, St. louis) were used as mitogens in culture. 
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Colony cells were mass-harvested with a Pasteur pipette, washed three times 
with phosphate buffered saline (PBS) and prepared for indirect immunofluor-
escence and E rosette formation. In one case (patient no. 6), the colony 
cells were analyzed cytogenetically (Dr. A. Hagemeyer, Dept. of Cell 
Biology and Genetics, Erasmus University, Rotterdam). 
Induction of IL2 receptors 
Short-term (18 hrs) suspension cultures supplemented with PHA or TPA to 
induce membrane receptors for ll2 were performed as described (16). After 
culture, the cells were washed three times with Pl:35 and prepared for in-
direct immunofluorescence with the anti ILZ surface receptor (alLLr)-anti-
body. 
Micro culture of NHL cells and in vitro blocking of ll2 receptors 
Proliferation of NHL cells in culture as measured by 3H-Thymidine uptake 
was examined with and without blocking of IL2 receptors. Parallel cultures 
were established to which MoAb aiLZr (lgGl, non cytotoxic), control MoAb 
(OKT3, 813. 9) or no MoAb had been added at their initiation. lxl05 cells 
were cultured in triplicate in round bottom microtiter wells (Greiner, 
Alphen aan den Rijn, The Netherlands) for 3 days in 1UU~1 RPMI 1640 medium 
(Gibco) with 10% heat-inactivated fetal calf serum supplemented with 
-5 5xl0 M b-mercaptoethanol and !-glutamine (referred to as complete RPMI 
medium) supplemented with 0.1% PHA. Sixteen hours before harvesting of the 
cells (Titertek cell harvester 550) 0.1 fCi of (3H)-Thymidine (Amersham, 
U.K., specific activity 2 Ci/mmol) was added to each microwell. Radioac-
tivity was measured by liquid scintillation counting (Beckman LS 38UU). All 
cultures were performed in triplicate. Data are expressed as mean d.p.m. ~ 
standard deviation of triplicate cultures. 
ILZ assay 
Murine IL2 dependent CTLL cells (a gift from Mrs. S. Knaan-Shanzer, Radio-
biological Institute TNO, Rijswijk, The Netherlands) were cultured in 
triplicate after three washings with Hanks Balanced Salt Solution (HBSS) in 
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Table 2 INDUCTION OF IL2 RECEPTORS AND COLONY FORMATION 
* COLONY FORMATIONx PATIENT IL2 RECEPTOR EXPRESSION 
(% positive cells) (different stimulatory conditions) 
Un- TPA# PHA# TPA TPA PHA PHA IL2 None 
treated + IL2 + IL2 (25 u) 
(25 u) (25 u) 
l 0 97 0 0 0 0 0 0 
2 0 47 0 30 0 0 0 0 0 
3 3 61 5 47 36 0 0 0 0 
4 0 20 0 14 0 0 0 0 0 
5 5 18 2 35 23 8 0 0 0 
6 0 22 95 41 0 166 106 0 0 
normal T$ 0 55 24 n.d. n.d. 539 88 0 0 
normal T$ 0 26 55 410 266 872 72 0 0 
,!: Determination of IL2 receptors following 18 hours of TPA/PHA supplemented 
suspension culture (see Materials and Methods) 
5 
x: Colony numbers per 2.10 plated cells 
*: See Table 1 for description of patients 
$: E positive lymphocytes purified from normal donor peripheral blood 
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complete RPMI medium at 1x105 cells/lUO fJl in microtiter wells. At 20 
hours, cultures were supplemented with 0-l~Ci 3H-TdH and 4 hours later the 
cells were harvested and assayed for 3H-TdR incorporation by liquid scin-
tillation counting. To estimate IL2 concentrations in T NHL culture-super-
natant, the proliferation of CTLL cells in the presence of these super-
natants was compared with proliferation in response to titrated r-IL:t. 
concentrations (ranging from O.Ul to 100 units per ml). 
Preparation of T NHL culture-supernatant 
6 2xlU cells T NHL cells per ml complete RPM! medium with or without l% v/v 
PHA in 6 ml tubes (Greiner) were placed in the incubator for 3 days. Super-
natants were then recovered, filter sterilized through a U-22 f!m filter 
(Millipore, Bedford, Mass) and stored at -zo•c. 
RESULTS 
Induction of IL2 receptors 
Untreated T ALL and T NHL cells, like normal peripheral blood T 
lymphocytes, did not express membrane receptors for IL2 as measured in 
indirect immunofluorescence using MoAb aiL2r (Table 2). Studies on cells 
from short-term (18 hrs) suspension-cultures then disclosed that Il2 recep-
tors appeared on significant proportions of the cells when TPA or PHA had 
been added to these cultures (Table 2). In the absence of TPA/PHA, !L2 
receptor induction did not occur. A striking discrepancy with respect to 
PHA sensitivity was evident between the prothymocyte or immature thymo-
cyte-like leukemia cells (i.e., patients no. 1-5) and the normal T lympho-
cytes. These leukemias, in contrast to the normal T cells, did not respond 
to PHA. In contrast, the cells of patient 6 carrying a mature thymocyte 
phenotype were sensitive to activation by both TPA and PHA, thus sharing 
this property with normal peripheral T cells. 
Colony stimulation 
To assess the proliferative response of the normal T and the T NHL/ T 
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ALL cells to ILZ, the cells were plated in colony culture under selected 
stimulatory conditions (Table 2). Colony formation by the normal T lympho-
cytes depended on the presence of both IL2 and mitogen (either PHA or TPA). 
When the addition of mitogen (i.e., PHA or TPA) was omitted from ll~ con-
taining cultures, no colonies were formed, which is in agreement with the 
finding that non-activated T cells lack membrane receptors for ILZ. Un the 
other hand, suboptimal colony formation was noted in the presence of TPA or 
PHA when no IL2 had been added to the cultures. The fact that some colonies 
develop in non IL2 supplemented cultures is most likely to be explained by 
endogenous production of ll2 by the T cells, stimulated by the 11 interleukin 
1 like11 activity of TPA (17) and/or some residual monocytes present among 
the cells. 
The colony forming abilities of the cells from patients no. 1-5 were 
clearly different from those of normal blood T lymphocytes. The cells did 
not form colonies in response to PHA, even when ll2 had been added to 
culture. In contrast, when combined with TPA, ll2 stimulated the formation 
of considerable numbers of colonies in all of these cases. The capacity of 
the cells to form colonies in response to TPA but not to PHA, was entirely 
in accordance with, respectively, the ability and inability of these com-
pounds to induce IL2 receptors in the individual cases. The cells of 
patient 6 showed a divergent response pattern: Colony formation and IL2 
receptor induction occurred with either TPA or PHA. 
To define the IL2 dependence of T ALL and T NHL colony forming cells, 
IL2 dose-titration experiments were performed (Fig. 2). These experiments 
show that the T ALL cells of patients 1 and 3, activated by TPA, like 
normal T lymphocytes require the addition of IL2 to the cultures for opti-
mal colony formation (panels A, B and D). Patient no. 1 is representative 
of the pattern in which the cells are typically absolutely dependent on the 
exogenous supply of IL2 to culture. This type of response also applies to 
that in patients no. 2 and 4. Plateau IL2 requirements for leukemic colony 
formation were variable, i.e., 25 units per culture dish for patient 1 and 
0.1 units per dish for patient 3. further increases in ll2 concentrations 
(up to 500 units per culture dish) did not significantly alter the numbers 
of (normal and leukemic) colonies. The TPA activated T ALL cells of patient 
3 produced colonies (although in suboptimal numbers) without the addition 
of IL2. A similar phenomenon was evident with the T NHL cells of patient 6, 
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cultured with PHA (panel C). These findings raise the possibility that 
certain T ALL and T NHL cells are capable of IL2 release and autostimu-
lation (see below). 
Colony typing 
Membrane marker analysis was performed after colony culture (Table 3) 
and the immunophenotypes of colony cells were compared with those of the 
fresh cells. Immunologic phenotypes of the leukemic colony cells in general 
reflected similar stages of maturation as the cells before culture. for 
example, colony cells from patient l, 2 and 3 still expressed the surface 
antigens, characteristic of their preculture immaturity (Table l). 
Table 3 SURFACE MEMBRANE ANTIGENS UN COLONY CELLS 
* Percentage of positive colony cells 
WTl T3 14 T6 Tti t:: 
1 96 0 0 5 1 u 
2 77 1 13 u 0 95 
3 88 3 0 3 0 85 
4 86 0 0 0 98 9U 
5 65 4 70 16 9 73 
6 lOU 58 85 0 0 96 
norma! T 65 90 60 u 26 86 
normal T 88 87 67 Q 27 9U 
# Preculture phenotypes of the leukemic cells are given in Table l 
* Assessed by indirect immunofluorescence (200 cells counted) 
Colony cells of patients no. 4 and 5 appeared slightly more mature 
than the cells before culture, since they had largely lost the T6 antigen. 
In neither of these two cases, however, maturation had progressed toward 
the T3 positive matu-re-thymocyte differentiation stage. Normal T-cell 
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colonies (Table 3) contained mature activated T lymphocytes with blastic 
appearance and a mature T-cell immunophenotype, i.e., T3+, T4 or TB+, T6-, 
wn+ and E+. Colony cells of patient 6 expressed the normal phenotype. It 
was identical to that of the pre-culture cells i.e., resembling that of 
mature activated normal helper T cells (T3+, T4+, T6-, TB-, TlO+). The fact 
that these colonies were indeed leukemic was apparent from cytogenetic 
analysis. It was found that 91% of the colony cells in metaphase had the 
complex cytogenetic abnormality 46, XY, 6q-, 7p+, t(Bp+; llp-q?), 12 q+, 
-14, 15p+, + Mar (14q-?) which had been demonstrated in 76% of the fresh 
NHL cells in metaphasis. 
Analysis of growth requirements of leukemic T cells that do not depend on 
the addition of IL2 for proliferation 
Colony formation in three cases occurred in spite of the absence of 
exogenous IL2 (i.e., in patients no. 3 and 5 with TPA alone and in patient 
no. 6 with PHA alone (Table 2, Fig. 2). Possible explanations for these 
findings are that these leukemias either proliferated independently on IL2 
or that IL2 was needed but provided by the neoplastic cells themselves. To 
clarify this question, the cells of patient no. 6 (NHL) were studied in 3H-
Thymidine incorporation microculture assays (Fig. 3). 
First, it was investigated whether the cells were capable of IL2 
production. Culture supernatants conditioned by PHA activated T NHL cells 
(T NHL-CM) were tested for IL2-activity by inducing proliferation of CTLL 
cells (murine IL2 dependent cell line). From figure JA it can be seen that 
increasing concentrations of T NHL-CM stimulated CTLL proliferation pro-
gressively. IL2 activity of the T NHL-CM was estimated at approximately 5 
u/ml by comparison with dose response relationships of pure riL2. Without 
PHA activation, the culture media conditioned by the NHL cells contained 
only l u/ml ILZ activity. 
The elaboration of IL2 in the culture medium by the NHL ·cells of 
patient no. 6 and the appearance of IL2 receptors on these cells following 
PHA stimulation suggested that their proliferation depended on the release 
of endogenous IL2. Therefore, we investigated the effect of blocking of IL2 
membrane receptors (with the anti IL2 receptor MoAb all2r) on the prolifer-
ation of the T NHL cells in the absence of exogenous IL2 (Fig. 38). Cul-
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turing of the cells in the presence of MoAb all2r resulted in a 60-70% 
inhibition of 3H-TdR incorporation. On the other hand, a) the incubation of 
T NHL cells with control MoAb OKT3 (IgG2a) or 81}.9 (IgGl), or b) the 
incubation of control (AML) cells with MoAb all2r did not result in a 
significant suppression of 3H-TdR incorporation. 
Taken together, these data confirm that the T NHL cells of patient 6 
indeed require IL2 for proliferation. Notably, however, exogenous IL2 is 
not required as the cells elaborate their own IL2 at effective concen-
trations. 
DISCUSSION 
The induction of proliferation of normal T lymphocytes in vitro 
involves a dual step mechanism in which an activator (e.g., antigen, 
lectin, phorbol ester) and the lymphokine IL2 (previously designated as T 
cell growth factor) are both essential components (18). Activation is 
required to induce receptors for IL2 on the T cell-membrane, thereby ren-
dering the cells sensitive to the growth factor. The discovery that certain 
(HTLV-infected) leukemias of mature T cell type continuously express IL2 
receptors without prior activation (8) and the finding that some cutaneous 
T cell leukemia/lymphoma cell lines produce and respond to IL2 (19,20) 
supported the idea that the growth of leukemic T cells depends on a per-
manent responsiveness to IL2 in association with the ability to self-pro-
duce this growth factor. Such a model of autostimulation, driven by IL2, 
was initially thought to be crucial in the development of HTLV associated 
neoplasms (19). However, this suggestion was later considered less likely, 
as it was found that not all HTLV induced leukemias are capable of IL2 
production. In addition, the cells of the latter neoplasms did not always 
require (endogenous or exogenous) IL2 for proliferation (21). 
In another class of mature T cell leukemia, i.e., malignant cutaneous 
T cell lymphoma (SI!zary' s syndrome) the cells wer-e found to produce and 
respond to IL2 in vitro following stimulation with PHA and TPA (22). S~zar-y 
cells, with few exceptions, are not infected with HTLV (23). They generally 
lack spontaneous IL2 receptor expression and ere therefore dependent on 
mitogenic stimulation. The autocrine secretion of IL2 by Sl!zary cells, 
however, is not a tumor associated characteristic, as normal T-helper 
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lymphocytes express the same ability (24,<5). 
The role of ILZ in the regulation of the growth of T ALL and T NHL 
has as yet remained a rather unexplored area. The present study was under-
taken to establish the in vitro culture requirements of these T cell neo-
plasms. The results from colony culture and 3H-Thymidine incorporation 
experiments indicate that T All and T NHL cells from 6 individual patients 
had remained dependent on IL2 (either added to the cultures or endogenously 
produced) for proliferation (Table 2, Figs. 2 and 3). Besides IL2, T ALL 
and T NHL cells require activation by TPA for colony growth. In all cases, 
colonies were formed in TPA plus IL2 supplemented cultures (Table£). TPA 
is needed for the induction of IL2 surface membrane receptors on the T ALL 
and T NHL cells. Fresh leukemic T cells lacked these receptors, whereas 
exposure to the phorbol ester resulted in their appearance on a high pro-
portion of the cells (Table 2). The induction of receptors for IL2 by TPA 
on certain leukemic T cell lines initially lacking such receptors has also 
been reported (26). Thus, TALL and T NHL cells share with normal T lympho-
cytes the requirement of activation before they are capable of responding 
to IL2. 
Whereas it is clear that the interaction of foreign antigen with 
antigen receptors on the cell surface is the in vivo activation signal for 
T lymphocytes and stage III thymocytes, no in vivo mechanism underlying 
activation of immature T cell types (i.e., not expressing the T3 antigen 
receptor complex on the cell membrane) is known. Therefore, no conclusions 
can as yet be drawn from our in vitro experiments as regards the role of 
ILZ in the proliferation of stage I and stage II thymocyte like T ALL and T 
NHL cells in vivo. However, it was recently shown that Ill receptors are 
present on a population of freshly isolated murine thymocytes with an 
immature (Ly2-, L3T4-) immunophenotype (27,2~), and on this basis it was 
suggested that thymocytes can be activated by a stimulus intrinsic to the 
thymus (27). If this hypothesis is correct it raises the possibility that, 
in vivo, the IL2 responsiveness of leukemic T cells with stage I or stage 
II thymocyte immunophenotypes can be induced, in situ, in the thymus. 
Notably, thymic involvement is frequently observed in T ALL end T NHL. 
Unlike TPA, PHA exerted an effect only in the one case of T NHL ex-
pressing a mature thymocyte (stage III) immunophenotype (Table 2, patient 
no. 6). The expression of ll2 receptors and colony formation were induced 
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by PHA (as well as by TPA) in this mature (stage III thymocyte) positive 
NHL. The other, pro- or immature (stage I, stage II) thymocytelike tumors 
lacked PHA responsiveness. They share this inability with their putative 
normal thymic counterparts (29). Using Jurkat cells and a variety of 
mutants derived from this cell line it was recently shown that PHA respon-
siveness of T cells is directly related to the expression of the J3- anti-
gen receptor complex on the cell surface (JU). 
In three cases (i.e., patients no. 1, 2 and 4), colony formation was 
strictly dependent on the addition of IL2 to culture. The fact that ll2 had 
to be added suggests that the neoplastic cells were not capable of IL2 
production. However, on the basis of our experiments we cannot exclude the 
possibility that some IL2, insufficient for autostimulation, was actually 
released by the cells of these patients. On the other hano, in the three 
other cases (i.e., patients 3, 5 and 6) colony growth was apparent with TPA 
or PHA as single additive to culture end did not require exogenous IL2. lt 
was documented in one of these cases (patient no. 6) that the neoplastic 
cells produced considerable amounts of IL2. Culture media conditioned by 
the T NHL cells of patient. 6 contained IL2 activity in the order of 5 units 
per ml. Thus, we propose that T ALL and T NHL may be subdivided into cat-
egories on the basis of in vitro proliferation characteristics, i.e-, (1) 
responsive to both TPA and PHA, ( 2) responsive to TPA but not to PHA, ( 3) 
capable of ll2 production in sufficient amounts for self-stimulation in 
colony culture and (4) not capable of significant IL2 production. Normal T 
cells at diffe.rent stages of maturation may express identical features. 
Therefore, the results of our in vitro studies as yet do not provide indi-
cations for a disordered response to IL2 underlying the uncontrolled pro-
liferation in T ALL and T NHL. However, it is at present not known whether 
critical abnormalities exist in these T cell leukemias as far as the de-
tailed requirements of activation of IL2 synthesis, activation and down 
regulation of IL2 receptors, and function of these recep~ors are concerned. 
Such abnormalities have been described for adult T cell leukemia and cer-
tain. leukemic T cell-lines (6,31). 
Results from immunophenotyping provided no positive evidence for 
differentiation of the T ALL and T NHL cells during colony formation in 
cultures supplemented with TPA. No acquisition of new differentiation 
antigens (e.g., E, T3, T6) indicative of in vitro maturation of the leu-
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kemic T cells was apparent (Table 1, Table 3). These data contrast with 
those of experiments with certain leukemic T cell lines (Jurkat, CtM and 
Molt-}) in which TPA was found to induce the expression of E rosette recep-
tors and T3 antigens (32,33,34). 
Cloning efficiencies of T All/T NHL cells in IL2 plus mitogen con-
taining cultures were significantly lower than of normal peripheral T cells 
(Table 2). This raises the question as to whether culture conditions were 
suboptimal for T ALL and T NHL, for example, because T ALL and T NHL cells 
require other lymphokines for proliferation besides ILZ. The finding that 
the afore mentioned subpopulation of mouse thymocytes (i.e., early lyl-/ 
L3T4- thymocytes) do not respond in vitro to IL2, although the cells ex-
press functional (i.e., high affinity) IL2 membrane receptors (L7,2~) 
suggests that other growth factors, in combination with IL2, act on early 
stages of (murine) T cell maturation and possibly on the leukemic counter-
parts of the analogous cell types. Results from previous work on non-T ALL 
indicated that in vitro colony formation by common and pre-~ ALL cells 
depends on the combined exposure to IL2 and a second factor elaborated by 
feeder leukocytes (16). However, we could not demonstrate a significant 
effect of the same crude source of stimulation on colony forming cells of 
ALL/NHL ofT lineage (results not shown). To further elucidate the critical 
requirements additional to ll2 far in vitro colony growth of T ALL and T 
NHL cells, the availability of pure (recombinant) growth factor prep-
arations will be essential. 
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Production ofT Lymphocyte Colony-Forming Units From Precursors 
in Human Long-Term Bone Marrow Cultures 
By lvo Touw and Bob LOwenberg 
T cell differentiation in human marrow was studied in 
D&;Kt&r Type long-term bone marrow cultures. In these 
cultures, T lymphocyte colony-forming units {TL-CFUl. E 
rosette-forming cells IE+), end T3". T4", end TS" cells 
(essayed by indirect immunofluorescence) were found to 
be present for at least 7 weeks. It was investigated 
whether the existence of T cells in long-term culture 
resulted from the persistence of inoculated T lymphocytes 
or from the production by immature progenitors. No signifi-
cant numbers of e+. T3". T4 •, or TS" cells were detected 
in cultures that were established from E" lymphocyte-
depleted bone marrow. indicating little or no production of 
T lymphocytes from E·negative precursors. On the other 
hand. bone marrow cells r;~urged of E+ lymphocytes did not 
contain TL·CFU. but ar;~peared to regain high numbers of 
TL·CFU during Dexter culture; this suggested that an 
DURING THE PAST FEW YEARS, factors reg· ulating the proliferation and activation of 
mature T lymphocytes have been identified, and it has 
now become possible to culture these cells under 
well·defined in vitro conditions. 1 Still, very little is 
known about the regulation of earlier steps of T cell 
differentiation. The thymus plays a major role in this 
process during ontogeny. However. recent studies in 
congenitally athymic (nude) mice have shown that 
functionally active T lymphocytes may also be pro· 
duced in the absence of this organ.~.J Dexter type 
long·term bone marrow cultures (LTBMC) have been 
employed to study in vitro T cell differentiation in 
murine bone marrow. 
Schrader and Schrader4 were the first to demon-
strate the potential of LTBMC to induce T cell com-
mitment in marrow-derived hematopoietic precursors. 
They showed that LTBMC gave rise to cells capable of 
differentiation into mature T lymphocytes when 
injected into irradiated mice. This finding was further 
substantiated by Janes-Villeneuve et al.5 who reported 
the maintenance in LTBMC of immature, Thy·l-
negative, progenitor cells in LTBMC, which could give 
rise to colonies of Thy·l-positive cells. These cells, 
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earlier step in T cell differentiation may take place in this 
culture system. The generation of TL·CFU in the E· 
negative long·t&rm marrow cultures only occurred when 
an adherent stroma layer had bean established in the 
culture flask: it did not require added mitogens or detect· 
able interleukin 2 in the culture medium. TL·CFU in fresh 
marrow tTL·CFU Ill are mature (E+. T3+) T calls and are 
car;~abla of r;~roducing helper (T4~) and suppressor/cyto· 
toxic (T8+) phenotype cells in colonies. The TL·CFU newly 
formed in E·der;~letad Dexter cultures (TL-CFU I) are dis· 
tinct from this population. as they are E-negative and give 
rise to colonies of the helper type only. T3 cell depletion of 
the marrow inoculum prior to culture did not prevent the 
appearance of TL·CFU I in long-term culture; this suggests 
that TL·CFU J are derived from an e· and T3. precursor 
(pre· TL-CFU). 
developing in vitro in the absence of a thymic micro-
environment. showed helper activity for cytolytic T 
lymphocyte precursors. a characteristic of a mature T 
lymphocyte subpopulation.6 To what extent T cell 
differentiation can occur in murine L TBMC has not 
been established. In one series of experiments,7 no 
Thy·l-positive cells were detected in the cultures. This 
suggested that terminal differentiation to T lympho· 
cytes was prohibited. By contrast, in investigations by 
Dorshkind and Phillips.H under appropriate culture 
conditions. Thy-1-positivc functional lymphocytes 
were maintained in LTBMC. although it was sug· 
gested that this was due to contamination of already 
mature T cells rather than the result of differentiation 
of immature (Thy·l-negative) precursors. 
The LTBMC system has been recently adapted for 
cells from other than the murine species.9- 11 In this 
article, we describe experiments directed towards T 
cell kinetics and differentiation in long·term cultures 
of human bone marrow. Our data indicate that termi-
nal differentiation from precursor cells does not take 
place, but that E·negative progenitors are produced in 
culture. These progenitors (TL-CFU I) give rise to 
mature helper phenotype progeny (ie, T3+. T4+, TS-) 
upon transfer to a T cell colony assay system. In this 
respect. they differ from the E .... T3+ TL.CFU subset 
(TL·CFU II) in fresh marrow. which is capable of the 
production of colonies of both the helper (T4 +) and the 
suppressor/cytotoxic (TS*) phenotypes. 
MATERIALS AND METHODS 
Bone Marrow 
Bone marrow cells obtained from posterior iliac spine aspirates 
from hematologically normal donors were collected in Hanks' hal-
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anced salt solution (HBSS) contaming preservative-free heparin. 
Excess red blood cells were removed by sedimenmuon (20 minutes) 
at una grav1ty in 0.1% methylcellulose. Light densay (::-;1.077 
gjmL) marrow fractions were obw.med by Ficoli-Isopaque sepo.r:l-
tion.1" 
E Rosetcing and E Depletion 
E rosemng of lymphocytes was achu:ved by usmg the method of 
Madsen and John~n. 1 -' wnh 2-aminocthylisothiouronium bromide 
(AET)-tre::~.ted ~beep red blood cell~ (AET-SRBC). E ro~tte­
negative (E-) cell fractions were obtained after centnfuganon of the 
rosetted cells through Ficoll-Isopaque. Accordmg to evaluations 
following a second reselling procedure. the E" fractions contained 
less than 2% E-positive (E•) lymphocytes. 
Antibody- and Complement-Mediated Cytotoxicity 
Some of the marrow specimens were treoted with cytOtoxic 
monoclonsl antibody (MoAb) OKT3 and rabbit complement (C') to 
remove T3-positive (TJ•) lymphocytes. F1rst. 2 x I O" marrow cells 
in 100 10L were incubated on icc with 5 ,uL OKT3 for 30 m1nute.~. 
When more than 2 x 10" cells were treated. the incubation volume 
and the :~mount of OKT3 were increased proportionally Subse-
quently. cells were washed with HBSS (I x). resuspended in I mL C' 
(30% voljvol in HBSS). and incubated for 30 minutes :l.t 37 °C. 
After addmg a few grains of deoxynbonuc\ease (bovine pancreas 
DNA-se I. B-grade: Calb1oehem, San Diego) to avoid cell clumping 
and washmg with HBSS (2x). cells were prepared for both viability 
(trypan blue exclusion) and indirect immunofluorescence (after :l 
second OKT3 labeling) assays to evaluate the efficiency of the lysis 
and for ti!<Sue culture experiments. Control incub<ltions w1th OKT3 
:~lone and with C' alone were mcluded in each experiment. These 
incubations did not show a cytoreductive effect. In one expcnment, a 
T3 deplcuon was applied to an E-dcpleted marrow suspension th:l.t 
contained less than 2% T3 • cells. In this case, the efficiency of the in 
vitro tre.::nmem was assessed in a parallel incubation of peripheral 
blood mononuclear cells with OKT3 and C'. 
Indirect Immun.ofiuorescence Studies 
Cells positive for T3. T4. T6. and TS cell surface antigens were 
assessed with indirect immunofluorescence ass.:J.ys using MoAbs of 
the OKT series (Ortho Pharmaceutical Corporation. Raritan. NJ) 
::..s the fin:tl::tyer ::tnd put1fied go::..t ::..nti-l'l'l.ou~e lg iml'l'lunoglobulin G 
coupled to fluorescein isothiocyanate (GAM/FITC) as the second 
layer. After fixation with paraformaldehyde, 14 cells were trcatcd on 
ice with MoAb (m titers of 1:20) and subsequently with 1:40 diluted 
GAMJFITC (Nordic Immunological Rcagents. Tilburg. The 
Netherlands). according to standard procedures.1} Using a Zc1ss 
fluorc:scen~ microscope with plan-neoflunr 2Sx and 63x lenses. 
200 cells per slide were studied. Control mcubatJons with GAM/ 
FITC alone. 1ncluded in cach test to check for nonspecific binding of 
the reagent to the cell surface. were negative in nil Cllperiments. 
Normal granulocyte macrophngc (CFU-GM) and :~cute and chronic 
myclo1d leukemia (AML and CML) colony cells were found to lack 
reacuv1ty with the OKT MoAbs used, indicating that these reagents 
were valid for studying T cell differentiation in colony culture. 
T Cell Colony Assay 
T lymphocyte colonies were grown in the PH A-leukocyte feeder 
system. as previously descnbed. 10 In bnef. 0.5 x I 0} cells were plated 
in a 0.4-mL liquid upper layer. supplemented wnh 0.01 mL PHA 
(Wellcome Diagnostics. Danford. England) upon a 1-mL O.S% agar 
layer containing 2 x 10• irradiated (2.500 rad) per1pheral blood 
nucleated cells in 35-mm Petn dishes (Costar. Cambridge. Mass). 
After seven duys of incubation (37 °C. So/~ C01 in air) m a 
humidified atmosphere. colonies of more than SO cells were counted 
with a Zeiss inverted microscope. Colony cells were harvested with a 
Pasteur pipette. washed twice with HBSS. and prepared for E 
rosette and indirect immunofluorescence assays. 
Long-Term Bone Marrow Culture (LTBMC) 
Dexter-type cultures for human bone marrow were set up in two 
phase~. In the first two to four weeks of culture. an adherent stroma 
cell layer. consisting or fibroblast-hkc cells. adipocytcs. and macro-
phages. was ;;~II owed to form. A second portion of autologous marrow 
cells. cryoprescrved 17 on the day of aspiration. was then added. The 
ume of addmon of this second inoculation (or recharge) was 
considered as the initi:Jtion or time zero of L TBMC. Culture 
conditions have been descr1bed in detail elscwhcrc.1' However. slight 
n1odifications were introduced to adapt the culture system for the 
~tudics reported here. Second moculates comained 3 to 10 x I o• 
Ficoll-lsopaque isolated marrow cells (either nondepleted. E 
depleted, or E depleted plus T3 depleted). Prior to the reinoculation. 
all the spent medium. including the rema1ning nonadherent cells of 
the first inoculate, was discarded. the adherent layer washed twice 
with 5 mL HBSS. and fresh medium ;;~ddcd. L TBMC were then 
monitored weekly. ic, the nonadhcrent cells 1n the cultures were 
counted and used for E resetting, immunofluore~ccnce. and T cell 
colony formation 
Detection of !nterleukin 2 (/L-2) Activity 
IL-2 activities of L TBMC conditioned mcdiJ were determined as 
de:;cribed by Gillis et al 1" for murine IL-2. The media were kept at 
-20 °C until use. After thaw1ng. they were added in a 10% dilution 
in culture med1um (lscove's with 10% fetal calf serum and 10·• 
moi/L beta-merCJptocthanol) in a vol of 0,2 mL to microliter wells 
contaming 5 x 10-' cells of a mtrrinc IL-2-dcpcndent cytotoxic 
lymphocyte line (Dr L. Aarden. Central Laboratory of the Nether-
lands Red Cross Blood Transfusion Service, Am~terdam). Signifi-
cant proliferation of the:;c cells was obtamed with ~mplcs contain-
ing 0.1 UjmL of partially purified (mitogen-free) human ll-2. 
RESULTS 
Kinetics ofT Lymphocytes in LTBMC 
Marrow cells in LTBMC were checked for the 
presence of E roselte (nine experiments) and T3. T4, 
T6. and T8 positive cells (three experiments). Cultures 
inoculated with nondepleted and with E rosette-
depleted marrow cells were compared. In the ·nonde-
pleted LTBMC, cells showing mature T cell character-
istics (ie, E+, T3+. and T6-) were maintained in 
relatively constant concentrations (20% lo 40% of the 
cells in suspension). Both T lymphocyles with the 
helper (T4+) and with the suppressor/cytotoxic (T8+) 
phenotype were present. On the other hand, in the 
cultures established from E rosette-depleted marrow, 
numbers of cells expressing these T cell markers 
remained low, indicating that production of mature T 
cells from precursors did not occur. Results of the 
weekly determinations ofT cell markers on LTBMC 
suspension cells in a complete experiment are given in 
Fig I. 
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Fi& 1. Kinetics of auap&n$iOn eells carrying T c.ll surfac:e 
antigena in L TBMC derived from nondepleted (eloted symbolal and 
from E rontt&-depleted marrow (open :~~ymbol:il). ( ~ J E: l*'l T3: 
Ill/ T4; (A/ T6; {()) TS. 
TL-CFU in the Marrow at the Time of Inoculation in 
LTBMC (TL-CFV II) 
Some characteristics of the TL-CFU present in the 
bone marrow prior to inoculation in long-term culture 
are presented in Table 1. In all cases. TL-CFU were 
removed from the marrow following E rosette deple-
tion. Most likely, this was the result of separation of 
the TL-CFU and not of removal of factors essential for 
colony growth, as colony formation was not restored in 
E-negative marrow samples by the reconstitution of 
the plated marrow suspension with irradiated E lym-
phocytes or by the addition of human leukocyte-
derived IL-2 to the colony culture. These results indi-
cate that the TL-CFU in the marrow are all E-positive 
cells. In separate experiments. it was found that TL-
CFU were completely eliminated from the bone mar-
row following in vitro treatment with MoAb OKT3 
and complement. but not with complement or MoAb 
alone. Thus. marrow TL-CFU are also positive for the 
T3 antigen and apparently represent a population of 
mature T lymphocytes. We have designated this col-
ony former as TL-CFU II. 
Kinetics of TL-CFU in LTBMC 
At first, TL-CFU numbers in nondepleted LTBMC 
were estimated in six experiments. In five experiments, 
it was found that TL-CFU numbers had increased 
during culture. Data corrected for the weekly culture 
medium replacements20 reveal a mean production of 
323% (range, 158% to 760%) as compared with TL-
CFU numbers in culture at time zero. An example of 
the TL-CFU kinetics in a nondepleted LTBMC (Fig 
2) indicates a constant increase of TL-CFU during six 
weeks of incubation. It was subsequently investigated 
as to whether E-negative cells were responsible for this 
TL-CFU production. LTBMC were established from 
E-depleted bone marrow, so that no TL-CFU II were 
inoculated in culture. The results of three separate 
experiments are given in Fig 3. It appeared that new 
TL-CFU were produced in these L TBMC and 
remained detectable in culture during five to six weeks 
(upper panel of the figure). 
Meanwhile, the consistent E-negative nature of 
these L TBMC throughout this period was evident in 
each experiment (lower panel). These results suggest 
that the new TL-CFU were generated in LTBMC 
from immature (E") cells. To exclude the possibility of 
production of TL-CFU due to the incomplete elimina-
tion of mature T lymphocytes from the marrow sus-
pension at the onset, LTBMC were set up with marrow 
cells that had been subjected to a double procedure of 
T lymphocyte elimination. After the E rosette separa-
tion, the cells underwent antibody- and complement-
mediated lysis with MoAb OKT3 (E- cells treated 
with C' alone serving as a control). Table 2 shows that 
the numbers of TL-CFU generated in LTBMC after 
inoculation with one step (E) and double step (E as 
well as T3) depleted bone marrow were comparable. 
Thus. the additional T3 depletion did not significantly 
affect the TL-CFU production in culture; this makes it 
unlikely that the newly formed TL-CFU originated 
Teble 1. T Lymphocyte Colony Growth From Human Bone Marrow (TL·CFU Ill 
F'er~e~t E" lymphoeyteB 
!MIOre ColortY CCJitu~ 
Noncktpleted marrow (n - 9) 
(low-density Ficoll-lsopt~qoo fraction) 
E rosette-depleted marrow (n - 9) 
+ 25U IL-2:(n- 2) 
+SOU IL·2: (n- 1) 
+ 100 U IL·2: (n- 1) 
+irradiated (2,500 red) E. lymphocytes:§ (n - 2) 
0KT3 + complemem-treeted marrow (n- 2) 
•Mean ± s.tandBTd devletion. 
tNumbers per 10° plated cells; E positivity of the colony cells was alweys verified. 
:t:Added tO the upper layer of the cultures. 
§Added numbers reconstituted the concentrations present in nondltpleted marrow. 
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Fig 2. Kine1:ics of TL-CFU in a nondaplated L TBMC. Total 
TL-CFU numbers per culture flask are expressed as values c:orrec-
tad for weekly medium replacements. according to Gregory and 
Eave1.>0 
from a residual population of mature phenotype T cells 
insufficiently removed from lhe marrow inoculates. In 
addition. it was excluded that TL-CFU production was 
the result of detachment of TL-CFU present in the 
preformed adherent stroma layer. In stroma preestab-
lished control cultures to which an irradiated (2,500 
rad) marrow portion had been added or in cultures 
without a second marrow charge. no TL-CFU were 
detected in suspension (data not shown). This provided 
evidence to indicate that E-. T3- precursor cells 
(without colony-forming capacities) gave rise to TL-
CFU in LTBMC. We considered the possibility that 
these newly formed TL-CFU in consistently T cell-
devoid cultures (Fig l) lacked T cell surface character· 
istics and were different in this respect from the 
common TL-CFU (TL-CFU II) in fresh bone marrow. 
E depletion experiments. performed on LTBMC sus-
pension cells afLer one week of culture. were carried 
out to test this possibility. It was found that two 
LTBMC suspensions still showed high concentrations 
Fig 3. T lymphocyte colony-forming calls (TL-CFU l) per 10' 
suspan1ion. calls measured at w"kly in.terval:il in L TBMC (upper 
panal) in comparison with the kinatics of E+ lymphocytes {lower 
panal). L TBMC were astabli8had from E rosatte-dapletad bona 
marrow. Reaultl are from thrae separate experiment~. 
Teble 2. Comparison of TL-CFU Production (TL-CFU I) in 
One-Step (E) an.d Two-Step (E a• wall as T3) T 
Lymphocyte-Depleted L TBMC 
Numberu of Tl-CFU per Cultura Flaokt 
Marrow• Week 0 Week 1 W""k 2. Week 3 Week 4 
E'deplotion~ 0 4.106 6,044 1,240 4,935 
Easwollas 
T3depletion§ 0 3,267 4,290 1,662 3,115 
•1n vitro treatment of the bone marrow was done at the time of the 
inoculation onto the prees~ablished stroma layer (time zero). TL-CFU 
were ~hen assess-ed at we-ekly intervals. 
tData are not corrected for the wookly removal of nonadherant cells 
due to medium replacements. 
:tE rosette-depletad bona marrow was incubated with C' only. 
§E' roseno-depleted bone marrow was Incubated with OKT3 end C'. 
Since E-negative bone marrow contained less than 2% OKT3-positive 
cells (Fig 1). the efficacy of the procedure was assessed in u parallel 
incubation on p-eripheral blood mononuclear cells using the same OKT3 
and C' batches in identical concemra~ions. The blood cells contained 54% 
OKT3-positive cella and w-ere all viable (on the basis of trypan blue 
e;w;clu~on); after the MoAb and C' treatment, OKT3 staining was reduced 
to 5%, and 54% of the coils had ingested trypan blue 
ofTL-CFU (ie, 543 and 207/10~ cells) after E deple-
tion. This indicated that the TL-CFU generated in 
LTBMC, in contrast to TL-CFU II, do not express the 
E rosette receptor. We have designated this E-ncgative 
TL-CFU population as TL-CFU I. 
PhenotypingofColony Cells 
The immunologic phenotypes of the colony cells 
grown from (E-) TL-CFU I harvested at week 2 and 
week 4 of E- LTBMC and from unfractionated fresh 
marrow-derived (E+, T3 ... ) TL-CFU II are given in 
Table 3. The data indicate that both TL-CFU I and 
TL-CFU II produced mature T lymphocyte. ie. E+, 
T3+. and T6- progeny. A marked difference, however. 
was evident with respect to the helper and suppressor/ 
cytotoxic phenotype of the colony cells. Colonies 
derived from the TL-CFU I were almost entirely of the 
Table 3. T Lymphocyte Surface Markert on Marrow Cells Befora 
and Aftar T Cell Colony Formation (Parcent Potltive Celli) 
Normal MOITOW E L TBMC Suspanslont lll·CFU II 
(Tl-CFU Ill w .. , w ... k4 
Bafore .. ,. Before 
Mark""' Cultu•e• Colonies Culture Colonie~~ Culture Colon I.,. 
TJ 46 90 <1 72 <1 72 
T4 30 60 <1 56 <1 75 
T6 <1 <1 <1 <1 <1 <1 
TS 16 26 <1 <1 8 
39 •• 91 0 97 
•Ficoll-lsopat:~ue-separeted light density (::; 1.077 g/ml) marrow 
cells. 
tNonadherent cells from E roseno-depleted marrow Inoculated cul-
tures, essayed 11t week 2 and at woo!( 4 of culture. 
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helper (T4+, T8-) phenotype. whereas those arising 
from the TL·CFU II contained T4+ and T8+ cells in 
the usual peripheral blood ratio. It appeared from 
morphological analysis. that both the TL-CFU I and 
the TL-CFU II colony cells resembled lymphoblasts. 
Determination of /L-2 Activity in LTBMC 
Supernatants of two LTBMC were assayed for IL-2 
at different times of culture. We detected no IL-2 
activities in the media at weeks 2. 3, and 4 of these 
cultures. 
DISCUSSION 
In this article. we have described experiments on T 
lymphocyte kinetics in human Dexter-type long-term 
bone marrow cultures (LTBMC) and have distin-
guished between three stages ofT cell differentiation 
(ie. a putative pre-TL-CFU. TL-CFU I. and TL-CFU 
II) on the basis of PHA-induced in vitro colony forma-
tion. Our results demonstrate that T lymphocytes are 
maintained in L TBMC when an unfractionated light 
density marrow sample is inoculated (Fig 1 ). However, 
when an E-depleted marrow fraction is used, cells with 
E. T3. T4, T6, or TS markers arc not detected in 
significant numbers in these cultures. Thus, differen-
tiation from immature precursors to T cells with a 
more mature immunologic phenotype does not occur. 
Similar findings have been described in the mouse 
system.8 
T lymphocyte colony-forming cells are produced in 
LTBMC. This was evident in nondepleted cultures 
(Fig 2) as well as in cultures set up with marrow from 
which T lymphocytes had been removed prior to 
inoculation in LTBMC (Fig 3, Table 2). The T cell-
depleted marrow had been rendered devoid of TL-
CFU (Table 1). The TL-CFU newly formed in 
LTBMC in the absence of T lymphocytes stemmed 
from immature (E-. T3-) cells without colony-form-
ing capacities. This step did not require the addition of 
mitogens to the system and occurred in the absence of 
assayable amounts of interleukin 2 in the culture 
medium. 
On the other hand. the generation ofTL-CFU in E-
LTBMC was dependent on the presence of stroma 
cells. Typically. cultures set up in the absence of a 
preestablished adherent cell layer failed to produce 
significant numbers of E- TL-CFU (data not shown). 
Thus. the production of TL-CFU was stimulated by 
the marrow stroma analogue in these cultures, similar 
to the production of the granulocyte/macrophage colo-
ny-forming cells. 18 We have no data to indicate the 
identity of the stroma-derived factors needed for this 
production. A recently discovered interleukin, IL-3, is 
a possibility, as Hapel and coworkers21 have demon· 
strated that. in mice. IL-3 promotes the commitment 
of Thy-1- precursors to T cell differentiation in the 
absence of IL-2. It should be emphasized that in 
concordance with the IL-3-induced progenitor cells. 
the LTBMC-derived immature TL-CFU in mice5 and 
in man (Table 2) produced no significant amounts of 
cytotoxic/suppressor phenotype T lymphocytes. but 
mainly, if not only, helper phenotype progeny. We 
designated theE- TL-CFU, which is generated in the 
human Dexter culture and is capable of the production 
of helper (T4+) colonies. TL-CFU I. 
It was found that TL-CFU detectable in uncultured 
marrow samples carry a mature T cell (ie. £+and T3+) 
phenotype, which is in agreement with a previous 
report.22 We have now designated these as TL-CFU II. 
Similar results have been published for peripheral 
blood-derived TL-CFU.22-2~ By contrast, other investi· 
gators have described the presence of E-. T3- TL-
CFU in the peripheral blood25 and marrow,26 using 
somewhat different colony culture techniques. The 
relationship between these and the Dexter culture-
derived TL-CFU I is not yet clear, but the results of 
colony phenotyping by Triebel et aF6 reveal progeny of 
both the helper (T4+) and the suppressor/cytotoxic 
(TS+) phenotypes and. therefore, suggest that they are 
different cell types. 
At present, we propose that the production of E-
TL-CFU (TL-CFU I) in LTBMC reflects an early 
step in bone marrow T lymphocyte differentiation. 
This hypothesis is also of interest in view of the 
observations of Messner et af7 that multilineage in 
vitro colony-forming cells from normal bone marrow 
are capable of T lymphocyte differentiation. notably 
only towards the helper (T4+. T8-) subset. 
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19 General Discussion 
Pa~ts of this ohapte~ have been 
pub~ished in The Jou~~ of 
Patho~ogy J49:J5-2J, 1986 
9.1. Interleukin 2: its role in the proliferation of neoplastic T and 8 
cells 
lnterleukin 2, previously termed T cell growth factor, stimulates the 
proliferation of normal peripheral blood or bone marrow T lymphocytes 
through its interaction with specific receptors. These receptors appear on 
the cell membrane following activation by antigens or lectins (Morgan, 
Ruscetti and Gallo, 1976). Recently, it has become clear that IL2 exerts a 
similar effect on activated B lymphocytes (Tsuda, Uchiyama and Uchino, 
1984; Mingari eta!., 1984; Nakagawa et al., 1985). Investigations were 
then initiated to clarify the role of IL2 in the proliferation of different 
types of B and T cell neoplasia. Studies along this line have made use of 
the availability of pure IL2 preparations (obtained by recombinant tech-
niques) (Devos et al., 1983), IL2 gene probes (Taniguchi et al., 1983) and 
monoclonal antibodies reacting with the IL2 membrane receptors (Uchiyama, 
Broder and Waldmann, 1981). The lymphoid malignancy most intensively stud-
ied so far has been adult T cell leukemia/lymphoma (ATL), the etiology of 
which is associated with the human T cell lymphotropic virus I (HTLV I) 
(see Wong-Steal and Gallo, 1985, for review). 
The fact that HTLV transformed cells can be grown relatively easily 
in vitro has contributed to the progress made in the analysis of prolifer-
ation of this malignancy (Wong-Steal and Gallo, 1985). Attempts to unravel 
the growth abnormalities of other lymphoid neoplasms, e.g., acute lympho-
blastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and non 
Hodgkin's lymphoma (NHL) have been hampered by the leek of adequate in 
vitro proliferation assays. 
The experiments of this thesis represent the first efforts to charac-
terize the factors involved in the growth of certain human lymphoid malig-
nancies (i.e., non-T ALL, B CLL, T ALL/T NHL) and have in particular been 
concerned with the role of IL2. 
9.!.1. Non-T acute lymphoblastic leukemia (non-T ALL) 
fresh non-T ALL cells of the undifferentiated (CALLA negative), the 
common (CALLA positive) or the pre-B (CALLA positive + cytoplasmic M heavy 
chain positive) immunophenotype did not express receptors for IL2 on their 
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surface as assessed with monoclonal antibody (MCA) anti Tee in indirect 
immunofluorescence (Chapters 2 and 3). Within 18 hrs following incubation 
of the cells with either PHA or the phorbol ester TPA significant pro-
portions (25-100%) of the cells exhibited receptors for IL2 on their mem-
brane. It became clear that the induction of these receptors on the cells 
directly relates to their proliferation ability. IL2, when added to cul-
tures of ALL cells, stimulated colony growth, although only when PHA or TPA 
and a leukocyte feeder layer were incorporated in the culture as well 
(Table 1). IL2 supplemented in sufficient concentrations was essential for 
colony formation by non-T ALL cells, and a dose effect relationship between 
IL2 concentration and colony response was apparent. The frequency of colony 
forming cells under optimal IL2 concentrations in the presence of PHA (or 
TPA) and a leukocyte feeder was estimated at 25-70 CFU per 105 cells. 
In a minority of patients, the ALL cells, though displaying IL2 
receptors, did not respond to IL2 in colony culture even when very high 
concentrations of IL2 (1000 u/ml) were supplied. 
The reason for this failure of response is as yet not understood but 
suggests variation of regulation of growth. We speculate that these differ-
ences relate to functional abnormalities of the IL2 receptor or to ad-
ditional growth factor requirements. 
Non-T ALL cells appeared to be firmly arrested in their maturation. 
The cells did not demonstrate alterations to later stages of differen-
tiation upon proliferation in culture. This was evident from morphological 
examination, analysis of B cell differentiation antigens using a panel of 
monoclonal antibodies and immunoglobulin expression. Notably, impaired 
differentiation in vitro was also evident in the cultures supplemented with 
TPA, a well established differentiation inducer of normal and neoplastic B 
lymphocytes. 
9.1.2. B cell chronic lymphocytic leukemia (CLL) 
B CLL cells spontaneously expressed IL2 receptors in 4 out of 5 cases 
(Chapter 5). The cells proliferated as measured in colony techniques and 
thymidine incorporation assays in response to PHA + IL2 or TPA + 1L2 (Table 
1, Chapters 5 and 6). Proliferation in response to IL2 could be inhibited 
by simultaneous blocking of the IL2 receptor with the anti-IL2 receptor 
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MCA. Because of the spontaneously activated IL2 receptors on 8 CLL cells, 
the addition of PHA (or TPA) to culture was not immediately required and 
could be delayed for 24 hrs without reducing the efficiency of stimulation 
of proliferation of the cells by IL2. When 8 CLL cells were kept devoid of 
PHA (or TPA) for longer periods, however, the cells lost their responsive-
ness to IL2. As a consequence, when PHA was withheld from these cultures 
for more than one day, the rate of proliferation of 8 CLL cells in vitro 
declined. 
In one case of CLL, a spontaneous 3H-TdR uptake by the CLL cells, 
i.e., independent on the addition of PHA end IL2 to the cultures, was 
observed (Chapter 6). This autonomous proliferation was most likely induced 
by endogenous IL2, since IL2 receptor blocking with MCA shut off 3H-TdR 
incorporation. Moreover, IL2 activity was detected in culture media con-
ditioned by the CLL cells of this patient. Similar to activated normal T 
and B cells, activated CLL cells express two types of IL2 receptors, one 
with a high affinity end one with a low affinity. This was shown in binding 
studies with radiolabeled IL2 (Chapter 6). B CLL cells differ from pre-B 
ALL in two aspects: e) they do not need feeder cells as an additional 
stimulating factor and b) B CLL cells differentiate further in vitro. B CLL 
colonies produced in culture consisted of plesmacelluler lymphocytes or 
fully developed plasma cells expressing the same heavy chain and light 
chain type in the cytoplasm, as was characteristic of the original 8 CLL 
lymphocytes (Chapter 5). 
9.1.3. T non Hodgkin•s lymphoma (T NHL) and T acute lymphoblastic leukemia 
(T ALL) 
We have studied the leukemic blood cells from 3 patients with T NHL 
and 3 patients with T ALL (Chapter 7). This series included one patient of 
a relatively mature (i.e. stage III) and 5 patients of a more immature 
(i.e. stages I or II) immunophenotype (Nadler et al., 1982). IL2 receptor 
expression on the cells was initially negative but such receptors appeared 
on significant percentages of the cells (20-97%) following exposure to TPA. 
Consistent with these findings was the observation that in cultures con-
taining TPA + IL2, colony growth was induced (at an average cloning ef-
ficiency of 30-76 per 105 cells). On the other hand, PHA was only capable 
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of activating IL2 receptor expression and inducing colony growth in the 
single case of NHL which showed the mature thymocyte phenotype (i.e., TdT-, 
WTl+ , E+, T3+, T4+, T6-, TS-, TlO+) among this limited series of patients. 
In the other five cell samples from patients with the stage I or II thymo-
cyte phenotype (i.e., TdT+, WTl+, E+ orE-, T3-, T4-, T6-, TS-, TlO+; or 
TdT+, WTl+, E+, T3-, T4+, T6+, TS+, TlO+) only TPA was effective in acti-
vating IL2 receptor expression (Table 1). Furthermore, it is noteworthy 
that in three of these cases exogenous IL2 was not required for stimulating 
proliferation. TPA alone in two cases, and PHA alone in one case induced 
colony growth. Nevertheless, also in the latter instances, it has become 
clear that proliferation depended on ILZ. It appeared that IL2 was provided 
endogenously by the neoplastic cells in culture: blocking of the IL2 recep-
tor by incubating the cells of these patients with the anti-Tac monoclonal 
antibody abrogated proliferation. It then also appeared that these cells 
were self-producers of IL2, since conditioned medium derived from the cells 
sustained the proliferation of an IL2 dependent cell line. No clear indi-
cations for in vitro maturation during colony culture of T ALL and T NHL 
cells were apparent. Surface marker analysis of colony cells did not pro-
vide evidence that the cells had proceeded to later stages of differen-
tiation. 
9.1.4. Different pathological subtypes of lymphoid malignancy express 
characteristic response patterns to IL2 
The patterns of IL2 dependence of the various lymphoid neoplasms are 
summarized in Table 1. Some characteristic features of the IL2 response of 
the different lymphoid malignancies could be recognized: a) B CLL: the 
spontaneous expression of IL2 receptors in certain cases; b) non-T ALL: the 
need for additional stimulation by feeder leukocytes for colony formation; 
c) T ALL/T NHL: immature and intermediate (i.e., stage I and stage II) thy-
mocytes can be induced to express IL2 receptors and to form colonies in the 
presence of IL2 with TPA but not with PHA, whereas mature (stage III) thy-
mocytes respond to both mitogens. These systematic differences between dif-
ferent disease categories are potentially useful in clinical practice. At 
the present time, it remains to be established as to whether a classi fi-
cation of the different cytopathological types of lymphoid malignancy on 
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Table l PATTERNS OF IL2 DEPENDENCE OF LYMPHOID NEOPLASIA IN MAN 
Normal T T NHL T NHL/T ALL B-CLL Non-T ALL 
lympho- (mature (immature or (unclass.; 
cytes stage) intermediate common; 
(blood) stage) pre-B) 
IL2 rece~tor exeression 
spontaneously +1-
following TPA induction + + + + 
following PHA induction + + + 
Proliferation upon 
stimulation with IL2 
IL2 
TPA + IL2 + + + + 
PHA + IL2 + + + 
TPA + IL2 + leuko-
cyte feeder + + + + 
PHA + IL2 + leuko-
cyte feeder + + + 
Autocrine IL2 
Eroduct1on +!- + +!- ? 
the basis of in vitro growth criteria will be of diagnostic value. 
9.2. Growth control of malignant lymphoid cells by external stimuli: Do 
abnormalities exist? 
To date, no experimental data have been produced that allow expla-
nations for the uncontrolled accumulation of cells in lymphoid malignancies 
with a nonviral etiology. One could argue that the growth of the malignant 
lymphoproliferative disorders results from an imbalance of growth regu-
lation, or from a complete loss of control by the complex of regulatory 
factors. In AML, clonogenic cells proliferate in reaction to granulocyte-
macrophage colony stimulating factor (GM-CSF), an es.tablished growth factor 
of normal myeloid progenitor cells. The proliferating cells at the same 
time are induced to further maturation, which is associated with a decrease 
in proliferative potential (Chapter 4, and reviewed by Griffin end LOwen-
berg, 1986). Clearly, the available evidence indicates that clonogenic AML 
cells have preserved the linkage of differentiation and loss of prolifer-
ation, which is a fundamental property of normal myeloid progenitor cells. 
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+ 
+ 
+ 
+ 
? 
One may therefore assume that the expensive growth of AML cells results 
from an imbalance, rather than a loss, of the regulation of growth end dif-
ferentiation by external factors. For example, alterations in the sensi-
tivities to growth stimulatory end inhibitory factors may account for this 
imbalance. One may also hypothesize that leukemia cells respond normally to 
the physiological growth regulators. In that situation, expansive growth 
could be due to certain intrinsic defects, which for instance make the 
cells less susceptible to mechanisms leading to cell death. 
Mechanisms by which certain oncogenic viruses have been found to 
alter the growth of their host cells (i.e., a) induction of constitutive 
growth factor receptors and b) direct activation of cytoplasmic or nuclear 
signal pathways resulting in the loss of growth factor dependence) have 
been mentioned in Chapter 1. Evidence that similar mechanisms are involved 
in the growth of the investigated types of lymphoid malignancy was not ob-
tained. Although a variety of in vitro growth patterns was observed, the 
cells nonetheless retained dependence on specific growth stimuli and acti-
vation signals. Autocrine stimulation, a third mechanism by which tumour 
cells have been proposed to escape growth factor control (see Chapter 1), 
was observed in certain cases of T cell malignancy (Chapter 7) and has been 
suggested also to occur in a case of B CLL (Chapter 6). However, IL2 driven 
autostimulation is also observed in a subpopulation of normal T lympho-
cytes. Therefore, there is no proof that this feature is specific of the 
neoplastic status of the cells. As little is still known of the growth 
regulation of normal B cells at various stages of differentiation, we are 
not sure as to whether self stimUlation by IL2 in B CLL is to be considered 
as typical of the transformed nature of the cells either. 
Taken together, the data -reported in this thesis raise the possi-
bility that mechanisms, other than those proposed for virally induced leu-
kemias, are responsible for the ·accumulation of neoplastic cells in non-
viral lymphoid malignancies. Possible alternative mechanisms could be based 
on the loss of differentiation capacity (e.g., observed in ALL) or on a 
decreased sensitivity to growth inhibitory regulators. 
9.3. Analysis of growth requirements of normal immature cell types 
To understand how leukemic cells are disturbed in their proliferation 
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and differentiation characteristics, a detailed knowledge of normal cells 
at comparable stages of maturation is necessary. This knowledge is rela-
tively easily obtained when the normal cells can be isolated directly from 
the hematopoietic tissues in large numbers and tested for their response to 
fully characterized growth stimuli. For instance, T lymphocytes can be 
grown in clonal cell culture stimulated by pure (recombinant) IL2. These 
studies are more difficult to conduct when the normal cells represent a 
minority population amongst the heterogeneous bone marrow. This situation 
typically applies to the scarcity of precursor cells in normal tissue from 
which leukemias often descend. As mentioned in chapter 1, some of these 
cell types, e.g., progenitor cells of myelomonocytic and erythroid differ-
entiation lineages, can be stimulated with pure growth factor preparations 
and form colonies in vitro (Metcalf, 1984). Nonetheless, the exact factor 
requirements of these cell types have not been fully elucidated yet, since 
the admixture of nonclonogenic marrow cells may drastically influence the 
outgrowth of the colony forming cells. This influence may be achieved by 
those cells through the elaboration of endogenous stimulatory or inhibitory 
components. Thus, a conclusive evaluation of factor responses is only 
possible when not only pure growth factors, but also highly purified cell 
populations are used. Purification methods for murine and human bone marrow 
stem cells and progenitor cells on the basis of monoclonal antibody and 
cell sorting technology are currently in development (Visser et al., 1984; 
Badger et al., 1983; Civin et aL, 1984). One may expect that the appli-
cation of flow cytometry of purified fractions in combination with direct 
cell deposition in microculture (Terasaki) trays will permit studies on the 
growth requirements of single clonogenic cells in the near future (Lansdorp 
et al., 1986). 
9.4. Comparison of growth requirements of neoplastic lymphoid cells with 
those of their non transformed analogues 
At this stage, it is not possible to compere the growth features of 
malignant lymphoid cells with those of their normal counterparts. 
Surprisingly little is known about the physiological regulation of the 
early stages of lymphoid proliferation and differentiation. This limited 
understanding of the regulation of lymphopoiesis is the immediate conse-
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quence of the lack of in vitro culture systems and of purified growth 
factor preparations for normal lymphoid precursor cells. The problem of 
scarcity of cells, already outlined in the foregoing paragraph (9.3.), is 
also encountered: the numbers of lymphoid progenitors in the various lym-
phopoietic tissues are often so small that their identification is diffi-
cult. These difficulties apply to the analysis of normal pre-B cells, 
prothymocytes and early B lymphocytes. 
9.5. Application of the long-term bone marrow culture system for the 
analysis of lymphoid precursor cell stages 
Several investigators have recognised the possibility that the long-
term bone marrow culture system (LTBMC), initially developed by Dexter and 
colleagues, could prove useful for the characterization of rare normal 
lymphocytic precursor cells and the isolation of these cell types. In this 
in vitro system, hematopoiesis is stimulated by an adherent cell layer of 
bone marrow stroma components (i.e., f~broblasts, macrophages, adipocytes, 
endothelial cells). LTBMC have been shown to generate very immature hemato-
poietic elements, including lineage restricted progenitor cells (CFU-GM, 
BFU-e, CFU-Meg) and pluripotent stem cells, over periods of more than one 
year (Dexter et al., 1977). Due to the lack of sufficient concentrations of 
growth factors that act at the terminal stages of hematopoietic differen-
tiation (i.e., CSFs, IL2, Epa), the production of mature cells is limited. 
As a result, immature cell populations are enriched in LTBMC suspensions as 
compared with fresh bone marrow samples. 
The mechanism by which the composite adherent cell layer stimulates 
hematopoiesis in L TBMC has remained unknown. Although it was initially 
believed that adipocytes (fat cells) played an important role, evidence 
against this suggestion was later obtained (Touw and LOwenberg, 1983). The 
establishment of cloned stroma derived cell lines may be of help to eluci-
date the nature of stromal stimulation of hematopoiesis in the near future 
(Zipori et al., 1985). 
The generation of lymphoid precursors in murine LTBMC was first 
demonstrated by injecting LTBMC-suspension cells in irradiated mice, which 
then gave rise to high numbers of concanavalin A (Con A) and lipopolysac-
charide (LPS) stimulable lymphoblasts (Phillips et al., 1978; Schrader and 
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Schrader, 1978; Janes-Villeneuve end Phillips, 1980). It was subsequently 
documented that murine LTBMC of certain (but not all) strains of mice are 
capable of generating and maintaining T cell progenitors, including pro-
thymocytes (Boersma and Eliason, 1982; van 8ekkum et aL, 1984) and T 
colony forming cells (Janes-Villeneuve et al., 1980). 
8 cell precursors at various stages of differentiation are also produced in 
LTBMC (Whitlock and Witte, 1982; Dorshkind and Phillips, 1983; Nagasawa et 
a!., 1985; Denis and Witte, 1986; Dorshkind, 1986). Recently, Muller-Sie-
burg et al. (1986) reported a hundred fold enrichment of murine pre-8 cells 
in LT8MC suspensions as compared with fresh bone marrow. 
In our laboratory we have used L T8MC to study early steps of T lym-
phocytic differentiation in humans. We have proposed the existence of two 
precursor cell stages of the T lymphoid differentiation lineage in the bone 
marrow, which were designated pre-TL-CFU and TL-CFU I (Chapter 8). 
Pre-TL-CFU is a postulated entity. It indicates the precursor of the TL-CFU 
I. Pre-TL-CFU ere present in fresh bone marrow which is depleted of T 
lymphocytes and are devoid of T colony forming capacities in response to 
stimulation by PHA, IL2 end irradiated leukocytes. Under the stimulatory 
influence of the adherent stroma layer, pre-TL-CFU give rise to colony 
forming T cell progenitors (TL-CFU I) in LTBMC. Following PHA/IL2/irradiat-
ed leukocyte stimulation, these TL-CFU I produce colonies typically con-
sisting of mature T lymphocytes of the T4 phenotype. TL-CFU I express an 
immature T cell phenotype, i.e., E- and T3-. Preliminary results of ad-
di tiona! phenotyping of TL-CFU I suggest that these precursors also lack 
reactivity with other T cell markers (i.e., T4, T8, WTl) but express anti-
gens characteristically found on hematopoietic progenitor cells (Ia, 516-
14.4) (Moberts, Touw and LOwenberg, unpublished results). Pre-TL-CFU, which 
were also E end T3 negative, have not yet been typed with additional mem-
brane markers. The immunophenotype of TL-CFU I is different from that of 
the cases of T ALL/T NHL described in Chapter 7, and presumably represents 
a more immature stage of differentiation. Thus, TL-CFU I cannot be regarded 
as normal counterparts expressing differentiation features of T ALL/T NHL 
cells. A detailed analysis of· the response of pre- TL-CFU and TL-CFU I to 
various proliferation and differentiation stimuli may nonetheless be of 
great value to elucidate specific growth abnormalities of immature T cell 
type malignancies. 
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9.6. Prospects 
Although this thesis has especially dealt with the regulatory role of 
IL2 in the growth of lymphoid neoplasms, obviously, we have to keep in mind 
the large body of evidence, mainly derived from experiments on mice, indi-
cating that factors other than IL2 control the growth of lymphoid cells, in 
particular of the B differentiation lineage. The eDNA of one of these 
factors, termed IgGl induction factor, was recently cloned and expressed in 
COS cells, and the protein purified to homogeneity (Noma et al., 1986). In 
the near future it will be of importance to test the response of malignant 
lymphoid cells to these and other stimuli, so that finally the probably 
highly complex system of growth factor regulation can be analysed to its 
full extent. Unfortunately, none of these activities have as yet been 
defined in man. For the study of the in vitro growth requirements of human 
lymphopoietic malignancies this remains a major limitation. Increasing 
numbers of research groups in the field of hematopoiesis are currently 
involved in the molecular cloning and expression of human genes encoding 
for a variety of growth factors and their receptors, as well as in the 
generation of monoclonal antibodies directed against these proteins. 
This development justifies the expectation that more factors controlling 
human lymphopoiesis will become available in purified form and their 
physiological actions evaluated. Such pure and highly specific materials in 
combination with primary in vitro cell culture are the necessary exper-
imental ingredients to obtain definite insights into the regulation of 
lymphoid cell growth. Investigations based upon these principles will 
settle the issue as to whether (and how) abnormal responses to growth and 
differentiation stimuli result in the uncontrolled cell growth of lymphoid 
neoplasia. 
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Summary- Samenvatting 
Summary 
Hematopoiesis is regulated by polypeptide hormones acting at the 
hematopoietic stem cells and at the proliferative cells of the lymphoid, 
myelomonocytic, erythroid and megakaryocytic differentiation lineages. 
These hormones (or growth factors) control the properly balanced supply of 
blood cells. In certain neoplastic disorders of the blood forming system, 
e.g., leukemia and malignant lymphoma, the homeostasis is disturbed, which 
results in an accumulation of neoplastic cells. The mechanisms leading to 
the expansive growth of leukemia/lymphoma cells have not been elucidated. 
An attractive hypothesis is that these malignant cells escape the hormonal 
control of proliferation, for example through an acquired ability to pro-
duce hormone(s) themselves, through alterations in the function of hormone 
receptors expressed on the cell membrane, or through a complete loss of 
hormone dependence. Each of these abnormalities has been reported for 
experimental tumours. In vitro culture of primary cell specimens appears 
particularly useful in a search for possible abnormalities of the hormonal 
responses in human leukemia/lymphoma. 
The experiments described in this thesis deal with the development of 
primary cell cultures for acute lymphoblastic leukemia of B as well as T 
cell lineage (non-T and TALL), B cell chronic lymphocytic leukemia (B CLL) 
end leukemic T cell non Hodgkin's lymphoma (T NHL). These in vitro tech-
niques were then applied to analyse growth and differentiation character-
istics of the lymphoid malignancies, and their responsiveness to the hor-
mone interleukin 2 (ll2). 
In CHAPTER ONE basic principles of hematopoiesis, leukemia, the 
physiological action of interleukin 2 end the use of in vitro culture tech-
niques are introduced. In addition, the concept that tumor cells may escape 
normal regulatory mechanisms of growth, and its experimental support, are 
briefly reviewed. A scheme of lymphoid differentiation proposed on the 
basis of immunological phenotyping is also included in this chapter. The 
cell types, from which the different lymphoid malignancies investigated in 
this thesis are believed to descend, ere indicated in this scheme. 
In CHAPTER TWO studies are presented dealing with the definition of 
cui ture conditions that permit the in vitro colony growth of common and 
-138-
pre-S ALL cells. By applying monoclonal antibodies reactive with membrane 
receptors for IL2 we demonstrated that the ALL cells express IL2 receptors 
following in vitro incubation in the presence of a lectin (PHA) or a phor-
bol ester (TPA). IL2 receptors were not detectable on the fresh ALL cells. 
In a culture system to which IL2, PHA or TPA and irradiated feeder leuko-
cytes had been incorporated ALL colony growth was observed. When one of 
these components was omitted from the culture system, colony growth was 
reduced or absent. Apparently, ALL colony growth depended on a complex of 
growth and activation stimuli including IL2, an unknown leukocyte component 
and a lectin or phorbol ester. Comparisons of the immunologic phenotypes of 
colony cells and fresh cells were not indicative of maturation of the ALL 
cells toward more mature 8 cell stages during colony culture. 
In CHAPTER THREE the studies of the in vitro characteristics of ALL 
cells are extended to 24 patients. This series also included four cases of 
unclassified ALL. Inducibility of IL2 membrane receptors and in vitro 
colony growth were systematically analysed for the three immunological 
types (i.e., unclassified, common and pre-B) of ALL. Colony formation was 
observed in 18 of the 24 cases. The analyses revealed no significant dif-
ferences between the immunological subgroups as regards their colony form-
ing abilities. In addition, no differences in in vitro characteristics 
between childhood and adult ALL were apparent. Again, in this larger series 
of patients, no indications were obtained that the ALL cells were capable 
of in vitro differentiation beyond the stage of the cells in vivo. 
In a parallel study presented in CHAPTER fOUR, the in vitro matu-
ration capacities of acute myeloblastic leukemia (AML) under comparable 
culture conditions were investigated. Using a panel of monoclonal anti-
bodies reactive with myelomonocytic differentiation antigens, we observed 
in 10 cases of AML that, although the AML colony forming cells produced 
progeny revealing progressive differentiation, this was clearly incomplete. 
Thus, ALL and AML colony forming cells share the inability to produce fully 
mature progeny in vitro. 
CHAPTER FIVE comprises studies which settled the conditions permit-
ting in vitro colony growth of 8 CLL. As compared with the in vitro charac-
teristics of ALL three marked differences became evident: 1) fresh CLL 
cells frequently expressed IL2 receptors on their cell surface, 2) CLL 
colony growth depended on the presence of IL2 and PHA or TPA in culture but 
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did not require additional stimulation by irradiated leukocyte feeder cells 
end 3) morphological and immunologic analysis of the CLL colony cells 
revealed that CLL clonogenic cells had retained the capacity to produce 
more mature progeny (i.e., plasma blasts and plasma cells) in vitro. 
Studies to determine the functional properties of ll2 receptors of 
8 CLL cells and additional analyses of the proliferative response of the 
cells to IL2 in 3H-thymidine incorporation assays are reported in CHAPTER 
SIX. Binding studies with radiolabeled IL2 revealed that CLL cells follow-
ing their activation in vitro express two classes of IL2 receptors, one 
with a high affinity and one with a low affinity for IL2. In this respect, 
CLL cells resemble normal activated 8 (and T) cells-
The 3H-thymidine uptake experiments in three cases showed that DNA syn-
thesis by CLL cells is stimulated by IL2 and PHA. Interestingly, however, 
in one case we observed an apparently spontaneous proliferation, i.e., 
completely independent on the addition of Il2 and PHA to the microcultures. 
Experiments involving the blocking of IL2 receptors during culture and 
determinations of IL2 activity in the growth medium revealed that the 
proliferation of these cells was stimulated by endogeneous IL2. These 
findings suggest that the CLL cells themselves were capable of synthesizing 
IL2. However, we have not been able to prove this at the transcriptional 
level, i.e., by demonstrating the presence of IL2 mRNA in the cells. As yet 
an autocrine mechanism of growth stimulation through ll2 had not been 
reported for human 8 cell malignancies. 
In CHAPTER SEVEN the in vitro growth features of T ALL and leukemic T 
NHL are presented. These T cell malignancies retained dependence on acti-
vation and on IL2 for in vitro proliferation. In this respect they differ 
from the T cell leukemias/lymphomas with a viral (Le., HTLV-1 induced) 
etiology, in which dependence on IL2 and activation is abrogated. Among the 
limited number of cases of T ALL and T NHL that we investigated variations 
in the in vitro response patterns were evident: 
1) activation (and IL2 receptor induction) of the immature T cell type 
leukemias/lymphomas was achieved with TPA, but the cells did not respond to 
PHA, whereas mature T cell type malignant cells could be activated by TPA 
as well as by PHA; 
2) in some cases of T ALL/T NHL the cells depended on exogeneous IL2 for 
proliferation, whereas in others, the cells were capable of producing IL2 
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themselves. Like in non-T ALL (chapters 2 and 3) the malignant cells in T 
ALL/T NHL appeared to be firmly arrested in their maturation: No indi-
cations of progressive differentiation during colony culture were obtained. 
In CHAPTER EIGHT studies are presented that represent our first 
efforts to analyse the immunophenotypes and growth requirements of normal 
T-lymphocytic precursor cells. For this purpose we applied the long-term 
bone marrow culture system (LTBMC). It is shown that under the influence of 
the bone marrow stroma components, bone marrow devoid of mature T cells, 
gave rise to clonable T-!ymphocytic progenitors. These progenitors, des-
ignated TL-CFU I, themselves lacked characteristics ofT lymphocytes (i.e., 
E rosette forming ability and T3 antigen expression), but formed colonies 
in response to PHA and IL2 consisting of T lymphocytes of predominantly the 
T3+T4+ phenotype. Further experiments along this line (which should also 
deal with the B-cell differentiation lineage) have to set a basis for 
comparisons of the growth features of lymphoid leukemia cells with their 
normal analogues. 
Finally, in CHAPTER NINE a brief overview is given of our current 
understanding of the role of IL2 in the growth of neoplastic T and B cells 
of the different histological categories. In addition, the results of this 
thesis are discussed in view of the hypothesis that in leukemia the control 
of proliferation and differentiation by external stimuli has been altered 
due to the neoplastic transformation. 
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Samenvatting 
De vorming van bloedcellen wordt gereguleerd door polypeptide hor-
monen die werken op de hematopoietische stamcellen en op de proliferatieve 
cellen van de lymfoide, myelomonocytaire, erythroide en megakaryocytaire 
differentiatiereeksen. Deze hormonen (of groeifactoren) zorgen voor een 
gebalanceerde toevoer van bloedcellen. In leukemieen en m~ligne lymfomen, 
neoplastische ziekten van het bloedvormend systeem,. is de homeostase ver-
stoord, hetgeen resulteert in een accumuletie van de neoplastische cellen. 
De mechanismen die ten grondslag liggen san de expansieve groei van leuke-
mie- en lymfoomcellen zijn onbekend. Een aantrekkelijke hypothese is dat 
deze kwaadaardige cellen ontsnappen san de hormonale contrOle van de groei, 
bijvoorbeeld door de eigenschap te verwerven zelf groeifactoren te gaan 
maken, door veranderingen in de werking van hormoonreceptoren op de celmem-
braan, of door een volledig verlies van hormoon-afhankelijkheid. Dergelijke 
afwijkingen zijn beschreven voor experimentele tumoren. 
In vitro kweek van primair celmateriaal is van groat belang voor het 
onderzoek near mogelijke afwijkingen in de hormonale respons van leukemia-
en lymfoomcellen. De in dit proefschrift beschreven experimenten zijn 
gericht op de ontwikkeling van primeire celkweken van acute lymfatische 
leukemieen van zowel de B- als de T-cel differentiatie-reeks (resp. non T 
ALL en T ALL), chronische lymfatische leukemie van het B type (B CLL), en 
leukemische T-cel Non Hodgkin lymfomen (T NHL). Deze in vitro technieken 
zijn vervolgens toegepast om de groei- en differentiatie-eigenschappen van 
de lymfoide maligniteiten, alsmede om hun gevoeligheid voor het hormoon 
interleukine 2 (IL2) nader te analyseren. 
In HOOFDSTUK EEN worden enkele grondbeginselen van de bloedcelvor-
ming, leukemie, de fysiologische werking van interleukine 2 (IL2) en het 
gebruik van in vitro kweektechnieken ingeleid. Daarnaast wordt het concept 
dat tumorcellen kunnen ontsnappen aan de normale groeiregulatie geintrodu-
ceerd en wordt een kart overzicht gegeven van de experimentele ondersteu-
ning hiervoor. Tevens is in dit hoofdstuk een schema opgenomen van de 
lymfoide differentiatie op basis van immunologische typering. In dit schema 
zijn celtypen, waaruit de verschillende maligniteiten geacht worden te zijn 
ontstaan, aangegeven. 
-142-
In HOOfDSTUK TWEE worden studies_ gepresenteerd die betrekking hebben 
op de definiering van de kweekcondities voor de koloniegroei van 11 Common 11 · 
en pre-8 ALL cellen. Met behulp van monoclonale antistoffen gericht tegen 
de membraanreceptoren voor IL2 werd aangetoond dat ALL cellen deze recep-
toren tot expressie brengen na incubatie, in aanwezigheid van een lectine 
(PHA) of een phorbol ester {TPA). IL2 receptoren werden niet gevonden op 
onbehandelde ALL cellen. In een kweeksysteem, waaraan IL2, PHA of TPA en 
bestraalde leukocyten werd toegevoegd, werd ALL koloniegroei waargenomen. 
Wanneer ~~n van deze componenten uit het kweeksysteem werd weggelaten, was 
de koloniegroei verlaagd of afwezig. Kennelijk is ALL koloniegroei afhanke-
lijk van een complex van groeistimulerende- en activerende factoren, wear-
onder IL2, een onbekende leukocytenfactor en een lectine of phorbol ester. 
Vergelijking van het immunologische fenotype van koloniecellen met dat van 
ongekweekte cellen wees er niet op dat ALL cellen tijdens koloniekweek 
differentieren near meer rijpe stadia van de B lymfocytaire reeks. 
In HOOFDSTUK DRIE is de bestudering van de in vitro eigenschappen van 
ALL cellen uitgebreid near 24 patienten. Oeze groep omvatte oak 4 gevallen 
van niet-classificeerbare ALL. 
De induceerbaarheid van IL2 membraanreceptoren en in vitro koloniegroei 
werd systematisch geanalyseerd in de drie immunologische subtypen (niet-
classificeerbaar, 11 common 11 en pre-B) van ALL. Koloniegroei werd waargenomen 
bij 18 van de 24 patienten. Er waren geen verschillen in kolonievormend 
vermogen waarneembaar tussen de immunologische subtypen en evenmin tussen 
ALL cellen van kinderen en van volwassenen. In deze uitgebreide groep van 
patienten werden opnieuw geen aanwijzingen verkregen dat ALL cellen in 
staat zijn in vitro verder te differentieren. 
In een vergelijkbare studie beschreven in HOOFDSTUK VIER werd het 
vermogen van acute myeloblasten leukemie (AML) cellen om in vitro verder 
uit te rijpen onderzocht. Met behulp van monoclonale antistoffen gericht 
tegen myelomonocytaire differentiatie-antigenen werd in 10 gevallen van AML 
waargenomen dat AML kolonievormende cellen nakomelingen produceren die 
kenmerken van verdere uitrijping vertonen. Deze uitrijping bleek echter 
incompleet. Dus, kolonievormende cellen in zowel ALL als AML missen het 
vermogen om in vitro volledig uitgerijpte dochtercellen te vormen. 
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HOOFDSTUK VIJF omvat de studies waarin de condities voor de in vitro 
koloniegroei van B CLL werden vastgesteld. In vergelijking tot de in vitro 
eigenschappen van ALL werden drie duidelijke verschillen zichtbaar: 
1) Ongekweekte CLL cellen brengen vaak IL2 receptoren tot expressie op hun 
celoppervlak; 
2) CLL koloniegroei is afhankelijk van IL2 en PHA of TPA, maar behoeft geen 
aanvullende stimulatie door bestraalde leukocyten en 
3) Uit morfologische en immunologische analyse van de CLL koloniecellen 
bleek dat clonogene CLL cell en het vermogen hebben behouden in vitro 
meer uitgerijpte nakomelingen (plasmablasten en plasmacellen) voort te 
brengen. 
Studies gericht op de functionele eigenschappen van IL2 receptoren 
van B CLL cellen, alsmede analyses van de proliferatieve respons van de 
cellen op IL2 in 3H-thymidine incorporatietests worden beschreven in 
HOOFDSTUK ZES. Uit bindingsexperimenten met radioactief IL2 bleek dat CLL 
cellen, na activering in vitro, twee typen IL2 receptoren tot expressie 
brengen, een met een hoge en een met een lege affiniteit voor IL2. In dit 
opzicht lijken CLL cellen op normale geactiveerde B- (en T-)cellen. In drie 
gevallen werd de DNA-synthese door CLL cellen gestimuleerd door IL2 en PHA. 
Interessant was echter dat in een vierde geval spontane proliferatie, 
d.w.z. volledig onefhankelijk van de toevoeging van IL2 en PHA, optred. 
Experimenten waarin IL2 receptoren tijdens de kweek werden geblokkeerd en 
bepalingen van de IL2 activiteit in het kweekmedium toonden aan dat de 
proliferatie van deze cellen gestimuleerd werd door endogeen IL2. Deze 
waarnemingen suggereren dat de CLL cellen van deze patient zelf in staat 
war en IL2 te maken. Deze hypothese ken echter niet worden bewezen op het 
niveau van de transcriptie, d.w.z. door het aantonen van IL2 mRNA in de 
cellen. Een autocrien groeimechanisme, gestuurd door IL2, is nag niet 
eerder beschreven voor humane B-cel maligniteiten. 
In HOOFDSTUK ZEVEN worden de in vitro groei-eigenschappen van T All 
en leukemisch T NHL gepresenteerd. Deze T-ee! maligniteiten behielden hun 
afhankelijkheid van activering en IL2 voor in vitro proliferatie. In dit 
opzicht verschilien zij van de T-cel leukemieen en lymfomen met een virale 
etiologie, d.w.z. geinduceerd door HTLV I, waarin de afhankelijkheid van 
IL2 en activering verloren is gegaan. In de beperkte groep T ALL en T NHL 
patienten die we onderzochten, kwamen varieties in de in vitro respons naar 
voren: 
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1) activering (en de inductie van IL2 receptoren) van de T-cel malignitei-
ten met een onrijp immunologisch fenotype was mogelijk met TPA, maar de 
cellen reageerden niet op PHA, terwijl maligne cellen met een rijp T-cel 
fenotype door zowel TPA als PHA konden worden geactiveerd; 
2) In enkele gevallen van T ALL en T NHL waren de cellen voor proliferatie 
afhankelijk van exogeen IL2, terwijl in andere gevallen de cellen z~lf 
IL2 konden maken. Evenals in non T ALL (hoofdstukken 2 en }), bleken de 
maligne cellen in T ALL en T NHL te zijn geblokkeerd in de uitrijping: 
er werden geen aanwijzingen verkregen dat verdere differentiatie tijdens 
koloniekweek optrad. 
In HOOFDSTUK ACHT wordt een onderzoek gepresenteerd dat de eerste 
aanzet vormt de immunofenotypen en de groeieigenschappen van normale T-lym-
foide voorloper cellen te analyseren. Ten behoeve hiervan werd het lange 
termijn beenmergkweeksysteem toegepast. Beenmerg waaruit tevoren T lymfocy-
ten waren verwijderd bleek in het lange termijn systeem onder invloed van 
stromale componenten kloneerbare voorloper cellen van de T reeks te genere-
ren. Deze voorlopers, aangeduid als TL-CFU I, missen kenmerken van T lymfo-
cyten (te weten het vermogen E rozetten te vormen en de expressie van T3 
antigenen), maar vormden onder invloed van PHA en IL2 kolonies van T lymfo-
cyten van voornamelijk het TJ+ T4+ immunofenotype. Aanvullende experimenten 
in deze richting (oak met betrekking tot de B eel differentiatie reeks) 
dienen een basis te vormen voor een vergelijking van de groeieigenschappen 
van lymfatische leukemiecellen en analoge normale celtypen. 
In HOOFDSTUK NEGEN, tenslotte, wordt een kart overzicht gegeven van 
onze huidige inzichten inzake de rol van IL2 bij de groei van neoplastische 
T- en 8-cellen. Tevens worden in dit hoofdstuk de resultaten van dit proef-
schrift besproken in het licht van de hypothese dat in leukemie de regule-
ring van de proliferatie en differentiatie door externe stimuli gestoord 
ken zijn. 
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